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Abstract: Pluripotency is defined as the capacity at the single cell level to initiate the formation of all
lineages of the mature organism in response to the signals from the embryo or cell culture environment.
Studying pluripotency is the foundation of mammalian development and embryonic stem cell (ESC)
biology. However, how pluripotency can be captured and maintained still remains an intriguing question
with many practical implications. ESCs can be derived and propagated from both mouse and rat strains.
The rat has long been an essential model of human health and disease and is traditionally preferred
over mice in many areas of the biomedical research. However, mouse models have gained popularity
over rats as a preferred model due to the inability to genetically manipulate the rat genome in the
sophisticated manner as in the mouse. Derivation of germline- ‐ competent rat ESCs from a wide variety
of rat strains will pave the way to targeted genetic manipulation of the rat genome. Nevertheless, rat ESC
culture system is still in its earlier stages and deeper understanding of molecular mechanisms regulating
pluripotency in rat ESCs is essential. We devised to establish authentic Brown Norway rat ESCs. Brown
Norway rats are the most widely used strain in the biomedical research and have an edge over the other
strains due to the decoding of its genome sequence. In the rat project, Brown Norway ESCs were derived
using defined culture conditions and characterized for their pluripotency. The established ESCs expressed
the characteristic ESC markers and were able to induce teratoma formation. Due to technical difficulties
and host incompatibility issues, it was nevertheless not possible to generate germline competent ESCs.
Stabilization of pluripotency in ESCs is a key question in order to efficiently derive and cultivate these
cells. Recently, a new gene family (Preferentially expressed antigen in melanoma- ‐like, Pramel) was
identified, which might play an important role in maintenance of pluripotency in mouse and rat ESCs. In
a parallel project on mouse ESCs (mESCs), we aimed at understanding the molecular factors regulated
by Pramel7, a member of this family. Pramel7 is a novel factor involved in maintenance of pluripotency
in mESCs, which is regulated through LIF/STAT3 pathway. LIF regulates transcription of Pramel7 via
STAT3. In vivo, Pramel7 is expressed in the pluripotent cells of the morula and blastocyst. Knockdown of
Pramel7 induces differentiation of mESCs whereas the overexpression maintains them pluripotent even in
the absence of LIF. Transcription of Pramel7 is reported to be blocked in the presence of GSK3￿ inhibitor.
GSK3￿ is an important player in three different signalling pathways, PI3K/Akt, Shp2/MAPK and Wnt/
￿- ‐catenin pathway, all of which are known to play key roles in the self- ‐renewal and differentiation of
pluripotent ESCs. To deeper understand the link between GSK3￿ /￿- ‐catenin and Pramel7 in ESCs,
genetic and biochemical examination of ESCs cultured in defined conditions was carried out. Analysis of
intracellular signalling pathways along with the genetic mutants of the target genes, ￿- ‐catenin and GSK3￿
sheds light on the circuitry involved. Initially, the question whether there is a link between ￿- ‐catenin and
Pramel7 was addressed. We observed
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“Learn from yesterday, live for today, hope for tomorrow. The important thing is to not stop 
questioning.”  
 
― Albert Einstein, Relativity: The Special and the General Theory 	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Abstract	  Pluripotency	  is	  defined	  as	  the	  capacity	  at	  the	  single	  cell	  level	  to	  initiate	  the	  formation	  of	  all	   lineages	  of	   the	  mature	  organism	  in	  response	  to	   the	  signals	   from	  the	  embryo	  or	  cell	  culture	   environment.	   Studying	   pluripotency	   is	   the	   foundation	   of	   mammalian	  development	  and	  embryonic	  stem	  cell	  (ESC)	  biology.	  However,	  how	  pluripotency	  can	  be	  captured	   and	   maintained	   still	   remains	   an	   intriguing	   question	   with	   many	   practical	  implications.	  	  ESCs	  can	  be	  derived	  and	  propagated	  from	  both	  mouse	  and	  rat	  strains.	  The	  rat	  has	  long	  been	  an	  essential	  model	  of	  human	  health	  and	  disease	  and	  is	  traditionally	  preferred	  over	  mice	   in	  many	   areas	   of	   the	   biomedical	   research.	   However,	  mouse	  models	   have	   gained	  popularity	  over	  rats	  as	  a	  preferred	  model	  due	  to	  the	  inability	  to	  genetically	  manipulate	  the	   rat	   genome	   in	   the	   sophisticated	  manner	   as	   in	   the	  mouse.	   Derivation	   of	   germline-­‐competent	   rat	   ESCs	   from	   a	   wide	   variety	   of	   rat	   strains	   will	   pave	   the	   way	   to	   targeted	  genetic	  manipulation	  of	  the	  rat	  genome.	  Nevertheless,	  rat	  ESC	  culture	  system	  is	  still	   in	  its	   earlier	   stages	   and	   deeper	   understanding	   of	   molecular	   mechanisms	   regulating	  pluripotency	  in	  rat	  ESCs	  is	  essential.	  	  We	  devised	  to	  establish	  authentic	  Brown	  Norway	  rat	  ESCs.	  Brown	  Norway	  rats	  are	  the	  most	  widely	   used	   strain	   in	   the	   biomedical	   research	   and	   have	   an	   edge	   over	   the	   other	  strains	  due	   to	   the	  decoding	  of	   its	  genome	  sequence.	   In	   the	  rat	  project,	  Brown	  Norway	  ESCs	   were	   derived	   using	   defined	   culture	   conditions	   and	   characterized	   for	   their	  pluripotency.	  The	  established	  ESCs	  expressed	  the	  characteristic	  ESC	  markers	  and	  were	  able	  to	  induce	  teratoma	  formation.	  Due	  to	  technical	  difficulties	  and	  host	  incompatibility	  issues,	   it	   was	   nevertheless	   not	   possible	   to	   generate	   germline	   competent	   ESCs.	  Stabilization	  of	  pluripotency	  in	  ESCs	  is	  a	  key	  question	  in	  order	  to	  efficiently	  derive	  and	  cultivate	   these	   cells.	   Recently,	   a	   new	   gene	   family	   (Preferentially	   expressed	   antigen	   in	  melanoma-­‐like,	   Pramel)	   was	   identified,	   which	   might	   play	   an	   important	   role	   in	  maintenance	  of	  pluripotency	  in	  mouse	  and	  rat	  ESCs.	  In	  a	  parallel	  project	  on	  mouse	  ESCs	  (mESCs),	   we	   aimed	   at	   understanding	   the	   molecular	   factors	   regulated	   by	   Pramel7,	   a	  member	   of	   this	   family.	   Pramel7	   is	   a	   novel	   factor	   involved	   in	   maintenance	   of	  pluripotency	   in	  mESCs,	  which	   is	   regulated	   through	  LIF/STAT3	  pathway.	   LIF	   regulates	  transcription	  of	  Pramel7	  via	  STAT3.	  In	  vivo,	  Pramel7	  is	  expressed	  in	  the	  pluripotent	  cells	  of	   the	  morula	  and	  blastocyst.	  Knockdown	  of	  Pramel7	   induces	  differentiation	  of	  mESCs	  whereas	   the	   overexpression	   maintains	   them	   pluripotent	   even	   in	   the	   absence	   of	   LIF.	  Transcription	  of	  Pramel7	   is	  reported	  to	  be	  blocked	  in	  the	  presence	  of	  GSK3β	  inhibitor.	  GSK3β	   is	   an	   important	   player	   in	   three	   different	   signalling	   pathways,	   PI3K/Akt,	  Shp2/MAPK	  and	  Wnt/	  β-­‐catenin	  pathway,	  all	  of	  which	  are	  known	  to	  play	  key	  roles	  in	  the	  self-­‐renewal	  and	  differentiation	  of	  pluripotent	  ESCs.	  	  To	  deeper	  understand	  the	  link	  between	  GSK3β	  /β-­‐catenin	  and	  Pramel7	  in	  ESCs,	  genetic	  and	   biochemical	   examination	   of	   ESCs	   cultured	   in	   defined	   conditions	   was	   carried	   out.	  Analysis	  of	  intracellular	  signalling	  pathways	  along	  with	  the	  genetic	  mutants	  of	  the	  target	  genes,	  β-­‐catenin	  and	  GSK3β	  sheds	  light	  on	  the	  circuitry	  involved.	  Initially,	  the	  question	  whether	   there	   is	   a	   link	   between	   β-­‐catenin	   and	   Pramel7	  was	   addressed.	  We	   observed	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that	   Pramel7	   was	   upregulated	   in	   β-­‐catenin	   KO	   ESCs.	   Signalling	   mutants	   of	   β-­‐catenin	  were	   derived	   and	   further	   experiments	   on	   these	   mutants	   did	   not	   indicate	   a	   direct	  involvement	   of	   β-­‐catenin	   in	   Pramel7	   transcription.	   In	   the	   next	   step,	   effect	   of	   various	  GSK3β	   mutations	   on	   Pramel7	   transcription	   was	   analysed.	   It	   was	   observed	   that	  knockdown	   of	   GSK3β	   using	   siRNA	   technology	   resulted	   in	   abrogation	   of	   Pramel7	  transcription.	   However,	   kinase	   function	   of	   GSK3β	   alone	   did	   not	   modulate	   Pramel7	  expression.	  Further	  experiments	  revealed	  that	  blocking	  activation	  of	  ERK,	  downstream	  of	  FGF4,	   in	  presence	  of	  GSK3β	  upregulated	  Pramel7.	  We	  propose	   that	  derepression	  of	  GSK3β	   along	   with	   the	   inhibition	   of	   ERK	   leads	   to	   the	   repression	   of	   a	   transcriptional	  repressor	  of	  Pramel7.	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Zusammenfassung	  Der	  Begriff	  der	  Pluripotenz	  wird	  definiert	  als	  die	  Fähigkeit	  einer	  Zelle,	  auf	  ein	  Signal	  von	  Embryo	  oder	  Zellkulturumgebung	  hin	  die	  Formation	  aller	  drei	  Keimblätter	  eines	  reifen	  Organismus	   zu	   bilden.	   Die	   Erforschung	   der	   Pluripotenz	   stellt	   somit	   eine	   Basis	   in	   der	  Biologie	  der	  Säugetierentwicklung,	  aber	  auch	   in	  der	  embryonalen	  Stammzellforschung	  dar.	   Trotzdem	   sind	   Fragen,	   etwa	   wie	   der	   Zustand	   der	   Pluripotenz	   stabilisiert	   und	  beibehalten	   werden	   kann,	   immer	   noch	   nicht	   vollumfänglich	   geklärt	   und	   bergen	   auch	  viele	  praktische	  Herausforderungen.	  Embryonale	  Stammzellen	  (ESCs)	  können	  von	  den	  beiden	  Modellorganismen	  Maus	  und	  Ratte	   erzeugt	   und	   erhalten	   werden.	   Dabei	   ist	   die	   Ratte	   schon	   lange	   als	   Modell	   zur	  Erforschung	  humaner	  Erkrankungen	  bekannt	  und	  wird	  der	  Maus	  traditionellerweise	  in	  vielen	   Bereichen	   der	   biomedizinischen	   Forschung	   vorgezogen.	   Dennoch	   hat	   die	  Popularität	   von	   Mausmodellen	   in	   den	   letzten	   Jahren	   stark	   zugenommen.	   Der	  Hauptgrund	  dafür	  liegt	  darin,	  dass	  im	  Bereich	  	  ausgereifter	  genetischer	  Manipulationen	  das	   Rattengenom	   demjenigen	   der	   Maus	   weit	   hinterherhinkt.	   Um	   diese	   Lücke	   zu	  schliessen	   müssen	   keimbahnkompetente	   ESCs	   der	   Ratte	   (rESCs)	   von	   vielen	  verschiedenen	   Stämmen	   erzeugt	   werden.	   Dies	   erlaubt	   in	   einem	   nächsten	   Schritt	   eine	  gezielte	   genetische	  Mutagenese	   des	  Rattengenoms.	  Da	   aber	   auch	  die	  Kultivierung	   von	  rESCs	  immer	  noch	  in	  ihren	  Anfängen	  steht,	  ist	  es	  unumgänglich,	  Verständnis	  und	  Wissen	  über	   die	   Erhaltung	   der	   Pluripotenz	   von	   rESCs	   zu	   erweitern.	   In	   der	   biomedizinischen	  Forschung	   werden	   grundsätzlich	   Ratten	   des	   Brown	   Norway-­‐Stamms	   verwendet,	   da	  deren	  Genom	  schon	  komplett	  sequenziert	  und	  decodiert	  worden	  ist.	   In	  diesem	  Projekt	  wurde	   nun	   geplant,	   authentische	   rESCs	   dieses	   Stamms	   zu	   etablieren.	   In	   einem	   ersten	  Schritt	   wurden	   dazu	   Brown	   Norway-­‐rESCs	   unter	   definierten	   Kulturbedingen	   erzeugt	  und	   anschliessend	   auf	   deren	   Pluripotenz	   getestet	   und	   charakterisiert.	   Die	   rESCs	  exprimierten	  die	  charakteristischen	  Pluripotenzmarker	  und	  zeigten	  die	  Fähigkeit,	  nach	  Injektion	   in	   immunsupprimierte	   Mäuse,	   Teratomas	   auszubilden.	   Wegen	   technischer	  Schwierigkeiten	  und	  Inkompatibilität	  der	  Stämme	  von	  rESCs	  und	  Ammenmutter	  war	  es	  jedoch	  nicht	  möglich,	  keimbahnkompetente	  rESCs	  zu	  generieren.	  Eines	  der	  grössten	  Hindernisse	  zur	  effizienten	  Erzeugung	  und	  Kultivierung	  von	  ESCs	  ist	  die	   Stabilisierung	   ihrer	   Pluripotenz.	   Neulich	  wurde	   die	   neue	   Familie	   der	  Pramel-­‐Gene	  (Preferentially	  expressed	  antigen	  in	  melanoma-­‐like)	  identifiziert,	  deren	  Mitglieder	  eine	  wichtige	   Rolle	   in	   der	   Pluripotenzerhaltung	   von	   ESCs	   von	  Maus	   und	   der	   Ratte	   spielen	  könnten.	   Deshalb	   zielten	   wir	   in	   einem	   Parallelprojekt	   darauf	   ab,	   die	   molekularen	  Faktoren	   zu	   identifizieren,	   welche	   von	   Pramel7,	   einem	   Mitglied	   der	   Pramel-­‐Familie,	  reguliert	  werden.	   Pramel7	  wurde	   vor	  Kurzem	  als	   ein	   in	   die	   Pluripotenzerhaltung	   von	  murinen	  ESCs	  (mESCs)	  involvierter	  Faktor	  identifiziert,	  welcher	  durch	  den	  LIF/STAT3-­‐Signalweg	  gesteuert	  wird,	  wobei	  LIF	  (Leukemia	  inhibitory	  factor)	  die	  Transkription	  von	  
Pramel7	  via	  STAT3	  reguliert.	  In	  vivo	  ist	  Pramel7	  in	  pluripotenten	  Zellen	  von	  Morula	  und	  Blastozyste	   exprimiert.	   In	   vitro	   induziert	   ein	   Knockdown	   von	   Pramel7	   die	  Differenzierung	   von	   mESCs,	   während	   dessen	   Überexpression	   die	   Zellen	   in	   einem	  pluripotenten	  Zustand	  zu	  halten	  vermag,	  auch	  in	  Absenz	  von	  LIF.	  Zudem	  wurde	  gezeigt,	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dass	   die	   Anwesenheit	   eines	   Inhibitors	   für	   GSK3β	   die	   Transkription	   von	   Pramel7	  inhibiert.	   GSK3β	   seinerseits	   hat	   wichtige	   Rollen	   in	   drei	   verschiedenen	   Signalwegen,	  nämlich	   in	  der	  PI3K/Akt-­‐,	   der	   Shp2/MAPK-­‐	  und	  der	  Wnt/β-­‐catenin-­‐Kaskade.	  Alle	  drei	  Signalwege	  werden	  unter	  anderem	  auch	  mit	  Selbsterneuerung	  und	  Differenzierung	  von	  pluripotenten	  mESCs	  in	  Verbindung	  gebracht.	  Um	   etwaige	   Zusammenhänge	   zwischen	   GSK3β/β-­‐catenin	   und	   Pramel7	   zu	   erörtern,	  wurden	   mESCs,	   kultiviert	   unter	   definierten	   Bedingungen,	   genetisch	   und	   biochemisch	  untersucht.	  Eine	  Analyse	  der	  intrazellulären	  Signalwege	  mit	  Hilfe	  genetischer	  Mutanten	  der	  beiden	  Zielgene	  β-­‐catenin	  und	  GSK3β	  sollte	  dabei	  helfen,	  mögliche	  Interaktionen	  und	  Zusammenhänge	   ans	   Licht	   zu	   bringen.	   Anfänglich	   wurde	   die	   Frage	   gestellt,	   ob	   eine	  Verbindung	   zwischen	  β-­‐catenin	  und	  Pramel7	   existiert,	   da	   in	  β-­‐catenin-­‐KO	  mESCs	   eine	  Hochregulierung	  von	  Pramel7	   festgestellt	  werden	  konnte.	  Für	  weitere	  Untersuchungen	  wurden	   als	   nächstes	   Signalmutanten	   von	   β-­‐catenin	   erzeugt;	   weitere	   Experimente	  mit	  ihnen	   zeigten	   aber	   keinen	   direkten	   Einfluss	   von	   β-­‐catenin	   auf	   die	   Transkription	   von	  
Pramel7.	   In	   einem	   nächsten	   Schritt	   wurde	   getestet,	   ob	   verschiedene	   Mutationen	   von	  GSK3β	  einen	  Effekt	  auf	  die	  transkriptionelle	  Aktivität	  von	  Pramel7	  zur	  Folge	  haben.	  Hier	  kam	   zum	   Vorschein	   dass	   ein	   Knockdown	   von	   GSK3β	   durch	   siRNA	   die	   Aktivität	   von	  
Pramel7	  zum	  Erliegen	  brachte.	  Es	  ist	  aber	  zu	  erwähnen,	  dass	  die	  GSK3β-­‐Kinasefunktion	  allein	   die	   Expression	   von	   Pramel7	   nicht	   zu	   ändern	   vermochte.	   Aus	   weiteren	  Experimenten	   konnte	   dann	   gezeigt	   werden,	   dass	   in	   Anwesenheit	   von	   GSK3β	   eine	  Blockierung	  von	  ERK,	  downstream	  von	  FGF4,	  Pramel7	  hochregulierte.	  Daraus	  schliessen	  wir,	  dass	  eine	  Derepression	  von	  GSK3β	  einhergehend	  mit	  einer	  Inhibierung	  von	  ERK	  zu	  einer	  Unterdrückung	  eines	  transkriptionellen	  Repressors	  von	  Pramel7	  führt.	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Outline	  The	  thesis	  mainly	  comprises	  of	  two	  projects.	  Below	  is	  an	  outline	  of	  the	  framework	  of	  the	  thesis.	  	  First	  part	  of	  the	  introduction	  begins	  with	  a	  generalised	  summary	  of	  stem	  cells	  and	  their	  applications	  followed	  by	  defining	  the	  term	  “pluripotency”.	  The	  next	  two	  chapters	  focus	  on	   the	   importance	   of	   rat	   in	   biomedical	   research	   and	   describe	   the	   different	   gene	  targeting	  methodologies	  developed	  over	  the	  past	  years.	  The	  last	  part	  of	  the	  introduction	  gives	  a	  broad	  overview	  on	  the	  embryo-­‐derived	  stem	  cells	  from	  the	  mouse,	  the	  intrinsic	  factors	  and	  the	  different	  extracellular	  signaling	  pathways	  involved	  in	  the	  maintenance	  of	  pluripotency.	   This	   is	   followed	   by	   the	   detailed	   description	   about	   Pramel7,	   the	   gene	   of	  interest	  for	  this	  project.	  The	  introduction	  is	  concluded	  by	  stating	  the	  goal	  of	  the	  thesis.	  The	  results	  section	  is	  split	  into	  two	  parts	  representing	  the	  two	  projects.	  In	  the	  first	  part,	  the	  results	  for	  the	  rat	  project	  are	  described.	  Regarding	  the	  rat	  project,	  establishment	  and	  characterization	   of	   the	   rat	   embryonic	   stem	   cells	   is	   presented.	   The	   second	   part	   of	   the	  results	  section	  describes	  the	  different	  molecular	  mechanisms	  involved	  in	  regulating	  the	  expression	  of	  Pramel7	  at	  the	  transcriptional	  level.	  The	  initial	  paper,	  which	  created	  the	  groundwork	  for	  the	  second	  project	  has	  been	  listed	  at	  the	  end	  of	  the	  thesis	  as	  Annex.	  The	  discussion	  chapter	   follows	  the	  structure	  of	   the	  results	  sections	  and	  is	  divided	  into	  two	   parts.	   In	   regard	   to	   the	   first	   project,	   the	   technical	   and	   the	   scientific	   issues	   faced	  during	  the	  establishment	  and	  characterization	  of	  rat	  embryonic	  stem	  cells	  are	  discussed.	  Concerning	   the	   second	   project,	   the	   findings	   relevant	   to	   the	   mechanisms	   controlling	  Pramel7	   transcription	   via	   different	   pathways	   involving	   GSK3β	   are	   reviewed	   and	   a	  hypothetical	   model	   representing	   the	   regulation	   of	   Pramel7	   transcription	   has	   been	  demonstrated.	  	  Finally,	   on	   the	   basis	   of	   the	   findings	   in	   the	   thesis,	   general	   conclusions	   are	   drawn	   and	  different	  experimental	  approaches	  are	  proposed	   that	  can	  be	  used	   to	  develop	  a	  clearer	  understanding	  of	  molecular	  mechanisms	  regulating	  pluripotency	  in	  both	  rat	  and	  mouse	  embryonic	  stem	  cells.	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A.	  Introduction	  
1. Stem	  cells	  and	  their	  applications	  Stem	  cells	  are	  specialized	  cells	  present	  in	  the	  multicellular	  organisms,	  which	  replace	  the	  existing	   injured,	   damaged	   or	   terminally	   differentiated	   cells	   thus	   maintaining	   tissue	  homeostasis.	  They	  are	  defined	  by	  their	  ability	  to	  self-­‐renew	  and	  undergo	  differentiation.	  Self-­‐renewal	  is	  a	  property	  of	  the	  cell	  to	  divide	  into	  two	  daughter	  cells	  where	  either	  one	  or	  both	  daughter	  cells	  are	   identical	   to	  the	  pre-­‐existing	  one	   i.e.	  one	  remains	  a	  stem	  cell	  and	   other	   may	   differentiate	   into	   a	   specialized	   cell	   type.	   Differentiation,	   on	   the	   other	  hand,	  means	   the	   transition	   of	   a	   stem	   cell	   into	   a	  more	   specialized	   cell	   type	   losing	   the	  ability	   to	  multiply	   itself	  and	   thus	  self-­‐renew	  (Smith,	  2001).	  They	  can	  be	  classified	   into	  totipotent,	   pluripotent,	   multipotent	   and	   unipotent	   based	   on	   their	   developmental	  potential	  as	  shown	  in	  Table	  1.	  	  
Table	  1:	  Definition	  of	  developmental	  options	  accessible	  to	  the	  cells	  Totipotent	   Form	  all	  the	  tissues	  of	  the	  organism	  including	  extraembryonic	  tissue	   Zygote	  and	  early	  blastomeres	  of	  the	  mammalian	  embryo	  Pluripotent	   Can	  differentiate	  into	  all	  3	  germ	  layers	  of	  an	  organism	   Embryonic	  stem	  cells	  
Multipotent	   Can	  differentiate	  into	  all	  cell	  types	  of	  a	  specific	  lineage	   Adult	  stem	  cells	  like	  haematopoietic	  stem	  cells	  Unipotent	   Can	  differentiate	  into	  cells	  of	  one	  type	   Spermatogonial	  stem	  cells	  	  These	   properties	   make	   them	   a	   very	   important	   tool	   for	   not	   only	   understanding	   the	  developmental	  processes	  but	  also	  developing	  stem	  cell	  based	  therapies	  for	  regenerative	  medicine.	  These	  attributes	  expand	   the	  horizon	  of	   studying	  mammalian	  embryogenesis	  and	  early	  differentiation	  processes	  in	  vitro,	  allow	  gene	  manipulation	  to	  study	  the	  role	  of	  specific	   genes,	   make	   them	   an	   important	   player	   in	   pharmaceutical	   field	   for	   drug	  development	  and	  toxicological	  testing.	  Most	  importantly,	  indefinitely	  renewable	  supply	  of	   cells	   makes	   them	   a	   possible	   source	   to	   treat	   huge	   spectrum	   of	   human	   ailments	  spanning	   neurodegenerative	   disorders	   (Brüstle	   et	   al.,	   1999),	   diabetes	   (Melton,	   2011)	  and	  myocardial	   infarction	  (Miyahara	  et	  al.,	  2006).	  However,	   it	   is	  a	   long	  way	  off	  before	  this	  becomes	  a	  reality.	  There	  are	  many	  potholes	  that	  need	  to	  be	  filled	  in	  order	  to	  reach	  this	   goal.	   A	   major	   problem	   lies	   in	   the	   tumor	   formation	   from	   undifferentiated	   or	  inefficiently	  differentiated	  stem	  cells	  after	  expansion	  in	  vitro,	  which	  may	  be	  overcome	  by	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applying	   appropriate	  methods	   to	   eliminate	   any	   such	   cells.	   Another	   question	   that	   still	  needs	   to	  be	   addressed	   is	  whether	   these	   stem	  cell	   derived	  differentiated	   cell	   types	   are	  fully	  functional	  after	  the	  transplantation,	  which	  prompts	  us	  towards	  establishing	  better	  models	  for	  transplantation.	  The	  biggest	  hurdle	  in	  cell	  replacement	  therapy	  still	  remains	  the	  immunological	  rejection,	  which	  may	  be	  obviated	  through	  reprogramming	  adult	  cells	  obtained	   directly	   from	   the	   patient	   (Takahashi	   and	   Yamanaka,	   2006).	   However,	   the	  prerequisite	   for	   overcoming	   these	   problems	   lies	   in	   the	   thorough	   and	   deeper	  understanding	  of	  molecular	  mechanisms	  regulating	  pluripotency	  of	  stem	  cells.	  Stem	  cells	  are	  broadly	  categorized	  into	  adult,	  embryo-­‐derived	  and	  induced	  pluripotent	  stem	  cells,	  which	  will	  be	  discussed	  later.	  Phenomenon	  of	  pluripotency	  and	  self-­‐renewal	  is	  discussed	  below.	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2. Pluripotency	  and	  Self-­‐renewal	  Pluripotency	  is	  defined	  as	  the	  ability	  of	  a	  cell	  to	  give	  rise	  to	  all	  cell	  types	  of	  an	  embryo	  and	  adult.	   It	   is	   a	  property	   that	   is	  possessed	  by	  ESCs.	  The	  pluripotency	  of	  ESCs	   can	  be	  determined	  through	  both	  in	  vivo	  and	  in	  vitro	  differentiation.	  In	  vitro	  differentiation	  can	  be	   achieved	   by	   formation	   of	   embryoid	   bodies	   (EBs)	   from	   the	   ESCs.	   They	   are	   formed	  when	  ESCs	  are	  grown	  either	  by	  drops	  hanging	  from	  the	  lid	  or	  by	  culturing	  them	  on	  non-­‐adherent	  dishes.	  ESCs	  then	  aggregate	  and	  differentiate	  into	  derivatives	  of	  all	  three	  germ	  layers	  (Martin	  and	  Evans,	  1975).	  Another	  test	  is	  through	  in	  vivo	  differentiation	  in	  which	  ESCs	  are	  either	  injected	  in	  the	  kidney	  capsules,	  testis	  or	  subcutaneously	  into	  the	  skin	  of	  an	  immune-­‐deficient	  mouse	  to	  check	  for	  the	  formation	  of	  teratomas	  consisting	  of	  tissues	  from	   all	   the	   three	   germ	   layers	   (Martin,	   1981).	   However,	   the	   most	   stringent	   test	   of	  pluripotency	  is	  generation	  of	  chimeras	  and	  germline	  transmission.	  This	  is	  done	  by	  either	  aggregating	   ESCs	   with	   morula	   or	   by	   injecting	   ESCs	   into	   the	   blastocoel	   of	   the	   host	  blastocyst	  embryo.	  The	  pluripotent	  ESCs	  should	   then	   integrate	  with	   the	  cells	   from	  the	  host	   embryo	   and	   contribute	   to	   the	   formation	   of	   tissues	   from	   the	   three	   germ	   layers	  including	  germ	  cells	  to	  produce	  chimeras,	  which	  are	  capable	  of	  generating	  offsprings	  in	  order	  to	  show	  germline	  transmission	  (Bradley	  et	  al.,	  1984).	  	  	  
Table	  2:	  Commonly	  used	  functional	  criteria	  to	  assess	  pluripotency	  Assay	   Experimental	  approach	  
In	  vitro	  differentiation	   Differentiation	   induced	   cells	   are	   assayed	   for	   expression	   of	   various	   lineage	  markers	  	  Teratoma	  formation	   Formation	   of	   tumours	   demonstrating	   the	   potential	   to	   form	   cell	   types	   of	   all	  three	  lineages	  Chimera	  formation	   Contribution	  of	  cells	  to	  normal	  development	  Germline	  transmission	   Capability	  of	  the	  cells	  to	  develop	  functional	  gametes/germ	  cells	  	  As	  mentioned	  previously,	   self-­‐renewal	   is	   the	   division	   of	   a	   cell	   into	   two	  daughter	   cells	  where	   at	   least	   one	   is	   identical	   to	   the	   parent	   cell.	   ESCs	   possess	   both	   the	   properties	   of	  proliferating	   indefinitely	   and	   differentiating	   into	   all	   cell	   types	   (Smith,	   2001).	  Maintenance	   of	   self-­‐renewal	   and	   pluripotency	   depends	   on	   intrinsic	   determinants	   and	  extrinsic	   signalling	   (Chambers	   and	   Smith,	   2004).	   Intrinsic	   factors	   are	   present	   in	   the	  pluripotent	   cells	   of	   an	   embryo	  where	   they	   regulate	   various	   developmental	   processes.	  However,	  extracellular	  signalling	  promoting	  self-­‐renewal	  of	  ESCs	  in	  culture	  may	  be	  an	  in	  
vitro	   phenomenon.	   This	   is	   probably	   because	   it	   is	   essential	   to	   provide	   nutrients	   for	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proliferation	   of	   ESCs	   and	   inhibit	   ESCs	   from	   their	   natural	   tendency	   to	   differentiate	   in	  culture	   conditions.	   Thus,	   it	   is	   debatable	  whether	   the	   extracellular	   signalling	   performs	  the	  same	  function	  in	  vivo.	  	  Both	   the	   various	   pluripotent	   cell	   types	   and	   the	   intrinsic	   and	   the	   extrinsic	   factors	  regulating	  self-­‐renewal	  in	  ESCs	  have	  been	  discussed	  in	  the	  chapters	  5,	  6	  and	  7.	  	   	  
Introduction	   	   5	  
3. Using	  the	  rat	  in	  biomedical	  research	  The	  laboratory	  rat,	  Rattus	  Norwegicus,	  was	  the	  first	  mammalian	  species	  to	  be	  used	  in	  the	  biomedical	  research.	  The	  first	  publication	  that	  used	  rat	  as	  an	  animal	  model	  dates	  back	  to	  1856	   where,	   French	   physician	   J.	   M.	   Philipeaux	   studied	   function	   of	   adrenal	   glands	   in	  albino	  rats	  (Philipeaux,	  1856).	  Over	  the	  next	  150	  years,	  the	  rat	  became	  an	  ideal	  animal	  model	   for	   research	   in	  psychology,	   physiology,	   toxicology,	   cardiology,	   immunology	   and	  neuroscience.	   More	   than	   800	   different	   inbred,	   mutant	   and	   congenic	   rat	   strains	   have	  been	  created	  to	  mimic	  various	  human	  diseases.	  Due	  to	   its	   larger	  size	   in	  comparison	  to	  the	  mouse,	  a	  variety	  of	  procedures	   including	   in	  vivo	   imaging,	  surgery,	  cannulation	  and	  sampling	  of	   cerebrospinal	   fluid	  are	  easier	   to	  perform.	  Rat	   is	   the	  preferred	  model	  over	  mouse	   in	   retinal	   degeneration	   rescue	   studies	   as	   it	   is	   easier	   to	   carry	   out	  electroretinograms	   analysis	   in	   them	   (Vasireddy	   et	   al.,	   2011).	   Rats	   are	   also	  physiologically	  more	  similar	   to	  humans	  and	  provide	  an	  accurate	   representation	  of	   the	  phenotype	  for	  inflammatory	  disorders	  and	  neurodegenerative	  disorders	  in	  comparison	  to	  mice.	   In	  Huntington’s	   disease	   studies,	   the	   death	   of	   striatal	   neurons	   is	   linked	   to	   the	  abnormal	   expansion	   of	   CAG	   repeat	   length	   in	   the	  Huntingtin	  gene.	   Rat	  models	   used	   to	  study	  this	  disease	  recapitulate	  the	  damage	  in	  the	  striatum	  with	  the	  similar	  CAG	  repeats	  as	   in	   the	   human	  mutation	   (von	  Horsten	   et	   al.,	   2003)	  where	   as	  mouse	  models	   require	  much	   longer	   repeats	   to	  mimic	   the	  human	  phenotype.	   In	  Parkinson’s	  disease	   research,	  overexpression	  of	  alpha-­‐synuclein	   in	   substantia	  nigra	  of	   rat	  models	   resulted	   in	   loss	  of	  dopaminergic	   neurons	   unlike	   the	  mice	   (Lo	  Bianco	   et	   al.,	   2004)	   (Yamada	   et	   al.,	   2004).	  Thus,	  there	  are	  several	  rat	  models	  that	  overcome	  the	  limitations	  of	  the	  mouse	  model	  to	  recapitulate	   the	   human	   diseases.	   They	   are	   more	   social	   and	   able	   to	   perform	   complex	  learning	   and	  memory	   tasks,	   which	   also	  make	   them	   an	   attractive	   tool	   in	   the	   study	   of	  learning,	  memory,	  cognitive,	  and	  motivational	  processes.	  	  Despite	  the	  many	  advantages	  of	  rat	  over	  mouse	  models,	  mouse	  is	  still	  the	  predominant	  mammal	   in	  the	  experimental	  research.	  This	   is	  due	  to	  the	   longstanding	  existence	  of	  the	  core	   technologies	   for	   genetic	   modifications	   in	   mice	   for	   the	   past	   30	   years.	   Recently,	  different	   strategies	  have	  been	  developed	   to	  manipulate	   the	   rat	   genome	  and	   these	  will	  significantly	  enhance	  the	  rat	  genomic	  toolbox	  and	  enable	  the	  growth	  in	  genetic	  research	  using	  rats.	  The	  different	  gene	  targeting	  technologies	  have	  been	  outlined	  below.	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4. Development	  of	  rat	  genetics	  The	  predominance	  of	   the	  rat	   in	  scientific	  research	  is	  second	  only	  to	  humans	  and	  there	  are	   more	   scientific	   publications	   using	   rat	   models	   in	   comparison	   to	   any	   other	   model	  system	  according	  to	  Pubmed	  searches.	  Thus,	  establishment	  of	  different	  genetic	  tools	  to	  manipulate	   the	   rat	   genome	   are	   quintessential	   to	   further	   studies	   on	   various	   human	  diseases.	   In	   the	   preceding	   years,	   various	   different	   strategies	   using	   transgenics,	   siRNA	  knockdown	  and	  ethyl-­‐nitrosyl	  urea	  (ENU)	  methodologies	  have	  been	  employed.	  
4.1. Mutagenesis	  via	  sperm	  manipulation	  One	  prospective	  access	  point	  to	  manipulate	  the	  rat	  genome	  is	  the	  male	  gamete.	  One	  of	  the	   successful	   approaches	   applied	   in	   this	   context	   is	   the	   ENU	  mutagenesis.	   ENU	   is	   an	  alkylating	  agent	   that	   introduces	   single	  base	  pair	   substitutions	   to	   induce	   random	  point	  mutations	   (Cordes,	   2005).	   It	   is	   estimated	   to	   create	   a	   functional	   mutation	   every	   100	  alleles,	  with	  1	   in	  every	  1000,	  resulting	   in	  a	  phenotype	  (Augustin	  et	  al.,	  2005).	  Zan	  and	  colleagues	   generated	   the	   first	   knockout	   rat	   in	   2003	   by	   applying	   ENU	   chemical	  mutagenesis	  on	  gonads	  of	  male	  rats.	  ENU	  targeted	  the	  spermatogonial	  stem	  cells	  (SSCs).	  Mutagenized	  male	  rats	  of	  two	  inbred	  and	  an	  outbred	  strain	  produced	  F1	  offsprings	  with	  mutations	   in	   breast	   cancer	   suppressor	   genes,	   Brca1	   and	   Brca2	   (Zan	   et	   al.,	   2003).	  Mutagenesis	   in	   rats	   using	   ENU	   can	   be	   utilized	   in	   a	   large-­‐scale	   forward	   genetic	   screen	  where	  a	  large	  number	  of	  F1	  animals	  can	  be	  generated	  by	  breeding	  the	  treated	  male	  rats	  with	  wild	  type	  female	  ones	  and	  screening	  them	  for	  desired	  phenotypes	  to	  identify	  gene	  mutations.	  It	  is	  a	  technically	  simple	  methodology	  to	  generate	  novel	  rat	  models	  and	  does	  not	  require	  any	  advanced	  genetic	  manipulations	  in	  oocytes	  or	  embryos	  and	  has	  the	  great	  advantage	  of	  automatic	  transmission	  of	  functional	  mutation	  through	  the	  germ	  line	  to	  the	  next	  generation.	  However,	  there	  are	  several	  limitations	  to	  this	  approach	  as	  well.	  First,	  it	  is	  very	  difficult	  to	  do	  genetic	  manipulation	  by	  gene	  targeting,	  as	  the	  mutations	  induced	  by	   ENU	   are	   random.	   Second,	   efficiency	   of	  mutagenesis	   is	   dependent	   on	   the	   dosage	   of	  ENU	   in	   different	   rat	   strains	   of	   various	   genetic	   backgrounds	   (van	   Boxtel	   et	   al.,	   2010).	  Third,	  a	   large	  number	  of	  F1	  generation	  animals	  need	  to	  be	  maintained,	  to	  enable	  high-­‐throughput	   screening,	   which	   can	   be	   costly	   and	   time-­‐consuming.	   Lastly,	   the	   random	  point	   mutations	   induced	   by	   ENU	   occur	   throughout	   the	   whole	   genome,	   including	  unknown	   mutations	   in	   background	   producing	   different	   phenotypes.	   Hence,	   a	  methodology	   for	   targeting	   specific	   regions	   of	   genes	   would	   be	   a	   better	   approach	   to	  circumvent	  the	  above	  issues.	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4.2. Transposon-­‐mediated	  insertional	  mutagenesis	  Transposons	   are	  mobile	   genetic	   elements,	  which	   can	   change	   their	   position	  within	   the	  genome.	  They	  require	  the	  presence	  of	  an	  active	  transposase	  enzyme	  to	  jump	  from	  one	  gene	   to	   another.	   Transposon-­‐mediated	   gene-­‐trap	   insertional	   mutagenesis	   in	   rodent	  models	   came	   into	   effect	  with	   the	   discovery	   and	   development	   of	   Sleeping	   Beauty	   (SB)	  transposon	   system	   in	   rats	   (Takeda	   et	   al.,	   2007)	   (Mátés	   et	   al.,	   2009).	   It	   was	   initially	  developed	   for	   random	   saturation	   mutagenesis	   in	   mice	   and	   then	   implemented	   for	  insertional	  mutations	  in	  rats	  (Kitada	  et	  al.,	  2009).	  The	  strategy	  behind	  the	  technique	  is	  to	   cause	   a	   null	   mutation	   by	   random	   insertion	   of	   a	   gene-­‐trap	   transposon	   into	   a	   gene,	  disrupting	   the	   open	   reading	   frame	   of	   the	   gene,	   thus	   creating	   a	   transposon	   knockout	  mutation.	  Technically,	   it	   is	  performed	  by	  generating	  and	  breeding	   two	  transgenic	  rats,	  one	  carrying	  the	  gene-­‐trap	  transposon	  and	  the	  other	  expressing	  the	  transposase	  vector,	  to	  create	  the	  so-­‐called	  doubly	  transgenic	  “seed”	  male	  rats	  that	  carry	  both	  the	  elements.	  In	  the	  spermatogonia	  of	  these	  seed	  rats,	  the	  transposase	  catalyses	  the	  excision	  of	  one	  or	  more	  gene-­‐trap	   transposons	   from	   the	  donor	   sites	  and	   inserts	   it	   into	   the	  new	  genomic	  site.	  The	  male	  “seed	  “	  rats	  are	  then	  mated	  with	  the	  wild	  type	  female	  rats	  resulting	  in	  the	  F1	  generation	  containing	  only	  the	  insertion	  fragment	  which	  is	  caused	  by	  segregation	  of	  the	   insertion	   fragment	   from	   the	   transposase	   enzyme,	   thus	   immobilizing	   the	   inserted	  transposon	  (Jacob	  et	  al.,	  2010)	  (Huang	  et	  al.,	  2011).	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Figure	  1:	  Diagrammatic	  representation	  of	  transposon-­‐mediated	  mutagenesis	  a)	  The	  gene	  trap	  cassette	  consisting	  of	  the	  reporter	  gene	  and	  polyadenylation	  tail	  is	  inserted	  into	  an	  endogenous	  gene	  disrupting	   the	   normal	   splicing	   of	   the	   gene.	   The	   mRNA	   is	   then	   translated	   into	   a	   fusion	   protein.	   b)	   The	   gene	   trap	  cassette	   is	   cloned	   into	   a	   transposon	  vector.	  Transgenic	   rat	   for	   gene-­‐trap	   transposon	   is	   then	  bred	  with	   transposase	  harbouring	  transgenic	  rat	  to	  produce	  double	  transgenic	  rat	  “seed”	  male.	  In	  presense	  of	  transposase,	  transposons	  are	  mobilized	  and	  get	  inserted	  into	  genes	  in	  the	  developing	  spermatogonia.	  The	  seed	  males	  are	  later	  bred	  with	  wild	  type	  rats	  to	  generate	  G1	  offsprings	  and	  screened	  for	  the	  mutations.	  Taken	  from	  (Jacob	  et	  al.,	  2010)	  	  Various	   different	   techniques	   such	   as	   reporter	   gene	   expression	   or	   PCR	   of	   the	   gene-­‐trapping	  cassette	  followed	  by	  breeding	  to	  obtain	  offsprings	  with	  single	  insertional	  sites	  can	  be	  used	  to	   identify	  the	  transposon	  mutants	  (Kitada	  et	  al.,	  2009).	  Thus	  transposon-­‐mediated	   mutagenesis	   strategy	   can	   be	   used	   to	   generate	   various	   novel	   models.	   By	  introducing	   the	   transposase	  under	   the	   tissue	   specific	  promoter,	   one	   can	  also	  generate	  somatic	  mutations	   in	   the	   tissue	   of	   interest.	   This	   has	   been	   used	   to	   develop	   transgenic	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mice	   to	   screen	   for	   cancer	   genes	   and	   modifiers	   within	   a	   specific	   tissue	   (Largaespada,	  2009).	  
4.3. Zinc-­‐finger	  nucleases	  Zinc	   finger	   nucleases	   (ZFNs)	  were	   first	   implemented	   in	   2009	   to	   create	   knockout	   rats.	  The	   technique	   involved	   microinjecting	   mRNA	   or	   plasmid	   DNA	   encoding	   engineered	  ZFNs	  into	  the	  rat	  embryos	  (Geurts	  et	  al.,	  2009).	  ZFNs	  are	  artificially	  engineered	  proteins	  that	   combine	   multimeric	   zinc	   finger	   DNA-­‐binding	   domains	   together	   with	   restriction	  endonuclease	  FokI	  cleavage	  domain.	  Each	  zinc	  finger	  motif	  is	  capable	  of	  recognizing	  and	  binding	  to	  triplets	  of	  DNA	  sequence	  in	  a	  sequence	  specific	  manner	  (Porteus	  and	  Carroll,	  2005)	   and	   three	   to	   six	   zinc-­‐finger	   motifs	   are	   combined	   to	   ensure	   target-­‐sequence	  specificity.	  The	  FokI	  cleavage	  domain	  functions	  to	  cleave	  the	  target	  sequence.	  However,	  it	  must	  form	  a	  dimer	  to	  cleave	  double	  stranded	  DNA,	  thus	  requiring	  two	  ZFNs	  targeting	  a	  specific	  sequence	  (Geurts	  and	  Moreno,	  2010).	  When	  two	  ZFNs	  are	   introduced	   into	   the	  cell,	   the	   dimerization	   of	   ZFNs	   at	   the	   recognition	   site	   generates	   a	   site	   –specific	   double	  strand	  break	  (DSB)	   in	   the	  chromosome.	  The	  cell,	  eventually	  repairs	   this	  DSB	  by	  either	  highly	   conserved	   homology-­‐dependent	   repair	   (HDR)	   or	   non-­‐homologous	   end	   joining	  (NHEJ)	  DNA	  repair	  pathway	  (Porteus	  and	  Carroll,	  2005).	  Mostly,	  DSBs	  are	  repaired	  by	  NHEJ	  DNA	  repair	  pathway,	  which	  is	  less	  accurate	  than	  HDR.	  It	  occasionally	  results	  in	  the	  addition	  or	  loss	  of	  nucleotides	  at	  the	  DSB	  site	  resulting	  in	  a	  frameshift	  mutation,	  leading	  to	   a	   truncated	   and/or	   nonsense	   peptide,	   thus	   generating	   a	   gene	   knockout	   (Lieber,	  2008).	  When	  DSBs	  are	  repaired	  by	  HDR	  pathway,	  a	  knock-­‐in	  mutant	  can	  be	  generated.	  It	  is	   possible	   to	   provide	   the	   template	   in	   the	   form	   of	   an	   exogenous	   DNA	   fragment	   with	  homologous	   arms	  and	   the	  HDR	  mechanism	   results	   in	   the	  precise	   incorporation	  of	   the	  template	  (Cui	  et	  al.,	  2011).	  ZFNs	  can	  be	  used	  to	  produce	  a	  high	  number	  of	  heritable	  site-­‐specific	  mutations	   in	   the	   rat	   by	   combining	   in	   vitro	   ZFNs	   DNA	   or	  mRNA	  with	   one-­‐cell	  embryo	  via	  standard	  microinjection	  techniques.	  ZFNs	  mode	  of	  action	  in	  the	  earliest	  cell	  divisions	  leads	  to	  a	  high	  percentage	  of	  modified	  chromosomes	  in	  the	  resulting	  offspring,	  which	  can	  then	  be	  genotyped	  for	  the	  intended	  mutation	  (Geurts	  et	  al.,	  2010).	  Incase	  of	  off-­‐target	  effects	  where	  ZFNs	  cause	  DSBs	  in	  untargeted	  loci,	  they	  can	  be	  easily	  mitigated	  by	  backcrossing,	  resulting	  in	  the	  loss	  of	  potentially	  undesired	  mutations.	  However,	  these	  off-­‐target	  effects	  of	  ZFNs	  in	  genomic	  modification	  strategy	  in	  rats	  have	  not	  been	  found	  to	  date.	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Recently,	   transcription	   activator-­‐like	   effector	   nucleases	   (TALENs)	   have	   been	   used	   to	  generate	  a	  knockout	  rat	  by	  microinjection	  technique	  (Tesson	  et	  al.,	  2011).	  TALENs	  are	  engineered	  proteins	  created	  by	   fusion	  of	   transcription	  activator-­‐like	  effectors	  with	   the	  catalytic	  domain	  of	  FokI	  nuclease.	  The	  mode	  of	  action	   is	  similar	  to	  ZFNs.	  However,	   the	  TALEN	  method	  still	  needs	   to	  be	  validated	  as	  a	  powerful	   tool	   for	  genetic	  modifications	  especially	  in	  rats,	  with	  only	  one	  paper	  published	  to	  date	  by	  Tesson	  et	  al	  (2011).	  	  
4.4. Embryonic	  stem	  cells	  In	  mice,	   targeted	   knockout	   and	   knock-­‐in	   by	   homologous	   recombination	   is	  most	   often	  performed	  in	  cultured	  ESCs,	  yielding	  thousands	  of	  genetically	  modified	  strains.	   In	  rats,	  the	   application	   of	   this	   ESCs-­‐based	   technology	   is	   essential	   for	   generating	   knock-­‐in	  models	  rather	  than	  the	  knockout	  ones,	  as	  there	  are	  many	  other	  strategies	  available	  for	  the	   latter	   purpose.	   The	   reasons	   for	   the	   delay	   to	   develop	   authentic	   ESCs	   in	   rats	   are	  related	   to	   the	   lack	   of	  maintained	   pluripotency	   in	   culture	   and	   germline-­‐competent	   rat	  ESCs.	   Multiple	   groups	   had	   reported	   the	   derivation	   of	   rat	   ESCs	   lines.	   However,	   the	  identity	   of	   these	   so-­‐called	   cell	   lines	   ranged	   from	   contaminating	  mESCs	   (Brenin	   et	   al.,	  1997)	  (Iannaccone	  et	  al.,	  1994)	  to	  cell	  lines	  with	  properties	  of	  extra-­‐embryonic	  lineages	  (Vassilieva	  et	  al.,	  2000)	  (Buehr	  et	  al.,	  2003)	  (Iannaccone	  et	  al.,	  1994)	  (Stranzinger,	  1996)	  (Ouhibi	  et	  al.,	  1995)	  and	  thus	  not	  capable	  of	  colonizing	  the	  germline	  of	  chimeras.	  In	   2008,	   Ueda	   et	   al	   (2008)	   reported	   the	   first	   putative	   rat	   ESCs	   that	   expressed	   the	  pluripotency	   markers;	   Nanog	   and	   Oct4	   and	   maintained	   more	   than	   40%	   normal	  karyotype	  over	  18	  passages.	  The	  rat	  ESCs	  were	  also	  capable	  of	  producing	  chimeras	  but	  failed	  to	  show	  germline	  transmission	  (Ueda	  et	  al.,	  2008).	  In	  late	  2008,	  the	  use	  of	  two	  or	  three	  inhibitors	  (2i:	  MEK	  inhibitor	  PD0325901	  and	  GSK3	  inhibitor	  CHIR99021;	  3i:	  FGF	  receptor	   inhibitor	   SU5402,	  MEK	   inhibitor	   PD184352	   and	   GSK3	   inhibitor	   CHIR99021)	  and	   a	   chemically	   defined	   basal	   culture	   media	   containing	   no	   fetal	   bovine	   serum	   was	  developed,	  which	  successfully	  established	  and	  maintained	  germline-­‐competent	  rat	  ESCs	  (Buehr	  et	  al.,	  2008)	  (Li	  et	  al.,	  2008)	  (Ying	  et	  al.,	  2008).	  Addition	  of	   leukemia	  inhibitory	  factor	  (LIF)	  led	  to	  more	  stable	  culturing	  conditions	  for	  deriving	  rat	  ESCs.	  These	  rat	  ESCs	  expressed	   the	  pluripotency	  markers	  and	  were	  able	   to	  differentiate	   into	  all	   three	  germ	  layers	   in	   vitro.	   The	   establishment	   of	   2i	   and	   3i	   cell	   culture	   system	   has	   promoted	   the	  derivation	  of	  rat	  ESCs	  from	  various	  different	  rat	  strains	  including	  Sprague-­‐Dawley	  (SD),	  Fischer	   344	   (F344),	   Dark	   Agouti	   (DA),	   Brown	  Norway	   (BN),	  Wistar	   (WI),	   Long-­‐Evans	  (LE)	   and	   spontaneously	   hypertensive	   rats	   (SHR)	   (Buehr	   et	   al.,	   2008)	   (Li	   et	   al.,	   2008)	  
Introduction	   	   11	  
(Zhao	   et	   al.,	   2010)	   (Hong	   et	   al.,	   2012)	   (Tong	   et	   al.,	   2011).	  However,	   the	  ESCs	  derived	  from	  F344	  strains	  have	  not	  been	  shown	  to	  be	  germline-­‐competent	  (Hong	  et	  al.,	  2012).	  It	  has	   also	   been	   shown	   that	   the	   use	   of	   DIA-­‐M	   cells	   or	   a	  mixture	   of	  MEFs	   and	   L-­‐cells	   as	  feeder	   layers	   are	   optimal	   for	   deriving	   rat	   ESCs	   from	   SD	   and	   DA	   strains,	   respectively	  (Buehr	  et	  al.,	  2008)	  (Li	  et	  al.,	  2008).	  Another	  approach	  using	  an	  inhibitor	  cocktail	  media	  including	   2i	   plus	   additional	   inhibitors	   of	   Rho-­‐associated	   kinase	   (Y26732)	   and	   TGF-­‐β	  signaling	   (A-­‐83-­‐01),	   collectively	   referred	   to	   as	   YPAC,	  was	   used	   to	   derive	  Wistar	   (WI),	  Long	  Evans	  Agouti	   (LEA)	  and	  hybrid	  Wistar/LEA	  ESCs.	  The	  additional	   inhibitors	  were	  used	   to	   prevent	   apoptosis	   and	   to	   enhance	   proliferation.	   The	   mouse	   ESCs	   medium	  containing	  20%	  fetal	  bovine	  serum	  was	  used	  as	  basal	  cell	  culture	  media	  and	  MEFs	  were	  used	   as	   feeders	   in	   this	   study	   but	   LIF	   was	   not	   necessary.	   The	   majority	   of	   cell	   lines	  demonstrated	  chimerism	  and	  germline	  transmissions	  (Kawamata	  and	  Ochiya,	  2010).	  	  Rat	  transgenesis	  via	  genetic	  modification	  in	  ESCs,	  in	  2010,	  marked	  the	  beginning	  of	  new	  era	   in	   rat	   genetics.	  Tong	  et	  al.	   (2010)	   created	   the	   first	   targeted	  gene	  knockout	   rat	   via	  homologous	   recombination.	   The	   DA	   ESCs	   derived	   in	   2i+LIF	   conditions	   were	   used	   to	  target	   the	   tumour	   suppressor	   gene	   p53.	   Targeting	   efficiencies	   in	   the	   two	   ESC	   lines	  derived	   from	  DA	  were	  1.12-­‐3.70%.	  Many	  of	   the	  properly	   targeted	  cell	   lines	  developed	  chromosomal	   abnormalities	   and	   were	   polyploid.	   However,	   two	   of	   the	   20	   clones	  examined	   had	   euploid	   chromosome	   numbers	   and	   led	   to	   the	   successful	   generation	   of	  viable	  knockout	  (Tong	  et	  al.,	  2010).	  This	  has	  been	  a	  historic	  achievement	  validating	  the	  culminated	  efforts	  of	  many	   researchers	   to	  enable	   targeted	  genetic	  manipulation	   in	   rat	  ESCs.	   Using	   rat	   LIF	   instead	   of	   human	   LIF	   also	   paved	   the	  way	   for	   successful	   germline	  transmission	   of	   a	   transfected	   rat	   ESC	   line	   harbouring	   humanized	   Kusabira-­‐Orange	  (huKO)	   gene	   by	   electroporation	   using	   the	   2i+LIF	   culture	  medium	   (Hirabayashi	   et	   al.,	  2010).	   Previous	   studies	   have	   shown	   that	   rat	   ESCs	   cultivated	   in	   2i+LIF	  medium	  were	  sensitive	   to	   electrophysical	   stimulation	   induced	   by	   electroporation	   causing	   cell	   death	  and	  the	  nucleofection	  method	  was	  found	  to	  be	  more	  efficient	  in	  gene	  introduction.	  It	  is	  possible	  that	  using	  rat	  LIF	  might	  be	  an	  option	  to	  keep	  these	  ESCs	  stable.	  Another	  study	  used	   the	   YPAC	   medium	   described	   earlier	   to	   generate	   Oct4-­‐Venus	   transgenic	   rats	   in	  Wistar	   and	   LEA	   strains.	   The	   transgene	   in	   which	   the	   Oct4	   promoter	   transcribed	   the	  Venus	  gene	  was	   introduced	  by	  nucleofection	   into	  the	  rat	  ESCs.	  The	  transgenic	  animals	  were	   produced	   through	   germline	   transmission	   of	   the	   selected	   clones	   and	   no	   adverse	  effects	  were	  observed	  on	  chimera	  contribution	  due	  to	  gene	  introduction	  (Kawamata	  and	  Ochiya,	   2010).	   Recently,	   protease	   activated	   receptor-­‐2	   (Par-­‐2)	   knockout	   rat	   have	   also	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been	  generated	  from	  DA	  rat	  ESCs	  in	  2i	  medium	  (Yamamoto	  et	  al.,	  2012).	  However,	  the	  rate	  of	  germline	  transmission	  is	  really	  low	  in	  ESCs	  derived	  from	  DA,	  SD	  and	  Wistar	  rat	  strains	   (Tong	   et	   al.,	   2011).	   To	   date,	   only	   DA	   rat	   ESCs	   have	   shown	   to	   be	   germline	  competent	  after	  gene	  targeting	  by	  injecting	  the	  DA	  rat	  ESCs	  into	  F344	  rat	  blastocysts	  but	  not	   into	   SD	   rat	   blastocysts	   (Tong	   et	   al.,	   2010)	   (Tong	   et	   al.,	   2011)	   (Hong	   et	   al.,	   2012).	  Thus,	   numerous	   challenges	   still	   remain	   in	   this	   field	   including	   the	   donor/host	   strain	  combinations	  for	  the	  efficient	  germline	  transmission	  from	  the	  chimeras.	  
4.5. Induced	  pluripotent	  stem	  cells	  Induced	  pluripotent	  stem	  cells	  (iPSCs)	  are	  ESC-­‐like	  cells,	  which	  have	  been	  derived	  from	  human,	  mice	  and	  rats	  by	  genetic	  reprogramming	  of	  the	  differentiated	  cells	  into	  a	  ground	  state	  of	  pluripotency	  (Lewitzky	  and	  Yamanaka,	  2007).	  Three	  different	  studies	  have	  yielded	  putative	  iPSCs	  from	  rats.	  Retroviral	  transfection	  of	  three	   mouse	   transcription	   factor	   genes	   (Oct3/4,	   Sox2	   and	   Klf4)	   into	   hepatocyte	  progenitor	   cell	   line	   in	   presence	   of	   MEF	   feeder	   cells,	   along	   with	   the	   addition	   of	   three	  chemical	  inhibitors	  (PD0325901,	  A-­‐83-­‐01	  and	  CHIR99021)	  and	  LIF	  to	  a	  defined	  culture	  media	  led	  to	  the	  successful	  isolation	  of	  iPSCs	  in	  this	  study.	  These	  progenitor	  cell-­‐derived	  iPSCs	   yielded	   chimeric	   rats	   but	   none	   of	   the	   chimeric	   animals	   could	   demonstrate	  germline	  transmission	  (Li	  et	  al.,	  2009).	  Another	  approach	  used	  human	  reprogramming	  factor	   genes	   in	   combinations	   of	   three	   (Oct3/4,	   Sox2	   and	  Klf4),	   four	   (Oct3/4,	   Sox2,	  Klf4	  
and	   c-­‐myc)	  or	   five	   (Oct3/4,	   Sox2,	  Klf4,	   c-­‐myc	  and	  Nanog)	   to	   transfect	  neural	  precursor	  and	  embryonic	  fibroblast	  cells	  in	  media	  containing	  FBS,	  PD0325901	  and	  CHIR99021	  and	  LIF	  on	   feeder	   cells	  derived	   from	  rat	   embryonic	   fibroblasts	   (Chang	  et	   al.,	   2010).	   In	   the	  third	   study,	   four	   transcription	   factors	   (Oct3/4,	   Sox2,	   Klf4	   and	   c-­‐myc)	  were	   transfected	  using	   a	   retrovirus	   to	   reprogram	   adult	   bone	   marrow	   and	   ear-­‐tip	   fibroblasts	   under	  undefined	  culture	  conditions	  using	  MEFs	  but	  without	  LIF	  and	  chemical	  inhibitors	  (Liao	  et	  al.,	  2009).	  Both	  the	  studies	  suggested	  successful	  establishment	  of	  putative	  pluripotent	  rat	  iPSCs	  by	  gene	  expression	  studies	  and	  differentiation	  assays	  (Chang	  et	  al.,	  2010)	  (Liao	  et	  al.,	  2009).	  However,	  neither	  of	  the	  latter	  two	  studies	  demonstrated	  testing	  their	  iPSCs	  via	   blastocyst	   injections.	   No	   germline	   competency	   of	   rat	   iPSCs	   had	   been	   reported	   till	  2011.	  In	  2011,	  Hamanaka	  et	  al.	  (2011)	  for	  the	  first	  time	  reported	  generation	  of	  germline	  competent	   rat	   iPSCs.	   They	   transfected	  Wistar	   or	   DA	   rat	   embryonic	   fibroblasts	  with	   a	  lentiviral	   vector,	   carrying	   three	  mouse	   reprogramming	   factors	   (Oct3/4,	   Sox2	  and	  Klf4)	  and	   seeded	   them	   on	   a	   layer	   of	   MEF	   feeders	   in	   a	   serum-­‐free	   medium	   containing	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inhibitors	   of	   MEK	   (PD0325901)	   and	   GSK3	   (CHIR99021).	   The	   established	   rat	   iPSCs	  possessed	  all	  the	  key	  features	  of	  pluripotency.	  They	  showed	  expression	  of	  pluripotency	  markers	  Oct4	  and	  Nanog,	   capacity	   to	  differentiate	   into	  all	   three	  germ	   layers,	  ability	   to	  produce	   chimeras	   with	   high	   efficiency	   and	   most	   importantly,	   contribute	   to	   germline	  transmission.	  High	  efficiency	  of	  germline	  transmission	  was	  obtained	  by	  injecting	  Wistar	  and	  DA	   rat	   iPSCs	   into	  Wistar	   blastocyst	   (Hamanaka	   et	   al.,	   2011).	   Thus,	   the	   successful	  generation	  of	   germline-­‐	   competent	   rat	   iPSCs	  has	  opened	   the	  doors	   to	   the	   tremendous	  utility	   of	   these	   cells	   for	   directed	   differentiation	   and	   phenotyping	   in	   vitro,	   as	   well	   as	  preclinical	  modeling	  strategies	  for	  tissue	  generation	  and	  organ	  repair.	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5. Pluripotent	  cell	  types	  of	  a	  mouse	  Embryonic	  Stem	  cells	  (ESCs)	  are	  derived	  from	  the	  preimplantation	  embryo	  of	  a	  mouse.	  Investigations	   into	   the	   nature	   of	   pluripotency	   have	   lead	   researchers	   to	   attempt	   the	  derivation	   of	   pluripotent	   cells	   from	   alternative	   sources.	   I	   have	   outlined	   below	   the	  various	  types	  of	  pluripotent	  cell	  types	  derived	  from	  mice	  till	  date.	  
5.1. Embryo-­‐derived	  stem	  cells	  	  Embryo	  derived	  stem	  cells	  can	  be	  obtained	  from	  pre-­‐	  and	  early	  post-­‐implantation	  stages	  of	  an	  embryo.	  They	  are	  categorized	  into	  embryonic	  stem	  cells,	  embryonic	  germ	  cells	  and	  epiblast	  stem	  cells.	  
5.1.1. Embryonic	  Stem	  Cells	  (ESCs)	  
5.1.1.1. Origin	  and	  derivation	  of	  embryonic	  stem	  cells	  The	   striking	   observation	   that	   the	   early	   mouse	   embryos	   engrafted	   into	   adult	   mice	  produced	  teratocarcinomas,	  containing	  a	  significant	  population	  of	  undifferentiated	  cells	  paved	  the	  way	  for	  the	  establishment	  of	  embryonic	  stem	  cells	  (Stevens,	  1970)	  (Solter	  et	  al.,	  1970).	  Co-­‐culturing	  the	  embryonal	  carcinoma	  (EC)	  cells	  with	  mitotically	  inactivated	  embryonic	  fibroblasts	  and	  fetal	  calf	  serum	  not	  only	  promoted	  efficient	  establishment	  of	  EC	   cells	   but	   also	   increased	   their	   differentiation	   capacity	   (Martin	   and	   Evans,	   1975)	  (Martin	   et	   al.,	   1977).	   Thus,	   these	   fibroblasts,	   which	   were	   providing	   some	   important	  factors,	   were	   described	   as	   feeder	   cells.	   The	   undifferentiated	   EC	   cells	   contributed	   to	  multilineage	   differentiation	   when	   injected	   into	   the	   host	   blastocyst	   to	   form	   chimeras.	  Martin	  and	  Kaufmann	  then	  went	  on	  to	  investigate	  culturing	  primary	  embryo	  cells	  in	  the	  presence	  of	  feeders.	  They	  termed	  these	  cells	  as	  embryonic	  stem	  cells	  to	  distinguish	  them	  from	  the	  EC	  cells.	  Thus	  the	  first	  ESCs	  were	  successfully	  derived	  from	  blastocyst	  in	  1981	  in	  the	  presence	  of	  serum	  and	  feeders.	  Embryos	  at	  the	  late	  blastocyst	  stage	  were	  plated	  intact	  on	  the	  feeders	  with	  serum	  for	  a	  few	  days	  before	  dissociating	  them	  into	  single	  cells	  (Evans	  and	  Kaufman,	  1981)	  (Martin,	  1981).	  ESCs	  closely	  resemble	  EC	  cells	  in	  accordance	  with	   the	   formation	   of	   teratomas	  which	   contain	   tissues	   from	   all	   three	   germ	   layers	   i.e.	  ectoderm,	  mesoderm	  and	  endoderm	  (Kaufman	  et	  al.,	  1983).	  Various	  techniques	  can	  be	  used	   to	   introduce	   ESCs	   into	   the	   preimplantation	   embryo	  where	   they	   contribute	   to	   all	  fetal	   lineages	   plus	   the	   yolk	   sac	   mesoderm,	   allantois	   and	   amnion	   but	   poorly	   to	  extraembryonic	   endoderm	   and	   almost	   never	   to	   trophoblast	   (Bradley	   et	   al.,	   1984)	  (Beddington	   and	   Robertson,	   1989).	   Unlike	   EC	   cells,	   ESCs	   have	   the	   ability	   to	   integrate	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into	  the	  embryo	  and	  produce	  viable	  chimeras.	  In	  contrast	  to	  EC	  cells,	  they	  have	  a	  diploid	  karyotype,	  which	   is	  necessary	   for	  meiosis	  and	  gives	   them	  the	  ability	   to	  generate	  germ	  cell	   lineage	   and	   thus	   promote	   germline	   transmission	   (Bradley	   et	   al.,	   1984).	   Another	  surprising	   feature	   of	   ESCs	   is	   that	   the	   majority	   of	   the	   ESC	   lines	   are	   40,	   XY.	   The	   XY	  genotype	  confers	  a	  huge	  advantage	  over	  XX	  for	  establishment	  of	  germline	  transmission	  as	   XX	   ESCs	   have	   both	   their	   X	   chromosomes	   active	   suggestive	   of	   a	   drawback	   for	   ESC	  propagation	   (Rastan	   and	   Robertson,	   1985).	  Male	   chimeras	   produce	  more	   offspring	   in	  comparison	   to	   female	   chimeras	   and	   also	   convert	   undefined	   genital	   ridges	   into	   male	  gonad	   development.	   As	   a	   result,	   all	   spermatocytes	   are	   of	   ESC	   origin	   (Bradley	   et	   al.,	  1984).	  For	   many	   years,	   ESC	   derivation	   was	   poorly	   understood	   and	   it	   became	   necessary	   to	  refine	  and	  define	  the	  conditions	  required	  for	  efficient	  generation	  of	  ESCs.	  In	  1988,	  two	  different	  studies	  by	  Smith	  and	  Williams	  showed	  that	  the	  essential	  self-­‐	  renewal	  function	  of	   feeder	   cells	   arose	   from	   cytokine	   produced	   by	   these	   cells	   termed	   as	   Leukemia	  inhibitory	  factor	  (LIF)	  (Williams	  et	  al.,	  1988)	  (Smith	  et	  al.,	  1988).	  Lately,	  serum	  has	  been	  replaced	   by	   the	   addition	   of	   bone	   morphogenetic	   protein	   4	   (Bmp4)	   consequently	  allowing	  the	  propagation	  of	  germline	  competent	  ESCs	  by	  supplementation	  with	  the	  two	  cytokines	  LIF	  and	  Bmp4	  (Ying	  et	  al.,	  2003).	  However,	  these	  conditions	  still	  did	  not	  lead	  to	   derivation	   of	   true	   ESCs	   from	   non-­‐permissive	   strains	   like	   CBA.	   Interestingly,	   the	  efficiency	   of	   ESCs	   derivation	   was	   dependent	   upon	   the	   genetic	   background	   of	   the	  embryo;	  129	  strain	  was	  found	  to	  be	  most	  permissive	  where	  as	  ESCs	  derivation	  from	  CBA	  strain	  was	  not	  possible	  (Batlle-­‐Morera	  et	  al.,	  2008)	  (Buehr	  and	  Smith,	  2003).	  This	  was	  reasoned	   with	   the	   strain	   specific	   variation	   of	   Erk	   signalling.	   Erk	   pathway	   is	  independently	  activated	  by	  FGF4	  and	  LIF	  (Batlle-­‐Morera	  et	  al.,	  2008)	  (Wray	  et	  al.,	  2010).	  In	  1999,	  Burdon	  et	  al.	  showed	  that	  the	  inhibition	  of	  Erk	  pathway	  promoted	  self-­‐renewal	  of	  ESCs	  by	  blocking	  differentiation	  cues	  provided	  by	  it	  (Burdon	  et	  al.,	  1999b).	  Inhibition	  of	   Erk	   also	   improved	   the	   efficiency	   of	   ESC	   derivation	   from	   non-­‐129	   strains	   of	   mice	  (Batlle-­‐Morera	  et	  al.,	  2008)	  (Buehr	  and	  Smith,	  2003).	  The	  embryonic	  diapause	  property	  of	   rodents	   also	   facilitates	   the	   derivation	   of	   ESCs.	   Diapause	   is	   a	   phenomenon,	   which	  occurs	  in	  mice	  and	  rats	  when	  the	  suckling	  mother	  produces	  embryos.	  In	  this	  situation,	  the	   embryos	  develop	   to	   the	  blastocyst	   stage,	   hatch	   from	  zona	  pellucida	   and	   segregate	  into	   the	   epiblast	   and	   the	   hypoblast	   but	   are	   not	   implanted	   until	   oestrogen	   is	   restored.	  The	   epiblast	   retains	   the	   expression	   of	   Oct4	   and	   Nanog	   and	   has	   both	   X	   chromosomes	  active	   in	   female	   embryos	   (Silva	   et	   al.,	   2009).	   These	   embryos	   can	   regain	   development	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even	   after	   3-­‐4	  weeks	   of	   implantation	   delay.	   LIF	   signalling	   has	   been	   shown	   to	   be	   very	  crucial	  for	  prolongation	  of	  the	  epiblast	  lifespan	  during	  this	  period	  thus	  creating	  a	  close	  relationship	   between	   early	   epiblast	   and	   ESCs	   (Nichols	   et	   al.,	   2001).	   ESCs	   were	   first	  derived	  from	  the	  blastocyst	  in	  diapause.	  Thus,	  it	  has	  been	  proven	  that	  LIF	  enhances	  the	  efficiency	  of	  ESC	  generation	  (Brook	  and	  Gardner,	  1997).	  Recently,	   small	   molecules,	   which	   inhibit	   specific	   kinases	   have	   become	   a	   great	   tool	   in	  establishing	  a	  new	  protocol	  for	  derivation	  and	  propagation	  of	  ESCs.	  This	  new	  cell	  culture	  regime	  termed	  2i	  specifically	   inhibits	  2	  kinases:	  mitogen	  activated	  protein	  kinase/	  Erk	  kinase	   and	   glycogen	   synthase	   kinase	   3	   (Fig.	   2)	   (Ying	   et	   al.,	   2008).	   Most	   importantly,	  inhibition	   of	   Erk	   signalling	   in	   the	   pre-­‐implantation	   stage	   embryo	   abrogates	   the	  differentiation	   processes	   required	   for	   the	   development,	   henceforth	   preventing	   the	  formation	  of	  hypoblast	  (Nichols	  et	  al.,	  2009).	  However,	  ESCs	  derivation	  is	  most	  efficient	  only	  when	  GSK3β	  is	  inhibited	  or	  LIF/Stat3	  pathway	  is	  activated.	  Using	  small	  molecules	  for	  ESC	  derivation	  has	  made	  it	  possible	  to	  efficiently	  generate	  germline	  competent	  ESCs	  from	  both	   the	  permissive	  and	  non-­‐permissive	  strains	  of	  mice	  as	  well	  as	   few	  strains	  of	  rat.	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5.1.1.2. Relationship	  between	  pre-­‐implantation	  stage	  embryo	  and	  embryonic	  stem	  
cells	  In	  the	  mouse,	  ESCs	  are	  derived	  from	  the	  early	  epiblast	  of	  E3.5	  blastocyst.	  It	  is	  essential	  to	   understand	   the	   development	   of	   an	   embryo	   to	   the	   blastocyst	   stage	   and	   genes	  regulating	   this	  process	   in	  order	   to	  comprehend	   the	  relationship	  between	  pluripotency	  and	  ESCs	  derived.	  	  Three	   different	   cell	   compartments	   are	   present	   in	   the	   blastocyst	   stage	   embryo:	   the	  trophoectoderm	   which	   produces	   the	   trophoblast/placenta	   and	   the	   chorion,	   the	  primitive	  endoderm/hypoblast	  which	  contributes	  to	  the	  yolk	  sac	  and	  the	  epiblast	  which	  forms	   the	   embryo	   proper,	   the	   umbilical	   cord	   and	   the	   amnion	   (Ralston	   and	   Rossant,	  2005).	  Two	  distinct	   lineage	   segregations:	   the	   trophoectoderm	  and	   the	   inner	   cell	  mass	  (ICM)	  segregation	  and	  the	  epiblast	  and	  the	  hypoblast	  segregation	  in	  the	  ICM	  leads	  up	  to	  the	  formation	  of	  blastocyst	  (Fig.	  3).	  	  
	  
Figure	  3:	  Different	  segregations	  of	  a	  pre-­‐implantation	  embryo	  The	  first	  lineage	  segregation	  occurs	  from	  late	  morula	  to	  early	  blastocyst	  where	  the	  outer	  cells	  form	  the	  trophectoderm	  and	  the	  inner	  cells	  form	  the	  inner	  cell	  mass	  and	  form	  a	  cavity	  called	  blastocoel.	  The	  next	  differentiation	  event	  occurs	  at	  the	  late	  blastocyst	  stage	  when	  inner	  cell	  mass	  segregates	  into	  epiblast	  and	  the	  hypoblast	  	  Fertilisation	   of	   the	   oocyte	   produces	   a	   zygote,	   which	   after	   three	   rounds	   of	   cleavage	  division	   leads	   to	   the	   formation	   of	  morula.	   The	   POU	   domain	   transcription	   factor	   Oct4	  (also	   known	   as	   Oct3/4	   or	   POU5F1)	   is	   expressed	   throughout	   the	   embryo	   till	   the	  blastocyst	  stage.	  	  The	   first	   segregation-­‐	   trophectoderm	   and	   ICM	   segregation	   occurs	   at	   the	   late	   morula	  stage	  when	  cell	  compaction,	  a	  process	  where	  the	  blastomeres	  become	  closely	  apposed	  to	  one	   another,	   takes	   place.	   Another	   gene,	   Cdx2,	   encoding	   caudal	   related	   transcription	  factor	   comes	   into	   play	   at	   this	   stage.	   The	   outer	   layer	   of	   the	   cells	   forms	   an	   epithelial	  structure	  called	  trophoectoderm,	  which	  creates	  a	  boundary	  around	  the	  other	  compacted	  cells	   and	   secretes	   proteins	   promoting	   the	   formation	   of	   an	   inner	   cavity	   or	   blastocoel,	  which	  pushes	  the	  ICM	  to	  one	  side.	  The	  embryo	  is	  now	  called	  the	  blastocyst	  and	  consists	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of	  the	  ICM	  and	  the	  trophectoderm.	  Oct4	  and	  Cdx2	  act	  as	  the	  selector	  genes	  for	  ICM	  and	  trophectoderm	  and	  act	  antagonistically	  to	  each	  other	  to	  regulate	  the	  cell	  fates	  (Strumpf	  et	   al.,	   2005).	   Recently,	   TEA	   DNA	   binding	   domain/transcription	   enhancer	   factor	  (TEAD/TEF)	   family	   transcription	   factor	   TEAD4	   has	   been	   shown	   to	   regulate	   the	  expression	  of	  Cdx2	  in	  pre-­‐implantation	  stage	  embryo.	  It	  acts	  in	  conjunction	  with	  its	  co-­‐activator	  protein	  YAP	  to	  induce	  the	  expression	  of	  the	  trophectoderm	  genes	  (Nishioka	  et	  al.,	  2009).	  Next	   differentiation	   event	   occurs	   at	   the	   late	   blastocyst	   stage,	   in	   mouse	   at	   E4.5,	   just	  before	  hatching	  from	  the	  zona	  pellucida	  where	  the	  ICM	  segregates	  into	  the	  epiblast	  and	  the	  hypoblast/primitive	   endoderm.	  The	  primitive	   endoderm	   forms	   an	   epithelial	   cover	  facing	  the	  blastocoel	  around	  the	  epiblast	  (Fig.	  3).	  Prior	  to	  the	  segregation,	  Oct4	  positive	  ICM	   has	   heterogenous	   constitution	   and	   consists	   of	   cells	   expressing	   Nanog	   and	   other	  cells	   expressing	   Gata6.	   These	   are	   the	   cells,	   which	   later	   on	   become	   the	   precursors	   of	  epiblast	  and	  hypoblast	  respectively.	  Thus	  Nanog	  and	  Gata6	  act	  as	   the	  selectors	   for	   the	  above	  lineages	  (Chazaud	  et	  al.,	  2006).	  In	  agreement	  with	  their	  in	  vivo	  expression	  pattern,	  Oct4	  and	  Nanog	  are	  also	  expressed	  in	  the	  pluripotent	  ESCs	  where	  as	  Cdx2	  and	  Gata6	  are	  not.	  This	  suggests	  that	  ESCs	  correspond	  to	  the	  epiblast	  cells	  beyond	  the	  development	  of	  trophectoderm	  and	  primitive	  endoderm.	  	  	  
	  
Figure	  4:	  Different	  gene	  expression	  patterns	  in	  vivo	  a)	  Different	  gene	  expression	  patterns	  during	  blastocyst	  formation.	  Oct4	  and	  Nanog	  both	  are	  expressed	  in	  all	  cells	  till	  late	  morula	  stage	  and	  then	  become	  restricted	  to	  the	  inner	  cell	  mass	  and	  epiblast	  of	  the	  blastocyst.	  Cdx2	  is	  expressed	  in	  the	   outer	   cells	   of	   the	   blastocyst	   forming	   the	   trophectoderm.	   Gata6	   is	   expressed	   in	   the	   primitive	   endoderm	   or	  hypoblast	  of	  the	  late	  blastocyst	  stage.	   	  b)	   Selector	   genes	   for	   lineage	   decision.	   Oct4	   and	   Cdx2	   act	   antagonistically	   to	   segregate	   into	   inner	   cell	   mass	   and	  trophectoderm	  lineage.	  Similarly,	  Nanog	  and	  Gata6	  expression	   leads	  to	  the	  second	  segregation	  within	  the	   inner	  cell	  mass.	  Modified	  from	  (Ralston	  and	  Rossant,	  2005)	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5.1.2. Epiblast	  stem	  cells	  Epiblast	  stem	  cells	  (EpiSCs)	  are	  pluripotent	  stem	  cell	  lines	  established	  from	  both	  mouse	  and	   rat	   post-­‐implantation	   embryos.	   They	   are	   derived	   from	   E5.5-­‐E6.5	   embryos	   and	  cultured	   in	   the	   medium	   supporting	   derivation	   and	   expansion	   of	   human	   ESCs,	   hence	  cultured	  in	  medium	  containing	  activin	  and	  bFGF	  (Tesar	  et	  al.,	  2007)	  (Brons	  et	  al.,	  2007).	  Upon	  blastocyst	  injection	  or	  morula	  aggregation,	  the	  capacity	  of	  EpiSCs	  to	  integrate	  into	  the	   pre-­‐implantation	   stage	   mouse	   embryo	   was	   really	   low	   leading	   to	   extremely	   low	  contribution	  towards	  chimera	  production.	  It	  can	  possibly	  be	  explained	  by	  the	  restricted	  capacity	   of	   these	   cells	   to	   develop	   into	   early	   cell	   lineages.	   However,	   they	   express	   the	  pluripotency	   markers	   Oct4,	   Sox2	   and	   Nanog	   and	   are	   capable	   of	   multi-­‐lineage	  differentiation	   proven	   by	   formation	   of	   teratomas	   containing	   a	  wide	   variety	   of	   tissues	  like	  muscle,	  cartilage,	   liver,	  gut	  and	  neuronal	  rosettes	  (Tesar	  et	  al.,	  2007)	  (Brons	  et	  al.,	  2007).	  Unlike	  mESCs,	  EpiSCs	  do	  not	  have	  reactivation	  of	  the	  X	  chromosome	  and	  express	  genes	  like	  FGF5	  and	  Nodal.	  They	  have	  no	  expression	  of	  genes	  like	  Rex1	  and	  Gbx2,	  which	  are	   specific	   markers	   of	   inner	   cell	   mass	   and	   ES	   cells.	   Although,	   they	   are	   pluripotent,	  EpiSCs	   have	   shown	   to	   differentiate	   in	   conditions	   required	   for	   self-­‐renewal	   and	  pluripotency	  of	  ES	  cells.	  They	  spontaneously	  differentiate	  into	  the	  somatic	  cell	  lineages	  like	  endoderm.	  Thus,	  due	  to	  their	  inclination	  towards	  differentiation,	  the	  self-­‐renewing	  state	   of	   EpiSCs	   is	   said	   to	   be	   primed	   pluripotent	   state	   rather	   than	   naïve	   one	   as	   of	   the	  mESCs.	  In	  2009,	  Guo	  et	  al.	  reported	  the	  conversion	  of	  naïve	  to	  primed	  pluripotent	  states	  by	  culturing	  ESCs	  in	  medium	  containing	  activin	  and	  bFGF	  to	  form	  EpiSC-­‐like	  cells	  which	  had	  an	  inactive	  X	  chromosome	  and	  same	  gene	  expression	  pattern	  like	  embryo-­‐derived	  EpiSCs	  (Guo	  et	  al.,	  2009).	  It	  has	  recently	  been	  possible	  to	  convert	  EpiSCs	  to	  ES-­‐like	  cells	  by	  introducing	  one	  of	  the	  transcription	  factors	  Klf4,	  Klf2,	  Nanog,	  cMyc,	  Nr5a1	  or	  Nr5a2	  to	  2I	  and	  LIF	  or	  serum	  and	  LIF	  on	  feeders	  (Guo	  et	  al.,	  2009)	  (Guo	  and	  Smith,	  2010)	  (Hall	  et	   al.,	   2009)	   (Silva	  et	   al.,	   2009)	   (Hanna	  et	   al.,	   2009).	  These	  EpiSC	  derived	  ES-­‐like	   cells	  behave	  as	  ESCs	  and	  contribute	  to	  chimera	  formation	  and	  germline	  transmission.	  It	  is	  of	  great	  interest	  to	  study	  EpiSCs	  because	  they	  are	  very	  similar	  to	  human	  ESCs.	  They	  both	   are	   derived	   and	   cultured	   in	   activin	   and	   bFGF,	   have	   an	   inactive	   X	   chromosome,	  flattened	  morphology,	   cellular	  heterogeneity	  and	  capacity	   to	   form	   teratomas	   (Tesar	  et	  al.,	   2007)	   (Brons	   et	   al.,	   2007)	   (Shen	   et	   al.,	   2008)	   (Vallier	   et	   al.,	   2005).	   Human	   ESCs	  cannot	   undergo	   the	   stringent	   test	   of	   pluripotency	   for	   formation	   of	   chimeras	   due	   to	  ethical	  issues.	  The	  fact	  that	  the	  preimplantation	  stage	  of	  human	  development	  is	  closer	  to	  the	  epiblast	  stage	  of	  mouse	  development	  suggests	  that	  human	  ESCs	  are	   in	  a	   less	  naïve	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state	   and	   henceforth	  more	   similar	   to	   the	   primed	   state	   of	   EpiSCs	   (Nichols	   and	   Smith,	  2009).	   It	   also	   provides	   us	   with	   the	   intriguing	   possibility	   of	   capturing	   human	   ESCs	   in	  their	   naïve	   state	   and	   studying	   the	  molecular	   mechanisms	   behind	   the	   pluripotency	   of	  human	  ESCs.	  
5.1.3. Embryonic	  Germ	  Cells	  Embryonic	  Germ	  Cells	  (EGCs)	  are	  pluripotent	  stem	  cells	  derived	  from	  primordial	  germ	  cells	  (PGCs)	  of	  the	  post-­‐implantation	  embryo	  E7.5-­‐	  E13.5.	  EGCs	  are	  derived	  from	  PGCs	  by	   culturing	   in	   vitro	   in	   the	  presence	  of	   stem	  cell	   factor	   (SCF),	   LIF	   and	  basic	   fibroblast	  growth	  factor	  (bFGF)	  (Matsui	  et	  al.,	  1992).	  Recently,	  EGCs	  can	  also	  be	  derived	  either	  by	  culturing	   PGCs	   in	   traditional	   medium	   followed	   by	   cultivating	   them	   later	   in	   2i+LIF	  medium	  or	  directly	  generating	  them	  in	  2i+LIF	  medium	  on	  SCF	  null	  feeder	  cells	  (Leitch	  et	  al.,	  2010).	  PGCs	  are	  progenitors	  of	   the	  germ	  cell	   lineage,	  which	  contribute	   to	   the	  development	  of	  healthy	   gametes	   in	   the	   adult.	   PGCs	   arise	   as	   alkaline	   phosphatase	   positive	   cells	   at	   the	  base	  of	  allantois	  at	  7.5dpc.	  At	  E8.5,	  they	  migrate	  and	  are	  found	  in	  the	  hindgut	  endoderm	  from	   where	   they	   later	   associate	   with	   dorsal	   mesenteries	   and	   translocate	   to	   genital	  ridges	   by	   10.5dpc	   (CHIQUOINE,	   1954)	   (Ginsburg	   et	   al.,	   1990).	   Transcriptional	  similarities	  between	  ESCs	  and	  PGCs	  are	  maintained	  between	  E8.5	   to	  E13.5	  when	   they	  express	  some	  key	  pluripotency	  genes	  like	  Sox2,	  Nanog	  and	  Oct4	  (Kurimoto	  et	  al.,	  2008)	  (Yamaguchi	   et	   al.,	   2005).	   Besides	   transcriptional	   changes,	   global	   epigenetic	  reprogramming	  events	  also	  occur.	  The	  inactive	  X	  chromosome	  starts	  to	  activate	  and	  is	  completely	  active	  by	  E14.5.	  Furthermore,	  histone	  modifications	  occur	   in	   the	  migrating	  PGCs	  where	  there	  is	  a	  decrease	  in	  histone	  3	  lysine	  9	  dimethylation	  (H3K9me2)	  for	  gene	  induction	   and	   increase	   in	   H3K27me3	   for	   gene	   repression	   between	   E7.5	   and	   E8.5	  (Hajkova	  et	  al.,	  2008)	  (Seki	  et	  al.,	  2005).	  From	  E10.5,	  PGCs	  start	  to	  colonize	  the	  gonads	  and	   involve	   genome	   wide	   DNA	   demethylation	   of	   imprinted	   genes	   and	   chromatin	  remodeling	   in	   order	   to	   reset	   the	   epigenome	   of	   germ	   line.	   Thus,	   mouse	   EGCs	   derived	  from	   E11.5-­‐E12.5	   PGCs	   lacking	   methylation	   imprints	   contribute	   to	   chimeras	   with	  abnormalities	  in	  contrast	  to	  the	  ones	  derived	  from	  E8.5	  to	  E11.5.	  	   	  
Introduction	   	   21	  
5.2. Induced	  pluripotent	  stem	  cells	  (iPSCs)	  and	  Reprogramming	  Reprogramming	  is	  the	  process	  of	  altering	  the	  epigenetic	  marks	  of	  the	  cell	  to	  change	  its	  developmental	   potency.	   Induced	   pluripotent	   stem	   cells	   are	   embryonic	   stem	   like	   cells	  that	   are	  derived	  by	   epigenetic	   reprogramming	  of	   a	   somatic	   cell	   to	   a	  pluripotent	   state.	  There	   have	   been	   several	   approaches	   towards	   efficient	   and	   successful	   reprogramming	  for	   decades.	   Cloning	   by	   somatic	   cell	   nuclear	   transfer	   technique	   was	   the	   very	   first	  technique	  in	  the	  history	  of	  reprogramming	  shown	  by	  John	  Gurdon	  in	  Xenopus(GURDON,	  1962)	   and	   few	   decades	   later	   by	   Ian	   Wilmut	   in	   sheep	   (Wilmut	   et	   al.,	   1997),	   which	  demonstrated	  that	  the	  epigenetic	  state	  of	  fully	  differentiated	  somatic	  cells	  is	  reversible	  and	  can	  be	  reprogrammed	  to	  an	  embryonic	  state.	  Further	  on,	  the	  fusion	  of	  somatic	  cells	  with	  embryonic	  stem	  cells	  (ESCs)	  or	  embryonic	  germ	  cells	  (EGCs)	  or	  exposure	  to	  ESCs	  or	   embryonic	   carcinoma	   extract	   was	   also	   shown	   to	   be	   a	   method	   for	   reprogramming	  (Taranger	  et	  al.,	  2005).	  But,	  Takahashi	  and	  Yamanaka	  achieved	  the	  major	  breakthrough	  in	  2006,	  when	  they	  showed	  that	  somatic	  cells	  could	  be	  reprogrammed	  by	  inducing	  the	  forced	  expression	  of	  four	  transcription	  factors	  –	  Oct4,	  Sox2,	  Klf4	  and	  cMyc	  via	  retroviral	  transduction,.	  These	   cells	   expressed	   the	  ESC	  markers	  and	  could	   contribute	   to	   chimera	  generation	   and	   were	   thus	   designated	   as	   induced	   pluripotent	   stem	   cells	   (iPSCs)	  (Takahashi	  and	  Yamanaka,	  2006).	  However,	  cMyc,	  one	  of	  the	  transcription	  factors	  used	  in	  reprogramming,	  is	  an	  oncogene,	  which	  frequently	  produces	  tumors	  in	  iPSCs	  chimeric	  mice	  and	  it	  would	  be	  better	  to	  obviate	  it	  from	  the	  reprogramming	  process.	  Wernig	  et	  al,	  in	   2008,	   showed	   that	   cMyc	   is	   dispensable	   for	   reprogramming	   (Wernig	   et	   al.,	   2008).	  Recently,	   Yamanaka’s	   group	   discovered	   Glis1,	   which	   belongs	   to	   the	   GLI	   family	  transcription	  factor,	  present	  in	  unfertilized	  eggs	  and	  oocytes	  and	  can	  replace	  cMyc	  in	  the	  reprogramming	   process	   thus	   decreasing	   the	   tumorigenicity	   (Maekawa	   et	   al.,	   2011).	  Nonetheless,	   in	   order	   to	   completely	   circumvent	   the	   issue	   of	   tumor	   formation	   and	   to	  bring	   iPSCs	  use	   in	   clinical	   settings,	   it	   is	   essential	   to	   look	   into	   viral	   and	   transgene	   free	  reprogramming	   approaches.	   Different	   non-­‐integration	   and	   removable	   systems	   include	  episomal	   vectors,	   piggybac	   transposon	   system	   and	  minicircle	   vectors.	   Although,	   these	  systems	  are	  detachable,	   they	  still	   involve	  the	   introduction	  of	   foreign	  DNA	  into	  the	  cell,	  which	   may	   cause	   genomic	   alterations.	   Thus,	   inducing	   the	   expression	   of	   the	  reprogramming	  factors	  in	  their	  protein	  form	  is	  highly	  desirable.	  This	  has	  been	  shown	  by	  fusing	  reprogramming	  factors	  with	  cell-­‐penetrating	  peptides	  and	  exposing	  fibroblasts	  to	  these	   recombinant	   proteins	   (Zhou	   et	   al.,	   2009)	   and	  more	   recently,	   by	   using	  modified	  mRNA	   encoding	   reprogramming	   factors	   (Warren	   et	   al.,	   2010).	   However,	   these	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techniques	  are	  expensive	  and	  difficult	  to	  replicate.	  Recent	  studies	  have	  also	  shown	  that	  microRNAs	   (miRNA)	   alone	   are	   able	   to	   reprogram	   somatic	   cells	   to	   pluripotent	   state.	  miRNA	   application	   has	   a	   great	   advantage	   over	   other	   methods	   as	   it	   avoids	   using	  oncogenic	   factors	   and	   does	   not	   involve	   introducing	   genetic	   changes	   into	   the	   genome	  (Lin	   et	   al.,	   2008)	   (Anokye-­‐Danso	   et	   al.,	   2011)	   (Miyoshi	   et	   al.,	   2011).	   However,	   the	  molecular	  mechanism	  on	  how	  miRNA	  activates	  pluripotency	  pathways	  is	  still	  unknown.	  	  Thus,	   there	   are	   still	   a	   significant	   number	   of	   hurdles	   to	   overcome	   like	   efficient	  reprogramming	  protocols,	   transplantation	   safety	   and	   immunogenecity	  before	  bringing	  iPSCs	  to	  the	  clinics.	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6. Intrinsic	  determinants	  of	  ESC	  self-­‐renewal	  Several	   transcription	   factors	   have	   been	   shown	   to	   play	   essential	   roles	   in	   both	   early	  development	   and	   maintenance	   of	   pluripotency	   in	   ESCs.	   They	   are	   regulated	   by	  themselves	  and	  the	  extrinsic	  signals	  described	  later.	  In	  the	  presence	  of	  these	  genes,	  the	  self-­‐renewal	  genes	  are	  activated	  and	   the	  differentiation	  genes	  are	   repressed.	  The	  core	  transcription	  factors:	  Oct4,	  Sox2	  and	  Nanog	  are	  described	  below.	  
6.1. Oct4	  Oct4	  is	  one	  of	  the	  key	  components	  of	  the	  molecular	  circuitry	  regulating	  embryonic	  stem	  cell	  proliferation	  and	  differentiation.	  It	  belongs	  to	  Octamer	  class	  of	  transcription	  factors	  that	  binds	  to	  an	  octamer	  sequence,	  ATGACCT	  (Falkner	  and	  Zachau,	  1984)	  (Parslow	  et	  al.,	  1984).	  Along	  with	  Pit	  and	  Unc,	  Oct	  proteins	  define	  the	  POU	  class	  of	  proteins	  that	  have	  two	  DNA	  binding	  domains:	  POU-­‐specific	  domain	  and	  POU	  homeodomain.	  During	  mouse	  embryo	   development,	   Oct4	   is	   expressed	   in	   the	   unfertilized	   egg,	   in	   all	   the	   cells	   of	   an	  embryo	  prior	  to	  segregation	  of	  ICM,	  and	  the	  ICM.	  It	   is	  also	  expressed	  in	  the	  epiblast	  of	  pre-­‐	   and	   post-­‐implantation	   stage	   embryo	   and	   later	   becomes	   restricted	   to	   migrating	  PGCs.	  Oct4	   deficient	   mouse	   embryos	   develop	   to	   a	   stage	   that	   look	   like	   blastocysts	   but	   are	  developmentally	   compromised.	   These	   embryos	   when	   allowed	   to	   attach	   in	   vitro	   and	  grow,	   form	   colonies	   that	   are	   only	   comprised	   of	   trophoectoderm	   cells	   (Nichols	   et	   al.,	  1998).	   As	   these	   structures	   do	   not	   have	   a	   genuine	   ICM,	   they	   cannot	   produce	   ESCs.	  Therefore,	   Oct4	   has	   been	   shown	   to	   be	   crucial	   for	   preventing	   trophectoderm	  differentiation	  and	  maintaining	  pluripotency	  during	  embryonic	  development.	  In	  mouse	  ESCs,	  loss	  of	  Oct4	  causes	  differentiation	  into	  trophectoderm.	  Overexpression	  of	  Oct4	  by	  150%	  results	  in	  differentiation	  into	  primitive	  endoderm	  and	  mesoderm	  indicating	  that	  a	  relative	   amount	   of	   Oct4	   determines	   the	   cell	   fate	   and	   precise	   levels	   of	   this	   gene	   are	  required	   in	   order	   to	  maintain	  ESC	   state	   (Niwa	   et	   al.,	   2000).	   Little	   is	   known	  about	   the	  upstream	  regulators	  of	  Oct4.	  Oct4	  contains	  conserved	  distal	  and	  proximal	  enhancers	  on	  its	  promoter	  that	  can	  either	  activate	  or	  repress	  its	  expression	  depending	  on	  the	  binding	  factors	  (Pan	  et	  al.,	  2002).	  Interestingly,	  Nanog	  can	  activate	  Oct4	  expression	  as	  well	  (Pan	  et	  al.,	  2006).	  Several	   target	   genes	   of	   Oct4	   have	   been	   identified.	   Few	   of	   them	   are	   FGF4,	   Rex1,	   Utf1,	  Fbx15,	   Opn	   and	   Sox2.	   LIF/STAT3	   pathway	   (discussed	   later)	   is	   an	   important	   pathway	  promoting	  ESC	  self-­‐renewal.	  However,	  LIF	  does	  not	  seem	  to	  regulate	  Oct4	  and	  Oct4	  does	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not	   appear	   to	   regulate	   JAK/STAT	   signalling.	   Thus,	   Oct4	   functions	   parallel	   to	   the	   LIF	  pathway.	  	  
6.2. Sox2	  Sox2	  is	  a	  member	  of	  a	  high	  mobility	  group	  (HMG)	  box	  DNA	  binding	  domain	  proteins.	  It	  is	  defined	  by	  the	  relationship	  of	  HMG	  box	  to	  the	  testis-­‐determining	  factor	  SRY	  and	  thus	  the	  name	   Sox	   (Sox,	   SRY	   HMG	   box)	   (Bowles	   et	   al.,	   2000).	   It	   plays	   a	   role	   in	   regulating	  transcription	  and	  chromatin	  architecture.	  Along	  with	  Oct4,	   it	   forms	   a	   complex	  on	   the	   enhancer	  DNA	   sequence	  of	  FGF4	   and	   acts	  synergistically	   to	   stimulate	   transcription	   (Ambrosetti	   et	   al.,	   2000).	   This	   interaction	  allows	  Sox2	  to	  play	  a	  role	  in	  the	  regulation	  of	  ICM	  and	  its	  derivatives.	  It	  is	  also	  present	  in	  ESCs	  and	  neural	  stem	  cells.	  Sox2	  null	  embryos	  do	  not	  have	  an	  epiblast,	  but	  this	  condition	  can	   be	   rescued	   by	   injecting	   wild	   type	   ESCs	   into	   the	   Sox-­‐/-­‐	   blastocysts.	   Unlike	   Oct4,	  outgrowths	   of	   Sox2-­‐/-­‐	   embryos	   generate	   colonies	   consisting	   of	   both	   trophectodermal	  and	  primitive	  endodermal	  cell	  types	  (Avilion	  et	  al.,	  2003).	  
6.3. Nanog	  Nanog	   is	   a	   homeodomain	   containing	   transcription	   factor,	   which	   maintains	   ESCs	  pluripotency	  independent	  of	  LIF.	  Wang	  et	  al.	  (2003)	  first	  described	  this	  gene	  as	  an	  ENK	  (early	   embryo	  NK)	   gene	   expressed	   in	   ESCs	   (Wang	   et	   al.,	   2003).	  However,	   its	   function	  was	   unknown	   then.	   It	  was	   later	   recloned	   and	   renamed	   as	   Nanog	   by	  Mitsui	   et	   al.	   and	  Chambers	   et	   al.	   independently	   in	   2003.	   Using	   in	   silico	   differential	   expression	   analysis	  and	   functional	  cDNA	  expression	  cloning,	  Mitsui	  et	  al.	  and	  Chambers	  et	  al.	   respectively,	  identified	  Nanog	  as	  the	  transcription	  factor	  maintaining	  ESCs	  pluripotency	  independent	  of	  LIF-­‐STAT3	  pathway	  (Mitsui	  et	  al.,	  2003)	  (Chambers	  et	  al.,	  2003).	  Nanog	  expression	  is	  first	   detected	   in	   the	   inner	   cells	   of	   the	   compacted	   morulae	   then	   in	   the	   ICM	   of	   the	  blastocyst	   stage	  embryo.	   It	   further	  gets	   restricted	   in	   the	  epiblast.	  Post-­‐implantation,	   it	  can	  be	  detected	  in	  primordial	  germ	  cells	  of	  the	  genital	  ridges.	  Nanog	  mRNA	  is	  enriched	  in	  ESCs,	  EGCs	  and	  ECs	  and	  not	  present	  in	  adult	  tissues	  (Chambers	  et	  al.,	  2003).	  	  Upon	  differentiation,	  Nanog	  expression	  is	  downregulated.	  Physiological	  levels	  of	  Nanog	  do	  not	  prevent	  differentiation	  of	  ESCs	  upon	  LIF	  withdrawal	   thus	  making	   it	   one	  of	   the	  transcription	   factors	   expressed	   in	   the	   pluripotent	   cells,	   which	   disappears	   upon	  differentiation.	  Nanog-­‐/-­‐	  embryos	  develop	  a	  blastocyst	  without	  an	  epiblast.	  It	  is	  possible	  to	   derive	   Nanog-­‐/-­‐	   ESCs	   from	   the	   embryos	   but	   they	   differentiate	   slowly	   into	   extra-­‐embryonic	  endoderm	  lineages	  as	  evident	  from	  the	  absence	  of	  the	  epiblast	  (Mitsui	  et	  al.,	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2003).	  Therefore,	  Nanog	  is	  essential	  for	  the	  maintenance	  of	  epiblast.	  Overexpression	  of	  Nanog	   in	  ESCs	  could	  maintain	   the	  cells	  pluripotent	  even	   in	   the	  absence	  of	  LIF.	   In	  cells	  overexpressing	   Nanog,	   the	   phosphorylation	   levels	   of	   STAT3	   remain	   unchanged	   and	  similarly,	  Nanog	  levels	  are	  not	  affected	  with	  altered	  Stat3	  signalling.	  Inhibition	  of	  Jak,	  an	  upstream	  activator	  of	  Stat3	  also	  does	  not	  modulate	  the	  levels	  of	  Nanog.	  Thus,	  it	  can	  be	  said	   that	   Stat3	  does	  not	   induce	   the	   expression	  of	  Nanog	   and	  Nanog	  does	  not	   regulate	  Stat3	  (Chambers	  et	  al.,	  2003).	  Interestingly,	  it	  has	  also	  been	  shown	  that	  Nanog	  physically	  interacts	   with	   SMAD1,	   thus	   inhibiting	   the	   activity	   of	   BMP	   signalling.	   Henceforth,	  balancing	   ESC	   pluripotency	   and	   differentiation	   by	   negative	   feedback	   mechanism	  between	   the	   two	  (Suzuki	  et	  al.,	  2006).	  This	   suggests	   that	  Nanog	  maybe	  a	  downstream	  effector	  for	  extrinsic	  factors	  (Chambers	  et	  al.,	  2003).	  
6.4. Combinatorial	  signalling	  between	  the	  core	  pluripotency	  factors:	  Oct4,	  Sox2	  
and	  Nanog	  One	   of	   the	  most	   studied	   and	   key	   interacting	   partners	   of	   Oct4	   is	   the	   Sox2.	   Sox2/Oct4	  complex	   has	   been	   shown	   to	   be	   important	   in	   regulating	   many	   genes	   required	   for	  embryogenesis	  and	  for	  ESC	  self-­‐renewal	  and	  pluripotency.	  The	  best	  characterized	  target	  of	  Oct4	  remains	  to	  be	  FGF4.	  In	  1995,	  Yuan	  et	  al.	   identified	  closely	  spaced	  binding	  sites	  for	  Oct4	  and	  Sox2	  on	  the	  FGF4	  enhancer	  and	  showed	  that	  the	  two	  transcription	  factors	  acted	  synergistically	  to	  activate	  the	  transcription	  of	  FGF4	  (Yuan	  et	  al.,	  1995).	  Since	  then,	  it	   has	   been	   shown	   that	   all	   of	   the	   Oct4	   downstream	   targets	   have	   oct/sox	   heptamer	  element	  in	  the	  promoter	  which	  promotes	  the	  binding	  of	  Oct4	  and	  Sox2	  and	  triggers	  the	  transcription	  of	  the	  genes	  like	  Utf1	  and	  Nanog	  (discussed	  below	  in	  detail)	  (Nishimoto	  et	  al.,	   1999)	   (Rodda	   et	   al.,	   2005).	   Oct4	   and	   Sox2	   also	   reciprocally	   regulate	   their	   own	  expression.	  Both	  Pou5f1	  and	  Sox2	  contain	  oct/sox	  elements	  that	  bind	  to	  Oct4	  and	  Sox2.	  Disruption	   of	   their	   own	   oct/sox	   cassettes	   lead	   to	   a	   strong	   reduction	   in	   the	   activity	   of	  Oct4	   and	   Sox2	   promoters	   in	   ESCs	   and	   ECs	   (Chew	   et	   al.,	   2005)	   (Tomioka	   et	   al.,	   2002)	  (Okumura-­‐Nakanishi	  et	  al.,	  2005).	  Thus,	  Oct4	  and	  Sox2	  work	  together	  in	  maintaining	  the	  expression	   of	   essential	   transcription	   factors	   through	   autoregulatory	   and	   multiple	  component	  loop	  network	  motifs.	  Deletion	  of	  Sox2	  in	  ESCs	  triggers	  their	  differentiation	  similar	  to	  Oct4	  deletion.	  However,	  enforced	  expression	  of	  Oct4	  in	  these	  cells	  can	  rescue	  both	  their	  ability	  to	  self-­‐renew	  and	  to	  differentiate	   into	  derivatives	  of	  all	   three	  germ	  layers.	  Thus,	   it	  can	  be	  concluded	  that	  the	  key	  contribution	  of	  Sox2	   is	   to	  maintain	   the	   level	  of	  Oct4.	  Masui	  et	  al.	   showed	   that	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Sox2	  regulates	  Oct4	   transcription	  by	  upregulating	  Nr5a2,	  which	  activates	  Oct4	  and	  by	  downregulating	   Nr2f2,	   which	   represses	   Oct4	   transcription.	   They	   also	   showed	   that	  expression	   of	   Oct/Sox	   target	   genes	   was	   not	   affected	   by	   the	   loss	   of	   Sox2	   probably	  because	  of	   the	   compensatory	  effect	  by	  expression	  of	   other	   Sox	   family	  members,	   Sox4,	  Sox11	   and	   Sox15	   in	   these	   ESCs	   (Masui	   et	   al.,	   2007).	   In	   addition	   to	   these	   knockout	  studies,	  Sox2	  overexpression	  studies	  showed	  a	  negative	  regulatory	  loop	  concerning	  the	  Oct4/Sox2	  target	  genes.	  It	  was	  shown	  that	  overexpression	  of	  Sox2	  not	  only	  inhibited	  the	  activity	   of	   its	   own	   promoter	   but	   also	   the	   activity	   of	   Oct4,	   FGF4,	   Nanog	   and	   Utf1.	  Surprisingly,	  the	  inhibitory	  effect	  observed	  with	  Sox2	  was	  not	  observed	  with	  Oct4.	  This	  led	  to	   the	  hypothesis	   that	  overexpression	  of	  Sox2	   in	  ESCs	  triggers	   their	  differentiation	  (Bernadt	  et	  al.,	  2004)	  (Boer	  et	  al.,	  2007).	  It	  is	  obvious	  from	  the	  findings	  above	  that	  Oct4	  and	   Sox2	   behave	   as	   molecular	   rheostat	   in	   maintenance	   of	   ESC	   self-­‐renewal	   and	  pluripotency.	  Recently,	   researchers	   found	   out	   that	   Nanog	   is	   a	   target	   of	   Oct4/Sox2	   complex.	   The	  promoter	   of	   Nanog	   has	   an	   oct/sox	   element,	  which	   promotes	   the	   binding	   of	   Oct4	   and	  Sox2	  to	  it	  and	  promotes	  the	  transcription	  and	  regulation	  of	  Nanog	  (Kuroda	  et	  al.,	  2005)	  (Rodda	  et	  al.,	  2005).	   It	  has	  been	  shown	  that	  high	   levels	  of	  Nanog	  are	  beneficial	   to	  ESC	  self-­‐renewal.	   However,	   overexpression	   of	  Nanog	   in	   cells	   that	   lacked	   both	   endogenous	  Oct4	   alleles	   and	   were	   cultured	   by	   doxycycline	   regulated	   Oct4	   transgene,	   could	   not	  reverse	   the	   differentiation	   that	   occurred	   due	   to	   repression	   of	   Oct4	   by	   presence	   of	  doxycycline.	   This	   confers	   the	   requirement	   of	   Oct4	   in	   Nanog	   mediated	   self-­‐renewal.	  However,	  Nanog	  expression	  could	  be	   readily	  detected	  even	   in	  Oct4	  deficient	  embryos,	  which	   implies	   that	   Oct4	   is	   not	   essential	   for	   expression	   of	   Nanog	   and	   there	   are	   other	  pluripotency	  factors	  contributing	  to	  the	  regulatory	  mechanisms	  for	  Nanog	  (Chambers	  et	  al.,	  2003).	  In	  a	  recently	  published	  paper	  by	  Pan	  et	  al.,	  a	  negative	  feedback	  loop	  formed	  by	  Nanog,	  Oct4	   and	   another	   pluripotent	   factor	   FoxD3	   is	   described.	   Oct4	   maintains	   Nanog	  expression	   by	   directly	   binding	   to	   its	   promoter	   when	   present	   below	   steady	   state	   but	  represses	   the	   expression	   of	   Nanog	   when	   above	   the	   normal	   level.	   Instead,	   FoxD3	  positively	  regulates	  Nanog	  to	  counter	  the	  inhibition	  by	  excess	  Oct4.	  Conversely,	  Nanog	  and	  FoxD3	  function	  as	  activators	  of	  Oct4	  and	  when	  the	  Oct4	  level	  goes	  above	  the	  steady	  state,	  Oct4	  represses	  its	  own	  promoter	  and	  Nanog	  exerts	  a	  negative	  feedback	  loop	  on	  its	  regulation	  thus	  maintaining	  ESC	  state	  (Fig.	  5)	  (Pan	  et	  al.,	  2006).	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Figure	  5:	  Illustration	  of	  the	  interconnection	  between	  core	  pluripotency	  factors	  The	  core	  regulatory	  network	  of	  ESCs	  is	  centered	  on	  Oct4	  and	  Sox2	  which	  are	  linked	  to	  Nanog,	  which	  is	   individually	  dispensable	  but	  collectively	  sustain	  pluripotency	  of	  ESCs.	  Oct4	  and	  Sox2	  autoregulate	  their	  expression	  and	  contribute	  to	  the	  transcription	  of	  Nanog.	  FoxD3	  positively	  regulates	  the	  expression	  of	  Nanog	  to	  repress	  the	  inhibition	  by	  excess	  Oct4.	  	  Overall,	   this	   study	   suggests	   that	   the	  key	  pluripotency	   factors	   always	  work	   together	   to	  regulate	  both	  their	  expression	  and	  those	  of	   their	  target	  genes	   in	  order	  to	  maintain	  the	  key	  properties	  of	  ESC	  self-­‐renewal	  and	  pluripotency.	  	   	  
Oct4 Nanog FoxD3 	  
Sox2 	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7. Extrinsic	  determinants	  of	  self-­‐renewal	  Three	   distinguishing	   characteristics	   of	   embryonic	   stem	   cells	   are	   pluripotency,	   self-­‐renewal	   and	   indefinite	   cell	   proliferations.	   Several	   exogenous	   factors	   are	   involved	   in	  modulating	   these	   traits	   both	   in	   vivo	   and	   in	   vitro.	   The	   most	   important	   pathways	  regulating	  self-­‐renewal	  in	  mESCs	  are	  those	  mediated	  by	  the	  cytokine	  LIF.	  Recently,	  Wnt	  canonical	  pathway	  has	  also	  been	  shown	  to	  play	  a	  role	   in	  maintenance	  of	  pluripotency.	  Reciprocally,	   it	  also	  plays	  a	  critical	   role	   in	   initiation	  of	   the	   lineage	  commitment.	  These	  different	   outcomes	   have	   created	   enormous	   controversies	   concerning	   Wnt	   signalling.	  The	   role	   of	   LIF	   signalling	   cascade	   and	  Wnt	  pathway	   in	   regard	   to	  maintenance	  of	   self-­‐renewal	  and	  pluripotency	  in	  mESCs	  is	  summarised	  below.	  
7.1. LIF	  signalling	  pathways	  LIF	  belongs	  to	  the	  interleukin-­‐6	  (IL-­‐6)	  cytokine	  family,	  which	  was	  initially	  identified	  by	  its	  activity	  to	  inhibit	  proliferation	  and	  induce	  differentiation	  of	  mouse	  myeloid	  leukemia	  cells	  (Tomida	  et	  al.,	  1984)	  (Gearing	  et	  al.,	  1987).	  It	  was	  later	  discovered	  that	  the	  mESCs	  can	  be	  established	  and	  maintained	  in	  the	  absence	  of	  feeder	  cells	  in	  conditioned	  medium	  prepared	  from	  Buffalo	  rat	  liver	  cells.	  The	  component	  of	  conditioned	  medium	  responsible	  for	   inhibition	   of	   differentiation	   in	   mESCs	   was	   named	   as	   DIA	   (Smith	   et	   al.,	   1988)	  (Williams	  et	  al.,	  1988).	  Eventually,	   investigators	  realized	  that	  the	  two	  proteins	  LIF	  and	  DIA	  were	  identical.	  	  LIF	  activates	  signal	  transduction	  from	  cell	  surface	  receptors.	  The	  LIF	  receptor	  consists	  of	  LIF-­‐specific	   receptor	   subunit	   LIFRβ	   and	   the	   common	   signal	   tranducing	   protein	   gp130	  (Davis	  et	  al.,	  1993).	  LIF	  binds	  directly	   to	   the	  LIFRβ	  that	  subsequently	  heterodimerizes	  with	  gp130	   forming	  a	   trimeric	   complex	   triggering	   three	  different	   signalling	  pathways:	  the	   JAK	   (Janus	   Kinase)/STAT3	   (signal	   transducer	   and	   activator	   of	   transcription	   3)	  pathway;	   the	  PI3K	  (phosphoinositide	  3	  kinase)/AKT	  pathway;	  and	  SHP2	  (SH2	  domain	  containing	  tyrosine	  phosphatase	  2)/MAPK	  (mitogen	  activated	  protein	  kinase)	  pathway	  (Fig.	  6).	  	  
Introduction	   	   29	  
	  
Figure	  6:	  LIF	  signalling	  cascade	  LIF/JAK/STAT3	   and	   LIF/PI3K/AKT	   pathway	   are	   involved	   in	   maintenance	   of	   self-­‐renewal	   and	   pluripotency.	  LIF/SHP2/MAPK	  pathway	  is	  involved	  in	  differentiation	  processes.	  (Graf	  et	  al.,	  2011)	  	  
7.1.1. LIF/JAK/STAT3	  signalling	  	  The	  tyrosine	  kinase	  JAK	  is	  constitutively	  bound	  to	  the	  gp130	  in	  its	  inactive	  form.	  Upon	  LIF	  binding,	  LIFRβ	  recruits	  gp130	  to	   form	  a	  heterodimer,	  which	  activates	   JAK	  through	  transphosphorylation	  within	   a	   single	   JAK	   or	   between	   two	   JAKs	   (Burdon	   et	   al.,	   2002).	  Among	  the	  four	  JAKs	  known,	  JAK1	  and	  JAK2	  are	  the	  important	  ones	  involved	  in	  the	  LIF	  signalling	  pathways.	  Activated	  JAKs	  phosphorylate	  the	  tyrosine	  residues	  on	  intracellular	  domain	   of	   gp130,	  which	   then	   act	   as	   a	   docking	   site	   for	   SH2	   domain	   of	   STAT3.	   STAT3	  proteins	   are	   then	   phosphorylated	   at	   Tyr705	   by	   JAKs,	   which	   mediates	   interaction	  between	  phosphorylated	  Tyr705	  of	  one	  STAT3	  with	  the	  SH2	  domain	  of	  the	  other	  leading	  to	   the	   formation	   of	   homodimers.	   By	   inducing	   dimerization	   of	   STAT3,	   Bromberg	   et	   al.	  (1999)	  have	  shown	  that	  spontaneous	  dimerization	  leads	  to	  constitutively	  active	  STAT3	  independent	  of	  Tyr705	  phosphorylation	  (Bromberg	  et	  al.,	  1999).	  Dimerized	  STAT3	  then	  binds	   to	   nuclear	   import	   proteins,	   importin-­‐alpha3	   and	   importin-­‐alpha6	   and	   is	  translocated	  to	  the	  nucleus.	  Shuttling	  of	  STAT3	  between	  nucleus	  and	  cytoplasm	  occurs	  constantly	   independent	   of	   Tyr705	   phosphorylation.	   Phosphorylation	   of	   Ser727	   on	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STAT3	  has	  also	  been	  shown	  to	  be	  important	  for	  transactivation	  of	  STAT3,	  although	  the	  mechanism	  still	  remains	  unknown	  (Zhang	  et	  al.,	  1995)	  (Wen	  et	  al.,	  1995).	  Three	  protein	   families	  negatively	  regulate	   the	   JAK/STAT	  pathway:	  Phosphatases;	  PIAS	  (protein	  inhibitor	  of	  activated	  STAT);	  and	  SOCS3	  (Heinrich	  et	  al.,	  2003).	  It	  is	  not	  known	  whether	  the	  former	  two	  are	  involved	  in	  the	  LIF/STAT3	  pathway.	  However,	  the	  latter	  one	  is	   upregulated	   upon	   LIF	   stimulation	   and	   acts	   by	   inhibiting	   JAKs	   by	   inserting	   their	  inhibitory	  region	  into	  the	  activation	  domain	  of	  JAKs	  (Boyle	  et	  al.,	  2009).	  STAT3	   is	   an	   essential	   component	   for	   self-­‐renewal	   and	   pluripotency	   of	   mESCs	   in	   the	  presence	  of	  FBS.	  Inhibition	  of	  STAT3	  through	  use	  of	  dominant	  negative	  mutant	  of	  STAT3	  prevented	   its	   activation	   resulting	   in	   differentiation	   of	   mESCs	   (Niwa	   et	   al.,	   1998).	  Furthermore,	  evidence	  to	  prove	  its	  sufficiency	  in	  maintenance	  of	  pluripotency,	  Matsuda	  
et	   al.	   used	   a	   chimaeric	   STAT3-­‐estrogen	   receptor	   (STAT3ER)	   which	   induced	  phosphorylation	   of	   Tyr705	   upon	   addition	   of	   4-­‐hydroxytamoxifen	   (4-­‐OHT),	   leading	   to	  self-­‐renewal	  of	  mESCs	  in	  presence	  of	  FBS	  without	  either	  LIF	  or	  feeder	  cells	  (Matsuda	  et	  al.,	  1999).	  Another	  study	  confirming	  the	  importance	  of	  STAT3	  in	  mESCs	  was	  carried	  out	  by	   Cinelli	   et	   al.	   (2008),	   where	   germline	   competent	   ESCs	   from	   non	   permissive	   FVB/N	  mouse	  strains	  using	  STAT3ER	  inducible	  system	  were	  generated	  in	  absence	  of	  LIF	  upon	  addition	  of	  4-­‐OHT	  (Cinelli	  et	  al.,	  2008).	  Although,	   the	   importance	   of	   LIF	   and	   STAT3	   in	   self-­‐renewal	   of	   mESCs	   is	   thouroughly	  documented,	   the	   downstream	   target	   genes	   of	   STAT3	   have	   remained	   elusive.	   Two	  different	   ways	   applied	   to	   understand	   how	   STAT3	   regulates	   pluripotency	   include	  identification	  of	  target	  genes	  of	  STAT3	  and	  analysis	  of	  protein	  interactions	  with	  STAT3.	  Various	  research	  groups	  have	  employed	  genome-­‐wide	  approaches	  like	  ChIP	  (chromatin	  immunoprecipitation)	   sequencing,	   ChIP	   on	   chip	   and	   DNA	   microarray.	   One	   of	   the	  microarray	  analysis	  study	  done	  on	  STAT3ER	  ESCs	  identified	  a	  group	  of	  26	  STAT3	  target	  genes.	  The	  expression	  of	  the	  four	  of	  the	  upregulated	  genes	  was	  restricted	  to	  the	  ICM	  of	  the	   blastocyst.	   Overexpression	   of	   two	   of	   these	   genes,	   Pem/Rhox5	   and	   Pramel7	  respectively,	  in	  absence	  of	  LIF,	  was	  shown	  to	  be	  sufficient	  to	  maintain	  the	  expression	  of	  pluripotent	  ESCs	  markers	  (Cinelli	  et	  al.,	  2008).	  Recently,	  Casanova	  et	  al.	  (2011)	  reported	  that	  Pramel7	  mediated	  LIF/STAT3	  dependent	  self-­‐renewal	  in	  mESCs	  and	  ablation	  of	  the	  former	   induced	   differentiation	   of	   mESCs	   (Casanova	   et	   al.,	   2011).	   Cartwright	   and	  colleagues	  have	  also	  shown	  a	  role	  for	  the	  transcription	  factor	  c-­‐myc	  in	  self-­‐renewal	  by	  functioning	   as	   a	   downstream	   STAT3	   target.	   It	   is	   rapidly	   downregulated	   following	   LIF	  withdrawal.	  Overexpression	  of	  c-­‐myc	  can	  retain	  cells	  in	  an	  undifferentiated	  state	  even	  in	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the	   absence	   of	   LIF	   where	   as	   expression	   of	   dominant	   negative	   form	   of	   it	   promotes	  differentiation	  (Cartwright	  et	  al.,	  2005).	  The	  transcription	  factor	  Klf4	  (Kruppel	  type	  zinc	  finger	   4)	   is	   another	   downstream	   target	   of	   STAT3,	   which	   maintains	   mESCs	   in	   an	  undifferentiated	  state	  and	  overexpression	  of	  which	  upregulates	  the	  expression	  of	  Oct4	  and	  self-­‐renewal	  of	  mESCs	  (Li	  et	  al.,	  2005).	  Together,	  these	  data	  shed	  some	  light	  on	  the	  mechanism	  involved	  in	  maintenance	  of	  self-­‐renewal	  through	  JAK/STAT3	  pathway.	  
7.1.2. LIF/PI3K/AKT	  signalling	  PI3K	  pathway	  is	  important	  for	  cell	  proliferation,	  survival	  and	  self-­‐renewal	  of	  ESCs.	  Upon	  binding	  of	  LIF,	  gp130	  receptor	  undergoes	  phosphorylation	  of	  Tyr757,	  which	  promotes	  recruitment	   of	   SHP2	   to	   the	   receptor.	   The	   SHP2	   is	   then	   phosphorylated	   in	   a	   JAK	  dependent	   manner	   and	   associates	   itself	   with	   the	   scaffold	   protein	   GAB1	   (GRB2-­‐associated	  binder	  protein),	  which	  then	  recruits	  PI3K	  to	  the	  cell	  membrane.	  PI3K	  is	  then	  activated	  via	  phosphorylation	  of	   its	   regulatory	   subunit	  p85	  and	   leads	   to	  generation	  of	  PIP2	   (phosphatidylinositol-­‐3,	   4-­‐biphosphate)	   and	   PIP3	   (phosphatidylinositol-­‐3,4,5-­‐trisphosphate).	   PIP2	   and	   PIP3	   are	   ligands	   for	   the	   PH	   domains	   of	   various	   signal	  transducers	   including	   serine/threonine	   kinases,	   PDK1	   (phosphoinositide-­‐dependent	  kinase	  1)	  and	  PKB/AKT	  (protein	  kinase	  B).	  AKT	  binds	  to	  PIP3	  and	  is	  translocated	  to	  the	  inner	  cell	  membrane	  where	  it	   is	  phosphorylated	  and	  activated	  by	  PDK1	  (Burdon	  et	  al.,	  2002).	  AKT	  inhibits	  GSK3β	  (glycogen	  synthase	  kinases	  3b),	  one	  of	  the	  major	  proteins,	  by	  two	  different	  mechanisms.	  Firstly,	  it	  directly	  inhibits	  GSK3β	  activity	  by	  phosphorylation	  of	   Ser9	   and	   secondly,	   facilitates	   nuclear	   export	   of	   GSK3β	   independently	   of	   its	  phosphorylation,	   thus	  blocking	   its	   action	  on	   target	  proteins	   in	   the	  nucleus	   (Doble	  and	  Woodgett,	   2003)	   (Bechard	   and	   Dalton,	   2009).	   GSK3β	   promotes	   ubiquitination	   and	  degradation	   of	   c-­‐myc	   by	   phosphorylation	   of	   Thr58	   (Bechard	   and	   Dalton,	   2009)	  (Cartwright	   et	   al.,	   2005).	   It	   also	   phosphorylates	   and	   activates	   p53,	   which	   promotes	  differentiation	  of	  mESCs	  by	  suppressing	  Nanog	  expression	  (Lin	  et	  al.,	  2005)	  (Storm	  et	  al.,	  2007).	  Thus,	   inhibition	  of	  GSK3β	  results	   in	  an	  increase	  of	  c-­‐myc	  and	  Nanog	  expression	  both	   of	   which	   play	   an	   important	   role	   in	   self-­‐renewal	   of	   mESCs.	   GSK3β	   also	   plays	   a	  pivotal	   role	   in	   self-­‐renewal	   of	   mESCs	   via	   Wnt	   pathway	   discussed	   later	   in	   detail.	  Although,	  LIF/PI3K/AKT	  pathway	  and	  Wnt	  canonical	  pathway	  have	  GSK3β	  in	  common,	  these	   pathways	   work	   independent	   of	   each	   other.	   Treatment	   of	   mESCs	   with	   LIF	   or	  enhanced	  activation	  of	  AKT	  does	  not	  increase	  the	  levels	  of	  b-­‐catenin.	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The	  LIF/PI3K/AKT	  pathway	  also	  plays	  a	  role	  in	  acetylation	  of	  lysine	  residues	  on	  STAT3	  (Ohbayashi	  et	  al.,	  2007).	  Acetylated	  STAT3	  forms	  more	  stable	  dimers	  and	  promotes	  the	  transcription	   of	   target	   genes	   without	   phosphorylation	   of	   Tyr705	   (Braunstein	   et	   al.,	  2003).	  However,	  this	  has	  not	  been	  shown	  in	  ESCs.	  The	  LIF/PI3K/AKT	  pathway	  has	  been	  associated	  with	  ESCs	  propagation	  through	  studies	  carried	  out	  on	  PTEN,	  which	   is	   a	   lipid	  phosphatase	   that	   acts	   as	   a	  negative	   regulator	  of	  PI3K	   pathway.	   It	   removes	   the	   phosphate	   from	   the	   3’	   position	   of	   3-­‐phosphoinositides.	  PTEN	  knockout	  ESCs	  have	  been	  shown	  to	  possess	  enhanced	  cell	  viability	  and	  increased	  rate	  of	   cell	  proliferation.	  These	  attributes	  are	  correlated	  with	   the	  elevated	  amounts	  of	  PIP3	  enhanced	  phosphorylation	  of	  PKB	  and	  inhibition	  of	  pro-­‐apoptotic	  protein	  Bad	  (Sun	  et	  al.,	  1999).	  It	  has	  also	  been	  shown	  by	  Paling	  et	  al.	  (2004)	  that	   inhibiton	  of	  PI3K	  with	  both	  a	  reversible	  inhibitor	  and	  a	  dominant	  negative	  p85	  subunit	  resulted	  in	  decrease	  of	  phosphorylated	   AKT,	   GSK3β	   and	   ribosomal	   S6	   proteins,	   increase	   in	   ERK1/2	  phosphorylation	  and	  decline	   in	   the	  ability	  of	   the	  mESCs	   to	   self-­‐renew.	  PI3K	   inhibition	  has	   no	   influence	   on	   the	   LIF/STAT3	   pathway	   (Paling	   et	   al.,	   2004).	   Inhibition	   of	   MEK	  reverses	   the	   effects	   of	   PI3K	   inhibition	   suggesting	   that	   PI3K	   pathway	   maintains	   self-­‐renewal	  by	  blocking	  ERK1/2	  pathway	  discussed	  below.	  Watanabe	  et	  al.	  (2006)	  showed	  that	  AKT	  activation,	  induced	  by	  transfecting	  constitutively	  active	  AKT	  gene,	  is	  sufficient	  for	   self-­‐renewal	   of	  mESCs	   in	   the	   absence	   of	   LIF	   and	   feeders	   (Watanabe	   et	   al.,	   2006).	  Thus,	   the	   studies	   above	   indicate	   a	   significant	   role	   of	   LIF/PI3K/AKT	   pathway	   in	   self-­‐renewal	  of	  mESCs.	  
7.1.3. LIF/SHP2/MAPK	  signalling	  The	  third	  LIF	  signalling	  pathway	  is	  less	  well	  characterized	  and	  is	  not	  directly	  involved	  in	  the	  maintenance	  of	  self-­‐renewal	  in	  ESCs.	  It	  regulates	  various	  different	  cellular	  responses	  and	  has	  a	  well-­‐documented	  function	  in	  proliferation	  and	  differentiation.	  	  Binding	   of	   LIF	   to	   the	   LIF	   receptor	   induces	   phosphorylation	   of	   gp130	   via	   JAK	   as	  mentioned	  above.	  This	   leads	   to	   the	  recruitment	  and	  phosphorylation	  of	  SHP2	  by	   JAKs.	  SHP2	   then	   binds	   to	   Grb2	   (Growth	   factor	   receptor	   bound	   protein	   2)-­‐SOS	   (son	   of	  sevenless)	  complex,	  which	  promotes	  activation	  of	  Ras.	  SHP2	  also	  associates	   itself	  with	  Gab1	  as	  mentioned	  above,	  which	  stabilizes	  the	  SHP2-­‐Gab1-­‐Grb2	  complex	  and	  enhances	  the	  effect	  of	  Ras	  This	  activation	  sets	  off	  a	  cascade	  of	  transphosphorylation	  involving	  Raf	  and	   MAPK	   kinase	   (MEK)	   kinases	   that	   together	   contributes	   to	   activation	   of	   ERK	  (Extracellular	   signal	   related	   kinases).	   Activated	   ERK	   can	   then	   phosphorylate	  
Introduction	   	   33	  
cytoplasmic	   targets	   and	   also	   be	   translocated	   to	   the	   nucleus	   where	   it	   modulates	   the	  activity	  of	  various	  transcriptional	  factors	  such	  as	  c-­‐Jun,	  c-­‐Fos,	  Ets	  and	  Elk	  (Kolch,	  2000).	  This	  pathway	  is	  known	  to	  induce	  differentiation	  of	  mESCs	  by	  downregulating	  Nanog	  and	  
Tbx3	   (Niwa	   et	   al.,	   2009)	   (Hamazaki	   et	   al.,	   2006).	   The	  Ras/Raf/MEK/ERK	   cascade	   can	  also	  induce	  differentiation	  of	  mESCs	  via	  activation	  by	  FGF4.	  Inhibition	  of	  ERK	  pathway	  either	  by	  use	  of	   small	  molecules	   to	  block	  MEK	  activity	  or	  by	   forced	  expression	  of	  Erk	  phosphatases	  enhances	  self-­‐renewal	  of	  mESCs	  by	  reducing	  differentiation	  (Burdon	  et	  al.,	  1999b).	   Inhibition	  of	  ERK	  enhances	   the	  activity	  of	  STAT3	  but	   it	   is	  not	  known	  whether	  the	  effect	  is	  direct	  or	  indirect.	  Thus,	  the	  balance	  between	  the	  two	  pathways	  converging	  downstream	   of	   LIF	   determines	   the	   choice	   between	   self-­‐renewal	   and	   differentiation	  (Burdon	  et	   al.,	   1999a).	   In	  mESCs,	  deletion	  of	   SHP2	  binding	   site	   from	  chimaeric	   gp130	  receptor	  blocks	  its	  association	  with	  Ras	  and	  promotes	  self-­‐renewal	  response	  (Burdon	  et	  al.,	  1999b).	  Genetic	  disruption	  of	  Grb2	  results	  in	  impaired	  differentiation,	  which	  can	  be	  rescued	  either	  by	  introducing	  Grb2-­‐SOS	  chimaera	  or	  an	  active	  form	  of	  Ras	  into	  the	  Grb2	  knockout	   ESCs	   (Cheng	   et	   al.,	   1998).	   Taken	   together,	   these	   results	   suggest	   that	   the	  LIF/SHP2/MAPK	   pathway	   promotes	   differentiation	   of	   mESCs	   and	   suppresses	   self-­‐renewal	  response.	  
7.2. Wnt	  signalling	  pathway	  Wnt	  signalling	  represents	  one	  of	  the	  key	  pathways	  involved	  in	  multiple	  developmental	  events	  during	  the	  entire	  lifespan	  of	  an	  organism.	  It	  contributes	  to	  the	  establishment	  of	  body	   axis	   and	   organogenesis	   during	   embryo	   development	   and	   in	   adult,	   it	   plays	  indispensable	   roles	   in	   tissue	   homeostasis,	   cell	   renewal	   and	   regeneration.	   Historically,	  Wnt	   signalling	   is	   categorized	   into	   two	   types-­‐	   canonical	   and	   non-­‐canonical	   pathway	  according	   to	   their	   dependence	   on	   β-­‐catenin.	   The	   canonical	   pathway	   revolves	   around	  stabilization	  and	  translocation	  of	  β-­‐catenin	  into	  the	  nucleus,	  which	  triggers	  transcription	  of	   various	   Wnt	   target	   genes.	   Non-­‐canonical	   pathway,	   on	   the	   other	   hand,	   involves	   all	  Wnt-­‐activated	  signalling	  pathways	  that	  do	  not	  promote	  β-­‐catenin	  dependent	  signalling	  and	   includes	   the	  planar	  cell	  polarity	  pathway	   that	  controls	  structuring	  of	  cytoskeleton	  and	   the	   Wnt/Ca	   pathway	   that	   plays	   a	   role	   in	   cell	   adhesion,	   migration	   and	   tissue	  separation	   (Tada	   et	   al.,	   2002)	   (Kühl	   et	   al.,	   2000).	   Wnt	   canonical	   pathway	   has	   been	  shown	  to	  play	  a	  role	  in	  self-­‐renewal	  of	  ESCs.	  However,	  this	  function	  of	  Wnt	  signalling	  is	  relatively	   complex	   and	   controversial	   as	   Wnt	   signalling	   mainly	   contributes	   to	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organogenesis	  and	  differentiation	  of	  ESCs.	  I	  will	  focus	  on	  Wnt	  canonical	  pathway	  and	  its	  role	  in	  maintaining	  pluripotency	  of	  ESCs	  below.	  In	  the	  absence	  of	  Wnt	  signal,	  the	  destruction	  complex	  regulates	  the	  stability	  of	  b-­‐catenin,	  which	   is	   a	   key	   component	   of	   the	   signalling	   output	   of	   Wnt	   canonical	   pathway.	   The	  multiprotein	   destruction	   complex	   consists	   of	   the	   scaffold	   proteins	   Axin	   and	   APC	  (Adenoma	  Polyposis	  Coli)	  and	  two	  constitutively	  active	  serine	  threonine	  kinases	  GSK3β	  and	  CK-­‐1	  (Casein	  kinase	  1).	  When	  Fz	  (Frizzled)/LRP	  (low	  density	   lipoprotein	  receptor	  related	  proteins)	   receptor	   are	  not	  bound	  by	  Wnt,	  GSK3β	  and	  CK1	  phosphorylate	  Axin	  bound	  β-­‐catenin	   at	   its	   ser/thr	   residues.	  This	   complex	   is	   then	   recognized	  by	   the	  F-­‐box	  WD	   repeat	   protein	   b-­‐TrCP,	   a	   component	   of	   an	   E3	   ubiquitin	   ligase	   complex	   where	   β-­‐catenin	  undergoes	  ubiquitination	  and	  rapid	  degradation	  by	   the	  proteasome	   (Aberle	  et	  al.,	  1997),	   thus	  blocking	  β-­‐catenin	  dependent	  activation	  of	   target	  genes	   in	   the	  nucleus.	  Upon	   activation	   of	   receptors	   by	  Wnt	   ligands,	   Dvl	   (Dishevelled)	   is	   recruited	   to	   the	   the	  receptor	   complex	   where	   it	   subsequently	   multimerises	   and	   induces	   formation	   of	   LRP	  associated	  Wnt	  signalosomes,	  which	  recruits	  Axin	   to	   the	  phosphorylated	  LRP	  receptor	  along	   with	   the	   kinases,	   thus	   destablilising	   β-­‐catenin	   degradation	   complex	   (Schwarz-­‐Romond	   et	   al.,	   2007)	   (Bilic	   et	   al.,	   2007).	   Recent	   studies	   by	   Li	   et	   al	   (2012),	   show	   that	  activation	  of	  Wnt	  signal	   leads	   to	   inhibition	  of	  β-­‐catenin	  ubiquitination	  by	  E3	  Ubiquitin	  ligase	   complex.	   The	   complex	   becomes	   saturated	   by	   phosphorylated	   form	   of	   β-­‐catenin	  and	  the	  newly	  synthesized	  β-­‐catenin	  thus	  accumulates	  in	  the	  cytoplasm	  and	  eventually	  translocates	  to	  the	  nucleus	  to	  activate	  Wnt	  target	  genes	  (Li	  et	  al.,	  2012).	  The	  mechanism	  behind	   the	   shuttling	  of	  β-­‐catenin	  between	   the	  cytoplasm	  and	  nucleus	   is	   still	  not	   clear,	  although	   the	   recent	   data	   suggests	   a	   function	   for	   microtubules	   in	   its	   nuclear	   import	  (Sugioka	   et	   al.,	   2011).	   β-­‐catenin	   also	   plays	   another	   role,	   independent	   of	   its	   signalling	  function,	   in	   the	   cell	   adhesion	   system	  where	   it	   binds	   to	   the	   intracellular	   domain	   of	   E-­‐cadherins	  (Peifer	  et	  al.,	  1992).	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Figure	  7:	  Different	  faces	  of	  β	  -­‐catenin	  Β-­‐catenin	  plays	  a	  dual	  role	  in	  the	  cell.	  At	  the	  adherens	  junctions,	  it	  binds	  to	  E-­‐cadherin	  and	  a-­‐catenin	  and	  modulates	  the	  actin	  cytoskeleton.	  Free	  b-­‐catenin,	  which	  is	  not	  involved	  in	  cell	  adhesion	  system	  is	  phosphorylated	  by	  degradation	  complex	  and	  degraded.	   In	   the	  presence	  of	  Wnt	  signalling,	  activity	  of	  destruction	  complex	   is	   inhibited	  and	  β-­‐catenin	  degradation	   is	   blocked.	   Free	   β-­‐catenin	   is	   then	   translocated	   to	   the	   nucleus	   where	   it	   binds	   to	   TCF/LEF	   family	   of	  transcription	   factors	  and	  others	   to	   initiate	   transcription	  of	  Wnt	   target	  genes.	  Amount	  of	  β-­‐catenin	   in	   the	  nucleus	   is	  modulated	   by	   its	   nuclear	   import/export.	   CTTA-­‐	   C	   terminal	   transcriptional	   activators;	   NTTA-­‐	   N-­‐terminal	  transcriptional	  activators.	  Taken	  from	  (Valenta	  et	  al.,	  2012)	  	  In	  the	  nucleus,	  β-­‐catenin	  can	  activate	  transcription	  of	  its	  target	  genes	  by	  binding	  to	  DNA	  binding	  partners,	  which	  bring	  it	  to	  the	  promoters	  of	  the	  target	  genes.	  As	  β-­‐catenin	  does	  not	  possess	  DNA	  binding	  domain,	  it	  can	  initiate	  transcription	  only	  by	  being	  a	  member	  of	  multimeric	  complexes	  (Huber	  et	  al.,	  1997)	  (Xing	  et	  al.,	  2008).	  In	  the	  Wnt	  off	  state,	  TCFs	  act	  as	  transcriptional	  repressors	  by	  binding	  to	  Groucho/TLE	  (transducing-­‐like	  enhancer	  of	   split)	   transcriptional	   repressors	  preventing	  gene	   transcription	   (Cavallo	  et	  al.,	  1998)	  (Roose	   et	   al.,	   1998).	   In	   the	   Wnt	   on	   state,	   binding	   of	   β-­‐catenin	   physically	   replaces	  Groucho/TLE	   and	   converts	   TCFs	   into	   transcriptional	   activator	   of	   Wnt	   target	   genes	  (Daniels	  and	  Weis,	  2005).	  β-­‐catenin	  acts	  as	  the	  central	  transcriptional	  activator	  of	  Wnt	  target	   genes.	   TCF	   (T-­‐cell	   factor)/Lef	   (Lymphoid	   enhancer	   factor)	   transcription	   factors	  act	  as	  the	  main	  nuclear	  partners	  of	  b-­‐catenin.	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Mammals	  possess	  four	  TCF	  genes:	  TCF1,	  TCF3,	  TCF4	  and	  LEF1	  amongst	  which	  TCF3	  is	  the	  most	  abundant	   in	  ESCs.	  TCF3	  has	  been	  shown	  to	  colocalise	  with	  core-­‐pluripotency	  associated	  factors	  Oct4,	  Sox2	  and	  Nanog	  including	  their	  own	  promoters.	  This	  study	  also	  showed	  that	  knockdown	  of	  TCF3	  in	  mESCs	  lead	  to	  upregulation	  of	  Oct4,	  Sox2	  and	  Nanog	  suggesting	   that	   TCF3	   acts	   as	   a	   transcriptional	   repressor	   (Cole	   et	   al.,	   2008).	  Independently,	   Pereira	   et	   al.	   (2006)	   also	   demonstrated	   inhibition	   of	   Nanog	   by	   TCF3	  (Pereira	  et	  al.,	  2006).	  Recently,	  Smith	  and	  colleagues	  extended	  these	  findings	  by	  showing	  that	   inhibition	  of	  GSK3β	   induces	   interaction	  of	  β-­‐catenin	  with	  TCF3,	  which	   inhibits	   its	  repressive	  effect	  on	  the	  activity	  of	  core	  pluripotency	  factors	  (Wray	  et	  al.,	  2011).	  This	  is	  consistent	  with	  the	   findings	   from	  two	  studies	  where	  TCF3	  null	  ESCs	  are	  pluripotent	   in	  the	  absence	  of	  LIF,	  replace	  the	  requirement	  of	  GSK3β	  inhibitor	  in	  defined	  conditions	  and	  overexpression	   of	   it	   destabilizes	   self-­‐renewal	   even	   in	   the	   presence	   of	   LIF	   and	   serum	  (Wray	  et	  al.,	  2011)	  (Yi	  et	  al.,	  2008).	  Recently,	  Smith	  and	  colleagues	  identified	  Esrrb	  as	  a	  direct	  functional	  target	  of	  TCF3	  downstream	  of	  GSK3β	  inhibition.	  It	  is	  both	  essential	  and	  sufficient	   for	   the	   response	   to	   GSK3β	   inhibition.	   Knockdown	   of	   Esrrb	   even	   in	   the	  presence	   of	   GSK3β	   inhibitor	   led	   to	   the	   loss	   of	   pluripotency	   markers.	   Conversely,	  overexpression	   of	   it	   phenocopied	   GSK3β	   inhibition	   or	   TCF3	   deletion	   by	   blocking	  differentiation	  of	  ESCs	  (Martello	  et	  al.,	  2012).	  However,	  Merrill	  and	  colleagues	  revealed	  that	   this	  cannot	  be	  the	  only	  mode	  of	  action.	  They	  showed	  that	  β-­‐catenin	   inhibits	  TCF3	  mediated	   repression	   and	   activates	   target	   genes	   together	   with	   TCF1	   (Yi	   et	   al.,	   2011).	  Thus,	   TCF3	   and	   TCF1	   combination	   contributes	   to	  Wnt	   stimulated	   self-­‐renewal.	   Albeit	  TCF/Lef	  dependent	  β-­‐catenin	  mediated	  transcription,	  β-­‐catenin	  has	  also	  been	  shown	  to	  physically	  interact	  and	  form	  a	  complex	  with	  Oct4	  and	  promotes	  the	  activity	  of	  the	  latter	  to	  regulate	  pluripotency	  (Kelly	  et	  al.,	  2011).	  	  ten	  Berge	  et	  al.	  have	  recently	  reported	  the	  physiological	  role	  of	  canonical	  Wnt	  pathway.	  They	   showed	   that	   Wnt3a	   protein	   secreted	   by	   mESCs	   in	   combination	   with	   LIF	   can	  support	  the	  expansion	  of	  mESCs.	  Inhibition	  of	  paracrine	  or	  autocrine	  activity	  of	  Wnt	  by	  blocking	  Wnt	  secretion	  or	  Wnt	  neutralization	  after	  secretion	  results	  in	  the	  transition	  of	  mESCs	   to	  mEpiSCs.	  Their	  demonstration	   that	  Wnt3a	  can	  replace	  GSK3β	   inhibitor	   in	  2i	  condition	   indicated	   that	   inhibition	  of	  GSK3β	   is	   attributed	   to	   its	   ability	   to	  activate	  Wnt	  pathway	  probably	   through	  the	  role	  of	  TCF3	   in	  regulating	  core	  pluripotency	  genes	  (ten	  Berge	  et	  al.,	  2011).	  However,	  there	  is	  no	  clear-­‐cut	  evidence	  to	  prove	  that	  Wnt	  canonical	  pathway	  alone	  is	  sufficient	  to	  maintain	  long-­‐term	  self-­‐renewal	  of	  mESCs.	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In	  addition	  to	  this,	  impact	  of	  deletion	  of	  β-­‐catenin	  in	  mESCs	  still	  remains	  a	  controversy.	  Lyashenko	  et	  al.	  reported	  that	  β-­‐catenin	  null	  mESCs	  remain	  pluripotent	  whereas	  earlier	  studies	  suggested	  that	  ablation	  of	  β-­‐catenin	  promotes	  transition	  to	  EpiSCs	  (Lyashenko	  et	  al.,	  2011)	  (Anton	  et	  al.,	  2007)	  (Soncin	  et	  al.,	  2009).	  These	  discrepancies	  in	  the	  phenotype	  can	  be	  due	  to	  the	  different	  genetic	  background	  of	  these	  mESCs	  lines.	  Indeed,	  Hanna	  et	  al.	  found	  that	  the	  stability	  of	  naïve	  pluripotent	  state	  in	  LIF	  and	  serum	  condition	  depends	  on	  the	  genetic	  background	  (Hanna	  et	  al.,	  2009).	  Thus,	  further	  studies	  need	  to	  be	  carried	  out	  to	   provide	   an	   important	   insight	   into	   the	   role	   of	   Wnt	   signalling	   in	   maintenance	   of	  pluripotency	  and	  self-­‐renewal.	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8. Gene	  of	  interest:	  Pramel7	  In	  mouse,	  Pramel7	  is	  present	  on	  chromosome	  2D	  and	  consists	  of	  conserved	  leucine	  rich	  repeats	   essential	   for	  protein-­‐protein	   interactions	  and	   lacks	   conserved	  domains	   typical	  for	   transcription	   factors	   thus	   does	   not	   directly	   play	   a	   role	   in	   gene	   transcription	  regulation.	  Two	  studies	  carried	  out	  by	  Cinelli	  and	  colleagues	  demonstrate	  Pramel7	  as	  a	  gene	  involved	  in	  maintenance	  of	  pluripotency	  in	  mESCs	  (Cinelli	  et	  al.,	  2008)	  (Casanova	  et	   al.,	   2011).	   It	   was	   initially	   found	   in	   a	   microarray	   study	   carried	   out	   by	   Cinelli	   et	   al.	  (2008)	   that	   Pramel7	   was	   strongly	   upregulated	   in	   conditionally	   overexpressing	   Stat3	  ESCs	   (Cinelli	   et	   al.,	   2008).	   In	   vivo	   analysis	   of	   wild	   type	   pre-­‐implantation	   embryos	  revealed	   expression	   of	   Pramel7	   in	   central	   part	   of	   the	   morula	   and	   the	   ICM	   of	   the	  blastocyst.	  Its	  expression	  was	  absent	  in	  the	  post-­‐implantation	  stage	  embryos	  indicating	  a	   possible	   role	   in	   maintenance	   of	   pluripotency	   in	   vivo.	   In	   vitro,	   ESCs	   overexpressing	  Pramel7	  can	  be	  propagated	  for	  several	  passages	  even	  in	  the	  absence	  of	  LIF.	  It	  has	  also	  been	  shown	  that	  overexpression	  of	  Pramel7	  prevents	  ESCs	  differentiation	  by	  promoting	  gradual	   reduction	   of	   Erk	   phosphorylation.	   Despite	   the	   presence	   of	   LIF	   and	  overexpression	  of	  STAT3	  in	  ESCs,	  knockdown	  of	  Pramel7	  induces	  differentiation	  of	  ESCs.	  Henceforth,	   it	   can	   be	   said	   that	   LIF	   mediated	   self-­‐renewal	   is	   dependent	   on	   Pramel7	  expression.	   However,	   unlike	   WT	   ESCs,	   LIF	   induction	   on	   Stat3	   null	   ESCs	   did	   not	  upregulate	  Pramel7	  transcription	  confirming	  that	  Pramel7	  is	  a	  direct	  downstream	  target	  of	   LIF/Stat3	   pathway.	   Interestingly,	   the	   basal	   level	   of	   Pramel7	   in	   Stat3	   null	   ESCs	   is	  higher	  than	  in	  WT	  ESCs	  suggesting	  a	  parallel	  pathway	  controlling	  Pramel7	  transcription.	  In	  presence	  of	  2i,	  upregulation	  of	  Pramel7	  upon	  LIF	  induction	  was	  significantly	  delayed.	  Intriguingly,	   presence	   of	   CH,	   an	   inhibitor	   of	   GSK3β,	   impaired	   the	   transcription	   of	  Pramel7	  in	  WT	  ESCs	  (Casanova	  et	  al.,	  2011).	  Taken	  together,	  these	  results	  suggest	  that	  the	   combined	   activity	   of	   LIF/STAT3	  pathway	   and	   one	   of	   the	  GSK3β	  pathways	   control	  
Pramel7	  transcriptional	  regulation.	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9. Goal	  of	  the	  thesis	  The	   overall	   aim	   of	   the	   thesis	   is	   to	   gain	   insight	   into	   different	   mechanisms	   regulating	  pluripotency	   in	  mouse	   and	   rat	   embryonic	   stem	   cells.	   The	   present	   thesis	   comprises	   of	  two	  projects:	  
• Project	   I:	  Establishment	  of	  pluripotent	  germline	  competent	   rat	  embryonic	   stem	  cells	  from	  Brown	  Norway	  strain	  
• Project	   II:	   Elucidating	   the	   molecular	   mechanisms	   regulating	   transcription	   of	  Pramel7	  in	  mouse	  embryonic	  stem	  cells	  	  
Project	   I:	   Establishment	   of	   pluripotent	   germline	   competent	   rat	   embryonic	   stem	  
cells	  from	  Brown	  Norway	  strain	  	  Goal	   of	   this	   project:	   To	   establish	   authentic	   rat	   embryonic	   stem	   cells	   which	   are	  pluripotent	  and	  germline-­‐competent.	  For	  this	  purpose,	  the	  following	  experiments	  were	  designed:	  -­‐ Breeding	  of	  Brown	  Norway	  rats	  -­‐ Collection	  of	  embryos	  	  -­‐ Derivation	  and	  expansion	  of	  embryonic	  stem	  cells	  	  -­‐ In	  vitro	  characterisation	  for	  pluripotency	  of	  the	  established	  cell	  lines	  -­‐ In	  vivo	  characterisation	  for	  pluripotency	  of	  the	  established	  cell	  lines	  -­‐ Generation	  of	  chimera	  and	  germline	  transmission	  However,	   as	   this	   project	   was	   not	   completely	   successful,	   it	   was	   necessary	   to	   further	  understand	  the	  molecular	  mechanisms	  regulating	  pluripotency	  in	  mouse	  ESCs	  and	  then	  transfer	  the	  knowledge	  to	  rat	  embryonic	  stem	  cells.	  Therefore,	  a	  decision	  was	  made	  to	  focus	  on	  a	  parallel	  project	  related	  to	  maintenance	  of	  pluripotency	  in	  mouse	  embryonic	  stem	  cells	  described	  below.	  	  	  
Project	   II:	   Elucidating	   the	   molecular	   mechanisms	   regulating	   transcription	   of	  
Pramel7	  in	  mouse	  embryonic	  stem	  cells	  	  Goal	   of	   this	   project:	   To	   deeper	   understand	   the	   molecular	   mechanisms	   driving	   the	  transcription	   of	  Pramel7	  by	   studying	   different	   pathways	   involved	   in	   self-­‐renewal	   and	  differentiation	  of	  the	  mouse	  embryonic	  stem	  cells.	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In	   particular,	   investigation	  was	   carried	   out	   into	   the	   link	   between	  Pramel7	   repression	  and	  inhibition	  of	  GSK3β	  by	  addressing	  the	  following	  questions.	  
• How	  is	  the	  expression	  of	  Pramel7	  regulated	  by	  the	  GSK3β	  downstream	  effector,	  β-­‐catenin	  via	  Wnt/canonical	  pathway?	  
• Is	  the	  transcriptional	  control	  of	  Pramel7	  occuring	  directly	  via	  GSK3β?	  
• Is	  it	  possible	  that	  regulation	  of	  Pramel7	  occurs	  via	  other	  GSK3β	  pathways	  such	  as	  MAPK/ERK	  pathway?	  To	   examine	   the	   link	   between	   Pramel7	   and	   the	   GSK3β	   target,	   β-­‐catenin,	   following	  experiments	  have	  been	  designed.	  -­‐ Derivation	   and	   characterisation	   of	   different	   β-­‐catenin	   mutants:	   knockout,	   N-­‐terminal,	  C-­‐terminal	  and	  constitutively	  active	  S33Y	  β-­‐catenin	  mutant	  -­‐ Analysis	  of	  Pramel7	  transcription	  in	  the	  above	  mutants	  -­‐ Examine	  STAT3	  phosphorylation	  in	  β-­‐catenin	  KO	  ESCs	  To	  investigate	  the	  direct	  role	  of	  GSK3β	  in	  driving	  transcription	  of	  Pramel7,	  below	  given	  experiments	  have	  been	  performed.	  -­‐ Carry	  out	  gene	  expression	  analysis	  to	  elucidate	  the	  transcription	  of	  Pramel7	  via	  GSK3β	  using	   three	   different	  GSK3β	  mutants:	   GSK3α/β	  double	   knockout	   (DKO),	  kinase	  inactive	  GSK3β;	  DKO_K85A	  and	  wild	  type	  GSK3β;	  DKO_GSK3β	  	  -­‐ Determine	   if	   there	   is	   any	   physical	   interaction	   between	   GSK3β,	   Pramel7	   and	  STAT3	  To	   explore	   the	   possibility	   of	   the	   involvement	   of	  MAPK/ERK	   pathway	   in	   regulation	   of	  Pramel7,	  following	  experiments	  have	  been	  planned.	  -­‐ Analysis	  of	  Pramel7	  expression	  in	  WT	  ESCs	  in	  both	  presence	  and	  absence	  of	  PD,	  a	  specific	  inhibitor	  of	  Erk	  kinase	  -­‐ Elucidate	   the	   regulation	   of	   Pramel7	   in	   GSK3β	   mutants	   in	   presence	   of	   Erk	  inhibition	  The	  above	  experiments	  have	  shed	  some	  light	  on	  the	  molecular	  mechanisms	  involved	  in	  the	  regulation	  of	  Pramel7	  at	  the	  transcriptional	  level.	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B.	  Results	  
1. Project	   I:	   Establishment	   of	   pluripotent	   germline	   competent	   rat	  
embryonic	  stem	  cells	  from	  Brown	  Norway	  strain	  
1.1. Derivation	  of	  rat	  ESC	  lines	  from	  Brown	  Norway	  (BN)	  rats	  The	  efficiency	  of	  isolating	  BN	  rat	  ESCs	  is	  shown	  in	  the	  table	  below.	  
	  
Table	  3:	  Derivation	  of	  rat	  ESCs	  in	  2i+LIF	  
	   No	  of	  ICMs	  plated	   Outgrowths	   Continuous	  ESC	  lines	  
Round	  1	   5	   5	   0	  
Round	  2	   4	   3	   0	  
Round	  3	   6	   4	   0	  
Round	  4	   8	   8	   0	  
Round	  5	   5	   5	   3	  
Round	  6	   4	   2	   2	  Outgrowth	   refers	   to	   the	   adherent	   primary	   explants.	   Continuous	   refers	   to	   indefinitely	   proliferating	   cultures	   of	  undifferentiated	  cells.	  	  Six	   independent	   experiments	  were	   carried	   out	  where	   immunosurgery	   on	   the	   E4.5dpc	  embryos	  was	  successful	  and	  showed	  outgrowths	  in	  all	  the	  experiments.	  However,	  only	  five	   ESC	   lines	   were	   established	   from	   these	   six	   independent	   rounds	   because	   a	   high	  number	   of	   outgrowths	   failed	   to	   form	   ESC	   colonies	   on	   subsequent	   plating.	   Derivation	  protocol	   was	   optimized	   in	   the	   different	   rounds	   to	   successfully	   establish	   the	   ESCs.	  Initially,	   classic	  B6	   feeders	  were	  plated	  on	  gelatinised	  plates	  and	   trypsin	  was	  used	   for	  dissociation	  of	  outgrowths.	  However,	  it	  was	  not	  possible	  to	  establish	  any	  ESC	  lines	  with	  this	   strategy	  and	   the	  protocol	   that	   led	   to	   the	  successful	  establishment	  of	  BN	  ESC	   lines	  comprised	   of	   plating	   SNL	   feeders	   over	   laminin	   coated	   plates	   and	   using	   Accutase	   for	  dissociation	  of	  outgrowths.	  All	   lines	   showed	   similar	   morphology	   and	   growth	   characteristics	   except	   BN_6.1	   and	  BN_6.2,	  which	  proliferated	  slightly	  slower	  compared	  to	  the	  others.	  All	  ESC	  lines	  formed	  compact	   colonies	   similar	   to	  mESCs	   and	   the	   individual	   cells	   showed	   a	   high	   nucleus	   to	  cytoplasm	  ratio,	  a	  typical	  characteristic	  of	  ESCs	  (Fig.	  8).	  Large	  colonies	  had	  the	  tendency	  to	   detach	   from	   the	   feeder	   layer	   and	  were	   therefore	   passaged	   every	   2-­‐3	   days.	   All	   the	  established	  ESC	   lines	   could	  be	  propagated	   continuously	   for	  more	   than	   a	   year	  with	  no	  discernible	  change	  in	  proliferation	  rate	  and	  morphology.	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Figure	  8:	  Establishment	  of	  rat	  ESCs	  a)	   Late	   blastocyst	   stage	   embryos	   used	   for	   derivation	   of	   rat	   ESCs	   b)	   Inner	   cell	   mass	   plated	   on	   feeders	   after	  immunosurgery	   c)&d)	   Morphology	   of	   2i+LIF	   colonies	   on	   feeders	   at	   low	   and	   high	   magnification	   e)	   typical	   ESCs	  characteristic,	  showing	  high	  nucleus	  to	  cytoplasm	  ratio	  f)	  Normal	  karyotype,	  42	  XY	  shown	  by	  Giemsa	  staining	  	  Karyotype	  analysis	  indicated	  that	  all	  the	  ESC	  lines	  had	  70%	  normal	  karyotype	  as	  shown	  in	  the	  table	  below.	  	  
Table	  4:	  Karyotype	  analysis	  for	  established	  rat	  ESC	  lines	  ESC	  line	   No.	  of	  chromosome	  spreads	   No	  of	  Normal	  karyotype	  BN_5.1	   39	   30	  BN_5.3	   27	   17	  BN_5.5	   50	   33	  BN_6.1	   27	   22	  BN_6.2	   22	   15	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1.2. Characterization	  of	  the	  ESC	  lines	  To	   assess	   the	   identity	   of	   the	   established	   ESC	   lines,	   expression	   of	   pluripotent	  markers	  was	  examined.	  Nuclear	  localized	  Oct4	  and	  cell	  surface	  SSEA-­‐1	  protein	  were	  detected	  by	  immunofluorescence	   microscopy.	   Strong	   positive	   staining	   was	   observed	   for	   alkaline	  phosphatase	  in	  the	  ESC	  lines	  confirming	  their	  pluripotent	  state	  (Fig.	  9).	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The	   differentiation	   potential	   of	   ESCs	   was	   tested	   using	   protocols	   to	   form	   embryoid	  bodies	  and	  to	  differentiate	  ESCs	  in	  vitro	  into	  neurons	  and	  muscles.	  They	  formed	  compact	  spherical	   embryoid	   bodies	   like	   mESCs.	   After	   10	   days	   induction,	   beating	   cells	   were	  evident	  inside	  the	  embryoid	  bodies,	  representative	  of	  cardiomyocytes.	  Cells	  cultured	  in	  unsupplemented	  N2B27	  expressed	  neural	  precursor	  marker	  and	  stained	  positive	  for	  β-­‐III	  TUBULIN	  and	  PAX6.	  On	  exposure	  to	  serum	  in	  absence	  of	  feeders,	  2i	  and	  LIF,	  all	  ESC	  lines	   differentiated	   and	   showed	   positive	   staining	   for	   smooth	   muscle	   actin	   (SMA),	   a	  marker	   for	   mesoderm	   (Fig.	   10).	   However,	   induction	   of	   both	   the	   neural	   and	   smooth	  muscle	  differentiation	  caused	  a	  higher	  cell	  death	  in	  the	  established	  ESC	  lines	  specifically	  BN_6.1	  and	  BN_6.2.	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To	   examine	   the	   differentiation	   potential	   of	   rat	   ESCs	   in	   vivo,	   the	   ESCs	   were	   injected	  subcutaneously	   into	   the	   severe	   combined	   immunodeficient	   (SCID)	   mice,	   which	   have	  impaired	   ability	   to	  make	  T-­‐	   or	  B-­‐	   lymphocytes	   and	   are	   immunocompromised.	   Four	   of	  the	  ESC	   lines,	  5.1,	  5.3,	  5.5	  and	  6.2,	   injected	  exhibited	  a	  macroscopic	   tissue	  mass	  at	   the	  site	   of	   injection.	   Immunohistochemical	   staining	   of	   the	   sections	   revealed	   classical	  features	  of	  a	   teratoma	  and	  exhibited	  positive	  staining	   for	  β-­‐III	   tubulin,	   smooth	  muscle	  actin	   and	  β-­‐catenin,	  markers	  of	   ectoderm,	  mesoderm	  and	  endoderm	  respectively	   (Fig.	  11).	  Thus	   the	  BN	  ESC	   lines	  are	   capable	  of	  producing	   teratomas	  and	  exhibiting	  mature	  multi-­‐lineage	  differentiation.	  	  
	  
Figure	  11:	  Immunofluorescence	  staining	  for	  the	  teratoma	  sections	  a)	   Tumour	   sections	   stain	   positive	   for	   β-­‐III	   tubulin,	   a	   well-­‐known	   neuron	   specific	   marker	   b)	   Sections	   also	   stained	  positive	   for	   smooth	   muscles,	   represented	   by	   immunofluorescent	   staining	   for	   anti-­‐α	   smooth	   muscle	   actin,	   SMA	   c)	  Colon-­‐like	  structures	  stained	  for	  β-­‐catenin,	  an	  endoderm	  marker	   	  
β-­‐III	  Tubulin/DAPI 
β-­‐catenin/DAPI 
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1.3. Chimera	  production	  from	  rat	  ESCs	  After	   expansion	   of	   ESCs	   for	   six	   passages,	   an	   attempt	  was	  made	   to	   generate	   chimeras	  from	   four	   of	   the	   rat	   ESC	   lines.	   The	   BN	   rat	   ESC	   lines	   were	   injected	   into	   Lewis	   strain	  blastocysts	  and	  then	  transferred	  into	  uterine	  horns	  of	  pseudo-­‐pregnant	  Wistar	  females.	  One	  live	  pup	  was	  born	  from	  BN_6.2G	  blastocyst	  injection	  round.	  However,	  it	  showed	  no	  coat	  color	  chimerism.	  	  
Table	  5:	  Generation	  of	  chimeras	  Cell	  line	   Passage	  no	   Host	  embryo	   Foster	  mother	   Injected	  embryos	   Live	  pups	   Chimeras	  BN_5.1G	   7	   Lewis	   Wistar	   30	   0	   0	  BN_5.3G	   7	   Lewis	   Wistar	   31	   0	   0	  BN_5.5G	   7	   Lewis	   Wistar	   35	   0	   0	  BN_6.2G	   7	   Lewis	   Wistar	   12	   1	   0	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2. Project	   II:	   Elucidating	   the	   molecular	   mechanisms	   regulating	  
transcription	  of	  Pramel7	  in	  mouse	  embryonic	  stem	  cells	  In	   the	   initial	   study	   carried	   out	   on	   Pramel7,	   it	   was	   shown	   that	   the	   presence	   of	   CH,	   a	  GSK3β	   inhibitor,	   retarded	   the	   transcription	   of	   Pramel7	   (Casanova	   et	   al.,	   2011).	   The	  published	  study	  has	  been	  attached	  as	  an	  Annex.	  Thus,	   it	   is	  plausible	   that	  at	   the	  mRNA	  level,	   Pramel7	   is	   regulated	   by	   the	   parallel	   activity	   of	   both	   LIF/STAT3	   and	   one	   of	   the	  pathways	  involving	  GSK3β.	  	  Based	   on	   the	   above	   hypothesis,	   experiments	   were	   planned	   to	   first	   examine	   the	   link	  between	  β-­‐catenin,	   an	   important	  GSK3β	  downstream	  effector	   and	  Pramel7.	  Follow	  up	  studies	  were	  carried	  out	  to	  understand	  the	  molecular	  mechanism	  by	  which	  GSK3β	  or	  its	  downstream	  targets	  regulate	  the	  transcription	  of	  Pramel7.	  
2.1. Generation	  and	  Characterisation	  of	  β-­‐catenin	  knockout,	  N-­‐terminal	  and	  C-­‐
terminal	  mutant	  ESCs	  β-­‐catenin	   protein	   is	  made	   up	   of	   12	   imperfect	   Armadillo	   repeats	   flanked	   by	  N-­‐	   and	   C-­‐	  terminal	  tails.	  The	  N-­‐terminal	  domain	  of	  the	  first	  repeat	  region	  is	  essential	  for	  binding	  of	  Legless/B-­‐cell	   lymphoma	  9	   (BCL9)	   to	  β-­‐catenin.	  BCL9	   in	   turn	   recruits	  Pygopus	  which,	  acts	  as	  a	   transcriptional	  activator	  of	  Wnt	   target	  genes.	  The	  central	   region	   is	  necessary	  for	   TCF/LEF	   mediated	   transcription	   and	   binding	   to	   the	   components	   of	   the	   adherens	  junctions.	  The	  C-­‐terminal	  tail	  along	  with	  Arm	  repeats	  R11-­‐	  R12	  mediates	  the	  interaction	  with	   various	   proteins	   such	   as	   TATA-­‐	   binding	   protein	   (TBP),	   CREB	   binding	   protein	  (CBP)/p300,	  Brahma/Brahma-­‐related	  gene	  1	  (Brg1),	  Mediator	  subunit	  12	  (MED12)	  and	  Hyrax/	  Parafibromin.	  Several	  of	  these	  are	  involved	  in	  chromatin	  remodeling	  complexes	  or	   along	  with	   β-­‐catenin	   promote	   the	   transcription	   of	  Wnt	   target	   genes.	   Three	  mutant	  variants	   for	   signalling	   and	   adhesion	   functions	   of	   β-­‐catenin	  were	   successfully	   derived.	  Given	   below	   is	   a	   scheme	   representing	   different	   mutations	   in	   β-­‐catenin	   used	   for	   the	  study	  (Fig.	  12).	  β-­‐cateninKO	  ESCs	  do	  not	  have	  the	  ATG	  start	  codon	  for	  β-­‐catenin	  thus	  no	  protein	  is	  expressed.	  N-­‐terminal	  mutation	  D164A	  prevents	  the	  binding	  of	  N-­‐terminal	  co-­‐activator	   BCL9	   to	   β-­‐catenin	   required	   for	   recruitment	   of	   Pygopus	   and	   transcription	   of	  Wnt	   target	   genes.	   C-­‐terminal	   truncation	   does	   not	   allow	   binding	   of	   C-­‐terminal	   co-­‐activators	  mentioned	  above	  and	  prevents	  the	  transcription	  of	  various	  Wnt	  target	  genes.	  Thus,	  the	  last	  two	  mutants	  behave	  as	  signalling	  mutants	  for	  β-­‐catenin.	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Figure	  12:	  Scheme	  representing	  different	  β-­‐catenin	  mutants	  derived	  β-­‐catenin	  protein	  consists	  of	  a	  central	  region	  made	  of	  12	  armadillo	  repeats	  as	  shown	  in	  the	  WT	  figure.	  β-­‐catenin	  KO	  does	  not	  possess	  the	  ATG	  start	  codon	  thus	  no	  protein	  is	  formed.	  β-­‐catenin-­‐D164A	  is	  an	  N-­‐terminal	  mutant	  containing	  a	   point	   mutation,	   which	   prevents	   the	   binding	   of	   N-­‐terminal	   coactivator	   BCL9	   to	   β-­‐catenin.	   β-­‐catenin-­‐ΔC	   mutant	  carries	   a	   C-­‐terminal	   truncation,	   which	   blocks	   the	   C-­‐terminal	   coactivators	   from	   binding	   to	   β-­‐catenin.	   Taken	   from	  (Valenta	  et	  al.,	  2011)	  	  The	  mutant	  ESCs	  were	  generated	  by	  breeding	  the	  heterozygous	  mice	  harbouring	  the	  β-­‐catenin	  mutant	  alleles,	  obtained	  from	  Prof.	  Basler	  group.	  Mouse	  ESCs	  were	  derived	  and	  expanded	   from	  E2.5	  embryos	  under	  serum	  free	  conditions	  using	  2i+LIF	  system	  (Table	  6),	   inhibiting	   mitogen	   activated	   kinase	   kinase	   using	   PD0325901	   and	   GSK3β	   using	  CHIR99021(Ying	  et	  al.,	  2008).	  	  
	  
Table	  6:	  Derivation	  of	  different	  β-­‐catenin	  mutant	  ESCs	  Genotype	   No.	  of	  breeding	  rounds	   No.	  of	  ICMs	   Outgrowths	   Continuous	  lines	  β-­‐catenin	  KO	   4	   15	   10	   4	  β-­‐catenin	  D164A	   6	   36	   5	   5	  β-­‐catenin	  Δ	  C	   15	   2	   2	   1	  	  ESC	   lines	  were	   established,	   genotyped	   and	   then	   chosen	   for	   further	   experiments.	   They	  were	   characterized	   by	   analyzing	   for	   stem	   cell	  markers,	   formation	   of	   embryoid	   bodies	  and	  in	  vitro	  differentiation	  of	  ESCs	  as	  shown	  in	  the	  table	  7	  below.	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Table	  7:	  Characterisation	  of	  β-­‐catenin	  ESCs	  
ESC	  nomenclature	   Genotype	   Expression	  of	  Pluripotency	  markers	   Embryoid	  body	  formation	   In	  vitro	  differentiation	  β-­‐catenin4.1WT	   Wild	  type	   X	   X	   X	  β-­‐catenin4.2KO	   Knock	  out	   X	   X	   X	  D164A_5.2HM	   N-­‐terminal	  homozygous	  mutant	   X	   X	   X	  D164A_5.5HM	   N-­‐terminal	  homozygous	  mutant	   X	   X	   X	  D164A_5.4WT	   Wild	  type	   X	   X	   X	  Δ	  C1.1_HM	   C-­‐terminal	  homozygous	  mutant	   X	   X	   X	  β-­‐catenin-­‐WT,	  -­‐D164A	  and	  -­‐ΔC	  ESC	  lines	  are	  pluripotent	  and	  express	  the	  pluripotency	  markers	  and	  have	  the	  ability	  to	  form	  embryoid	  bodies	  and	  differentiate	  into	  the	  three	  germ	  layers	  upon	  induction	  with	  the	  differentiation	  stimuli	  	  β-­‐catenin4.2KO	   (β-­‐cat4.2KO)	   ESCs	   line	   was	   derived	   from	   breeding	   β-­‐catenin	  heterozygous	   mice	   and	   was	   chosen	   as	   a	   knockout	   line	   for	   further	   experiments.	   β-­‐cat4.2KO	  ESCs	  lacked	  detectable	  β-­‐catenin	  protein.	  This	  was	  confirmed	  by	  Western	  blot	  (Fig	  13a)	  and	  PCR	  analysis.	   In	  order	   to	  determine	   the	   functional	   consequence	  on	  Wnt	  signalling,	   quantitative	   real	   time	   PCR	   (QRT-­‐PCR)	   was	   performed	   on	   the	   known	   TCF	  target	   genes,	   Axin2	   and	   CyclinD1	   (Fig.	   13b).	   Both	   the	   genes	   were	   downregulated	   in	  comparison	   to	   wild	   type	   in	   2i+LIF	   medium.	   2i	   medium	   contains	   CH	   which	   inhibits	  GSK3β	   and	   blocks	   degradation	   of	   β-­‐catenin.	   Thus,	   it	   promotes	   the	   expression	   of	  Wnt	  target	  genes.	  β-­‐catKO	  ESCs	  do	  not	  activate	  Wnt	  target	  genes	  in	  2i	  conditions	  confirming	  absence	  of	  β-­‐catenin	  in	  these	  cells.	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Unlike	   wild	   type	   ESCs,	   they	   have	   a	   flattened	   morphology	   suggesting	   cell-­‐adhesion	  defects	  caused	  by	  the	  absence	  of	  β-­‐catenin.	  An	  increased	  number	  of	  single	  cells	  observed	  in	   culture	   confirmed	   cell-­‐cell	   adhesion	  abnormality	   (Fig.	   14a).	  However,	   expression	  of	  self-­‐renewal	   genes	  Oct4,	  Nanog	   and	  Rex1	  was	  not	   altered	   supporting	   the	   findings	   that	  cell	  adhesion	  is	  not	  essential	   for	  maintenance	  of	  self-­‐renewal	  (Fig.	  14b	  &	  14e)	  (Ying	  et	  al.,	  2008)	  (Soncin	  et	  al.,	  2009).	  
	  
	  
Figure	  14:	  Characterisation	  of	  β-­‐cat4.2KO	  ESCs	  a)	  Phase	   contrast	   image	  of	  β-­‐cat4.2KO	  ESCs	   cultured	   in	  2i+LIF,	   show	   flattened	  morphology	   for	   the	  ESC	   colonies	  b)	  Immunostaining	   on	   β-­‐cat4.2KO	   ESCs	   shows	   positive	   staining	   for	   pluripotency	   markers	   Oct4	   and	   SSEA-­‐1	   c)	   Phase	  contrast	   image	  of	  WT	  ESCs	  showing	  round	  compact	  morphology	  d)	  WT	  ESCs	  are	  positive	   for	  nuclear	   localised	  Oct4	  and	  cell-­‐surface	  marker	  SSEA-­‐1	  e)	  Relative	  expression	  of	  pluripotency	  markers,	  Oct4,	  Nanog	  and	  Rex1	  in	  comparison	  to	  WT	  ESCs	  cultured	  in	  2i+LIF	   	  






WT	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The	   in	   vitro	   differentiation	  potential	   of	   these	   cells	  was	   analysed	  using	   embryoid	  body	  formation	  and	  differentiation	  protocols.	  Embryoid	  bodies	  formed	  from	  β-­‐cat4.2KO	  ESCs	  did	   not	   have	   a	   compact	   ball-­‐like	   structure,	   were	   smaller	   compared	   to	   WT	   embryoid	  bodies	   and	   started	   to	   disaggregate	   after	   approximately	   a	  week	   of	   differentiation	   (Fig.	  15a	   and	   15b).	   Expression	   profiles	   of	   ectodermal	   marker	   genes	   FGF5	   and	   Sox9	   in	   β-­‐cat4.2KO	   embryoid	   bodies	   was	   almost	   similar	   to	   WT	   ones.	   However,	   expression	   of	  endoderm	   marker	   gene	   Gata4	   was	   slightly	   reduced	   and	   mesoderm	   marker	   gene	   T-­‐
brachyury	   was	   completely	   absent	   in	   β-­‐cat4.2KO	   embryoid	   bodies	   suggesting	   an	  abnormality	  in	  mesendodermal	  differentiation	  (Fig.	  15c).	  
	  
	  
Figure	  15:	  In	  vitro	  differentiation	  of	  β-­‐cat4.2KO	  ESCs	  a)	  Spherical	  compact	  ball-­‐	  like	  WT	  embryoid	  bodies	  b)	  Phase	  contrast	  image	  showing	  disaggregating	  morphology	  of	  β-­‐cat4.2KO	  embryoid	  bodies	  and	  floating	  single	  cells	  confirming	  cell-­‐cell	  adhesion	  abnormalities	  b)	  Histogram	  showing	  upregulation	  of	  ectoderm	  markers,	  FGF5	  and	  Sox9	  and	  absence	  of	  mesoderm	  marker	  T-­‐brachyury	  	   	  
b) 
c) 
β-­‐catKO	  EBs WT	  EBs a) 
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In	  contrast	  to	  β-­‐catenin4.2KO	  ESCs,	  D164A	  and	  ΔC	  homozygous	  mutant	  ESCs	  both	  have	  the	   classical	   compact	   round	   morphology	   of	   ESCs	   like	   the	   WT	   ESCs	   (Fig.	   16a).	   They	  express	  the	  known	  pluripotent	  markers	  Oct4	  and	  Nanog,	  although	  the	  expression	  of	  Oct4	  appears	  to	  be	  downregulated	   in	  the	  mutants	   in	  comparison	  to	  WT	  ESCs	  as	  seen	   in	  the	  real	  time	  analysis	  (Fig.	  16c	  &	  16d).	  
	  
Figure	  16:	  Analysis	  for	  pluripotency	  in	  N-­‐terminal	  (D164A)	  and	  C-­‐terminal	  mutant	  a)	  &	  b)	  Representation	  of	  classical	  round	  and	  compact	  morphology	  of	  WT,	  N-­‐terminal	  and	  C-­‐terminal	  mutant	  ESCs	  in	  low	   and	   high	  magnification	   c)	   &	   d)	   Histogram	   showing	   expression	   of	   pluripotent	  markers,	   Nanog	   and	   Oct4	   in	   N-­‐terminal	  and	  C-­‐terminal	  β-­‐catenin	  mutants	  respectively;	  down-­‐regulation	  of	  Oct4	  observed	  in	  both	  the	  mutants	  	  
In	  vitro	  differentiation	  experiments	  were	  carried	  out	  by	  embryoid	  body	   formation	  and	  their	   analysis	   using	   real-­‐time	   PCR.	   Embryoid	   bodies	   from	   both	   N-­‐terminal	   mutants;	  D164A_5.2HM	   and	   D164A_5.5HM	   and	   C-­‐terminal	   mutant;	   C1.1	   have	   the	   classical	  compact	   ball-­‐like	   structure	   and	   do	   not	   show	   any	   cell	   adhesion	   defects	   (Fig.	   17a).	  Interestingly,	   expression	   of	   differentiation	   markers,	   FGF5,	   Gata4	   and	   T-­‐brachyury	  between	   the	   two	   mutants	   is	   contrary	   to	   each	   other.	   Embryoid	   bodies	   from	   the	   N-­‐
a) b) 
c) d) 
WT	  ESCs	  in	  2i+LIF WT	  ESCs	  in	  2i+LIF 
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terminal	   mutants	   show	   downregulation	   of	   differentiation	   markers	   where	   as	   the	   C-­‐terminal	  mutants	  show	  an	  upregulation	  (Fig.	  17b	  &	  17c).	  The	  real-­‐time	  data	  for	  the	  two	  N-­‐terminal	  mutants,	  D164A_5.2HM	  and	  D164A_5.5HM	  is	  not	  consistent	  and	  they	  show	  variations	  in	  the	  expression	  of	  differentiation	  markers	  among	  themselves.	  
	  
	  
Figure	  17:	  In	  vitro	  differentiation	  of	  C-­‐terminal	  and	  N-­‐terminal	  β-­‐catenin	  mutant	  a)	   Representation	   of	   a	   classical	   compact	   ball-­‐like	   embryoid	   body	   for	   both	   N-­‐	   and	   C-­‐	   terminal	   mutant	   ESCs	   b)	   C-­‐terminal	  mutant	  shows	  an	  upregulation	  of	  all	  the	  differentiation	  markers	  specifically	  T-­‐brachyury	  which	  increases	  by	  40	   fold	   c)	   N-­‐terminal	  mutant	   shows	   downregulation	   of	   differentiation	  markers	   which	   are	   differentially	   expressed	  between	  the	  two	  homozygous	  N-­‐terminal	  mutants	  	   	  
a) 
b) c) 
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2.2. Pramel7	  transcription	  is	  not	  directly	  regulated	  via	  β-­‐catenin	  Pramel7	  has	  been	  shown	  to	  be	  a	  novel	  downstream	  target	  of	  STAT3	  in	  the	  LIF/STAT3	  pathway.	   Casanova	   et	   al.	   also	   showed	   that	   Pramel7	   transcription	  was	   impaired	  when	  GSK3β	  was	   inhibited	  by	  CHIR99021	   (Casanova	   et	   al.,	   2011).	   This	   suggested	   a	   role	   for	  either	   GSK3β	   or	   its	   downstream	   effectors	   in	   regulation	   of	   Pramel7	   independent	   of	  STAT3.	  β-­‐catenin	  is	  a	  known	  key	  GSK3β	  substrate	  which	  accumulates	  in	  the	  absence	  of	  GSK3β	  activity.	  These	   two	   findings	   together	   suggests	   a	  possible	   regulatory	   interaction	  between	  the	  key	  players	  of	  Wnt	  pathway	  –	  β-­‐catenin	  and	  GSK3β;	  and	  Pramel7.	  To	   test	   this	   hypothesis,	   we	   analysed	   the	   expression	   of	   Pramel7	   at	   the	   transcriptional	  level	  in	  β-­‐cat4.2KO	  ESCs	  in	  2i+LIF	  conditions,	  which	  are	  the	  standard	  culture	  conditions	  used	  in	  this	  study.	  	  The	  analysis	  was	  performed	  using	  real-­‐time	  PCR.	  Pramel7	  expression	  was	  upregulated	  by	  10fold	   in	  comparison	   to	  WT	  ESCs.	  Upregulation	  of	  Pramel7	   in	   the	  absence	  of	  β-­‐catenin	  suggests	  an	  inhibitory	  action	  of	  β-­‐catenin	  on	  Pramel7.	  Analysis	  of	  Stat3	   expression	   showed	   no	   changes	   in	   Stat3	   at	   the	   transcriptional	   level	   in	   the	   β-­‐catenin4.2KO	  ESCs	  (Fig.	  18).	  
	  
Figure	  18:	  Histogram	  showing	  expression	  of	  Pramel7	  and	  Stat3	  in	  β-­‐cat4.2KO	  ESCs	  The	  real	  time	  PCR	  analysis	  on	  β-­‐catenin4.2KO	  ESCs	  shows	  an	  upregulation	  of	  Pramel7	  by	  11	  fold	  in	  comparison	  to	  WT	  ESCs.	  No	  significant	  changes	  are	  observed	  in	  the	  expression	  of	  Stat3	  in	  β-­‐catenin4.2KO	  ESCs	  when	  compared	  to	  WT	  ESCs.	  Levels	  of	  mRNA	  were	  determined	  by	  quantitative	  real-­‐time	  PCR	  and	  normalized	  to	  the	  housekeeping	  gene,	  β-­‐actin.	  The	  levels	  of	  WT	  are	  set	  as	  1.	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In	   order	   to	   check	   if	   the	   β-­‐catenin	   and	   Pramel7	   act	   antagonistically	   to	   each	   other,	   we	  analysed	   the	   expression	   of	   β-­‐catenin	   in	   Pramel7	   overexpressing	   ESCs	   expanded	   in	  2i+LIF	   system.	  No	   downregulation	   of	   β-­‐catenin	  was	   observed	   indicating	   that	   Pramel7	  did	  not	  regulate	  the	  transciption	  of	  β-­‐catenin	  (Fig.	  19).	  	  
	  
Figure	  19:	  Histogram	  showing	  expression	  of	  β-­‐catenin	  in	  Pramel7	  overexpressing	  ESCs	  Pramel7	  overexpressing	  ESCs	  were	  labeled	  Pramel7_2D4.	  Both	  WT	  and	  Pramel7-­‐2D4	  ESCs	  were	  expanded	  in	  2i+LIF	  medium	  and	  the	  expression	  of	  β-­‐catenin	  was	  checked	  in	  comparison	  to	  WT	  ESCs.	  Overexpression	  of	  Pramel7	  had	  no	  effect	  on	  transcription	  of	  β-­‐catenin.	  Levels	  of	  mRNA	  were	  determined	  by	  quantitative	  real-­‐time	  PCR	  and	  normalized	  to	  the	  housekeeping	  gene,	  β-­‐actin.	  The	  levels	  of	  WT	  are	  set	  as	  1.	  	  To	   assess	   whether	   overexpression	   of	   β-­‐catenin	   had	   an	   effect	   on	   transcription	   of	  
Pramel7,	   we	   stably	   transfected	   wild	   type	   ESCs	   with	   a	   “S33Y”	   vector	   expressing	  constitutively	   active	   β-­‐catenin	   harbouring	   a	   single	   point	   mutation	   in	   the	  phosphorylation	   site	   recognised	   by	   GSK3β	   degradation	   complex	   (obtained	   from	   Prof.	  Basler	   group).	   Successfully	   transfected	   clones	   were	   named	   “WT_S33Y”.	   Surprisingly,	  WT_S33Y	   clones	   expressed	   more	   Pramel7	   in	   comparison	   to	   WT	   ESCs.	   Interestingly,	  evaluating	   the	  expression	  of	  Pramel7	  among	   the	  clones	   showed	   that	  Pramel7	   reduced	  upon	  increase	  in	  the	  transcriptional	  levels	  of	  β-­‐catenin	  in	  various	  clones	  (Fig.	  20).	  Clones	  1	   and	   2	   have	   5-­‐10	   fold	   of	   β-­‐catenin	   in	   comparison	   to	   wild	   type	   and	   they	   retain	  significantly	   high	   Pramel7	   expression.	   However,	   a	   15	   fold	   increase	   in	   the	   levels	   of	   β-­‐catenin	   as	   seen	   in	   clone	   3	   leads	   to	   a	   drastic	   downfall	   in	   the	   expression	   of	   Pramel7.	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WT_S33Y	  ESC	  clones	  show	  an	  upregulation	   in	  Stat3	  upon	  constitutive	  expression	  of	  β-­‐catenin.	  
	  
Figure	  20:	  Relative	  expression	  of	  Pramel7	  and	  Stat3	  compared	  to	  WT	  ESCs	  in	  clones	  expressing	  constitutively	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Figure	  21:	  Expression	  of	  Pramel7	  in	  N-­‐terminal	  and	  C-­‐terminal	  β-­‐catenin	  mutants	  a)	   The	   two	  N-­‐terminal	   D164A	  mutants	   show	   variation	   in	   expression	   of	   Pramel7	   b)	   C-­‐terminal	  mutation	   increases	  Pramel7	   transcription	  by	  4	   fold	  where	  as	   reduces	  Stat3	  expression	  by	  5	   fold.	  Levels	  of	  mRNA	  were	  determined	  by	  quantitative	  real-­‐time	  PCR	  and	  normalized	  to	  the	  housekeeping	  gene,	  β-­‐actin.	  The	  levels	  of	  WT	  ESCs	  are	  set	  as	  1.	  	  Taken	  together,	  these	  results	  indicate	  that	  the	  Pramel7	  is	  indirectly	  regulated	  through	  β-­‐catenin	  and	  suggests	  a	  role	  for	  GSK3β	  which	  is	  a	  central	  regulator	  of	  β-­‐catenin.	  	   	  
a) b) 
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2.3. Effect	   of	   GSK3β	   inhibition	   on	   Pramel7	   transcription	   is	   not	   mediated	   via	   β-­‐
catenin	  In	   order	   to	   see	   if	   it	   is	   the	   absence	   of	   β-­‐catenin	   and/or	   presence	   and	   activity	   of	   free	  GSK3β	   which	   is	   regulating	   Pramel7	   transcription,	   we	   monitored	   Pramel7	   expression	  using	   QRT-­‐PCR	   after	   CH+LIF	   and	   LY+LIF	   induction.	   CH	   and	   LY	   are	   small	   molecule	  inhibitors.	   They	   are	   selective	   inhibitors	   of	   GSK3β	   and	   PI3K	   respectively.	   CH	   inhibits	  GSK3β	  by	  blocking	  its	  kinase	  activity.	  LY	  is	  a	  potent	  and	  cell-­‐permeable	  inhibitor	  of	  PI3K	  which	  inhibits	  ATP	  binding	  to	  the	  catalytic	  subunit	  of	  PI3K	  and	  blocks	  its	  kinase	  activity.	  This	  prevents	  the	  phosphorylation	  of	  GSK3β,	  thus	  maintaining	  its	  kinase	  activity.	  β-­‐cat4.2KO	  ESCs	  were	  cultured	  and	  expanded	  normally	  in	  2i+LIF.	  The	  medium	  was	  later	  changed	  to	  N2B27,	  which	  is	  the	  defined	  medium	  without	  the	  2	  inhibitors	  and	  LIF,	  for	  4	  hrs	  before	  incubating	  the	  cells	  for	  1hr,	  5hrs	  and	  24hrs	  with	  CH+LIF	  or	  LY+LIF.	  	  After	  4hrs	  N2B27,	  Pramel7	  was	  upregulated	   in	  β-­‐cat4.2KO	  ESCs	   in	   comparison	   to	  WT	  ESCs	  similar	  to	  cells	  cultured	  in	  2i+LIF	  conditions	  (Fig.	  22a).	  However,	  upon	  stimulation	  with	  CH+LIF,	  Pramel7	  level	  reduced	  to	  WT	  ESCs	  level	  (Fig.	  22b).	  In	  comparison	  to	  4.2KO	  ESCs	  in	  N2B27,	  CH+LIF	  stimulated	  cells	  again	  showed	  downregulation	  of	  Pramel7	  (Fig.	  22c).	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Figure	  22:	  Histogram	  showing	  expression	  of	  Pramel7	  with	  CH+LIF	  stimulation	  in	  β-­‐cat4.2KO	  ESCs	  a)	  There	  is	  10fold	  higher	  expression	  of	  Pramel7	  in	  β-­‐cat4.2KO	  ESCs	  in	  comparison	  to	  WT	  ESCs	  both	  cultured	  in	  4hrs	  N2B27	   b)	   Pramel7	   expression	   in	   β-­‐cat4.2KO	   ESCs	   is	   similar	   to	  WT	   ESCs	   after	   24hr	   CH+LIF	   stimulation	   Levels	   of	  mRNA	  were	  determined	  by	  quantitative	  real-­‐time	  PCR	  and	  normalized	  to	  the	  housekeeping	  gene,	  β-­‐actin.	  The	  levels	  of	  WT	  ESCs	  cultured	  in	  N2B27	  are	  set	  as	  1.	  c)	  In	  comparison	  to	  β-­‐cat4.2KO	  ESCs	  cultivated	  for	  4hrs	  N2B27,	  Pramel7	  is	  10fold	   downregulated	   after	   24hrs	   CH+LIF	   stimulation.	   Levels	   of	  mRNA	  were	   determined	   by	   quantitative	   real-­‐time	  PCR	  and	  normalized	  to	  the	  housekeeping	  gene,	  β-­‐actin.	  The	  levels	  of	  β-­‐cat4.2KO	  ESCs	  cultured	  in	  N2B27	  are	  set	  as	  1.	  	   	  
a) b) 
c) 
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Surprisingly,	   cells	   stimulated	   with	   LY+LIF	   did	   not	   show	   strong	   upregulation	   in	  expression	  of	  Pramel7	  compared	  to	  0hr	  stimulation	  (Fig.	  23).	  	  
	  
Figure	  23:	  Histogram	  showing	  expression	  of	  Pramel7	  in	  β-­‐cat4.2KO	  ESCs	  upon	  LY+LIF	  stimulation	  No	  massive	   upregulation	   of	   Pramel7	   was	   observed	   in	   presence	   of	   LY+LIF.	   Histogram	   shows	   an	   initial	   increase	   in	  Pramel7	  by	  2	  times	  which	  gradually	  decreases	  after	  24hrs	  LY+LIF	  	  However,	   CH	   timepoint	   analysis	   clearly	   suggests	   that	   inhibiting	   the	   activity	   of	   GSK3β	  affects	  the	  transcription	  of	  Pramel7	  in	  β-­‐cat4.2KO	  ESCs.	  	  To	   assess	   if	   the	   changes	   in	   expression	   of	   Pramel7	   in	   β-­‐cat4.2KO	   ESCs	   after	   CH+LIF	  stimulation	  is	  due	  to	  differential	  phosphorylation	  of	  STAT3	  in	  these	  ESCs,	  we	  analysed	  the	  β-­‐cat4.2KO	  ESCs	  for	  phosphorylation	  of	  STAT3	  at	  Y705	  by	  performing	  Western	  blot	  with	   antibodies	   for	   Y705	  phosphorylation.	   Phosphorylation	   of	   STAT3	   at	   Y705	   residue	  plays	  an	  important	  role	  for	  dimerisation,	  nuclear	  translocation	  and	  activity	  of	  STAT3	  to	  regulate	   the	   expression	   of	   its	   downstream	   target	   genes	   like	   Pramel7.	   There	   were	   no	  changes	   in	   the	   phosphorylation	   of	   STAT3	   compared	   to	   WT	   ESCs	   except	   the	   24hr	  timepoint.	   In	   the	   24hr	   timepoint,	   a	   weak	   band	   for	   phosphorylation	   of	   STAT3	   is	   still	  observed	  in	  WT	  ESCs	  unlike	  the	  β-­‐cat4.2KO	  ESCs	  which	  show	  absence	  of	  it	  after	  24hrs	  (Fig.	  24).	  Overall,	  this	  experiment	  suggests	  that	  the	  regulation	  of	  Pramel7	  in	  β-­‐cat4.2KO	  ESCs	  in	  presence	  of	  CH+LIF	  is	  independent	  of	  STAT3	  phosphorylation.	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Figure	  24:	  Immunoblot	  for	  β-­‐cat4.2KO	  ESCs	  using	  antibodies	  against	  Stat3	  Y705	  phosphorylation	  and	  Tubulin	  	  To	  check	  if	  there	  is	  a	  link	  between	  β-­‐catenin,	  GSK3β	  and	  Pramel7,	  we	  stimulated	  the	  WT	  ESCs	   as	   per	   above	   protocol	   with	   N2B27+	   CH	   only.	   It	   was	   observed	   that	   Pramel7	  expression	  was	  2	  fold	  higher	  after	  1hr	  CH	  stimulation	  but	  was	  gradually	  downregulated	  with	  longer	  time	  points	  (Fig.	  25).	  	  
	  
Figure	  25:	  Pramel7	  expression	  in	  WT	  ESCs	  upon	  CH	  stimulation	  	  This	  gives	  a	  clear	  indication	  that	  upregulation	  of	  Pramel7	  in	  β-­‐catKO	  ESCs	  is	  due	  to	  the	  activity	   of	   free	   GSK3β,	   not	   bound	   to	   β-­‐catenin	   for	   degradation.	   However,	   a	   clear	   link	  between	  the	  trio	  is	  still	  not	  confirmed.	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2.4. Transcription	  of	  Pramel7	  is	  dependent	  on	  the	  presence	  of	  GSK3β	  To	  confirm	  the	  hypothesis	   that	   it	   is	   the	  presence	  of	  GSK3β	  that	  regulates	  Pramel7,	  we	  performed	   a	   knockdown	   experiment	   in	   WT	   ESCs	   cultured	   in	   2i+LIF	   conditions.	   We	  transfected	  WT	  ESCs	  with	  siRNAs	  against	  GSK3β	  and	  confirmed	  the	  specific	  knockdown	  by	  QRT-­‐PCR	  analysis.	  We,	  then	  investigated	  the	  expression	  of	  pluripotency	  markers	  and	  Pramel7	  at	  the	  transcriptional	  level.	  Transcription	  of	  Pramel7	  was	  completely	  abrogated	  indicating	  the	  importance	  of	  the	  presence	  of	  GSK3β	  protein	  in	  its	  regulation.	  However,	  the	  ESCs	  still	  expressed	  markers	  of	  pluripotency,	  Nanog	  and	  Rex1	  (Fig.	  26).	  
	  
Figure	  26:	  Expression	  analysis	  for	  siRNA	  knockdown	  of	  GSK3β	  Absence	   of	   GSK3β	   expression	   upon	   siRNA	   transfection	   confirms	   the	   knockdown	   of	   GSK3β.	  WT_siRNA_GSK3β	  ESCs	  express	  the	  pluripotency	  markers,	  Nanog	  and	  Rex1	  and	  lack	  FGF5	  expression,	  a	  differentiation	  marker.	  In	  comparison	  to	   WT	   ESCs,	   transcription	   of	   Pramel7	   is	   completely	   blocked	   in	   the	   absence	   of	   GSK3β.	   Levels	   of	   mRNA	   were	  determined	  by	  quantitative	  real-­‐time	  PCR	  and	  normalized	  to	  the	  housekeeping	  gene,	  β-­‐actin.	  The	  levels	  of	  WT	  ESCs	  cultured	  in	  2I+LIF	  are	  set	  as	  1.	  	  To	  further	  assess	  the	  dependence	  of	  Pramel7	  expression	  on	  the	  presence	  and	  activity	  of	  GSK3β,	  we	  examined	  induction	  of	  Pramel7	  in	  WT	  ESCs	  on	  addition	  of	  either	  CH99021,	  PD0325901	   (PD),	   or	   both	   after	   incubating	   the	   cells	   for	   4hrs	   in	   N2B27	   only.	   PD	   is	   a	  potent	  and	  selective	  inhibitor	  of	  Erk	  kinase.	  We	  confirmed	  the	  observation	  that	  Pramel7	  regulation	  is	  blocked	  in	  presence	  of	  CH.	  We	  observed	  that	  Pramel7	  was	  upregulated	  in	  the	  presence	  of	  PD	  and	  GSK3β	  suggesting	  that	  it	  is	  the	  activity	  of	  GSK3β	  and	  inhibition	  of	  Erk	  modulating	  the	  expression	  of	  Pramel7	  (Fig.	  27).	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Figure	  27:	  Pramel7	  regulation	  in	  WT	  ESCs	  upon	  stimulation	  with	  PD,	  CH	  and	  PD+CH	  There	   is	   an	   upregulation	   of	   Pramel7	   by	   4	   fold	   when	   stimulated	   with	   PD	   in	   the	   presence	   of	   GSK3β	   and	   reduced	  expression	  with	  CH	  stimulation	  in	  WT	  ESCs.	  The	  levels	  of	  WT	  ESCs	  cultured	  in	  2I+LIF	  are	  set	  as	  1.	  	  To	  test	  the	  robustness	  of	  this	  hypothesis,	  we	  then	  carried	  out	  a	  timepoint	  experiment	  on	  the	   following	   GSK3β	   mutants	   described	   in	   Materials	   and	   Methods	   2.1.3	   section.	   The	  mutants	  DKO,	  DKO_GSK3β	  and	  DKO_K85A	  ESCs	  obtained	  from	  Prof.	  Doble	  (Kelly	  et	  al.,	  2011)	  which	  were	  generated	  and	  expanded	   in	   serum+LIF	  conditions.	  The	  above	   three	  cell	   lines	   were	   incubated	   for	   24hrs	   in	   standard	   ESC	   medium	   containing	   serum	   and	  without	  LIF.	  They	  were	  then	  stimulated	  with	  PD	  only	  to	  simulate	  the	  effect	  of	  absence,	  presence	  of	  GSK3β	  and	  activity	  of	  GSK3β.	  Pramel7	  was	  downregulated	  in	  the	  presence	  of	  PD	   in	  DKO	  ESCs	   (Fig.	  28b).	   It	  was	  maintained	  at	   the	  wild	   type	   levels	  or	  showed	  slight	  upregulation	   in	   DKO_GSK3β	   and	   DKO_K85A	   in	   the	   presence	   of	   PD	   (Fig.	   28c	   &	   28d).	  Intriguingly,	   in	   comparison	   to	   DKO	   ESCs,	   expression	   of	   Pramel7	   was	   reduced	   in	  DKO_GSK3β	  and	  upregulated	   in	  kinase	   inactive,	  DKO_K85A	   (Fig.	   28a).	  All	   the	  mutants	  were	   cultured	   in	  normal	  ESCs	  medium	  with	   serum	  and	  LIF.	  This	   shows	  an	   inclination	  towards	   the	  presence	  of	  GSK3β	   rather	   than	   its	   activity	   in	  ESCs	   cultured	   in	   serum+LIF	  conditions.	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Figure	  28:	  Expression	  of	  Pramel7	  upon	  PD	  stimulation	  in	  different	  GSK3β	  mutants	  a)	   In	   comparison	   to	   DKO	   ESCs,	   kinase	   inactive	   DKO_K85A	   ESCs	   show	   slight	   upregulation	   of	   Pramel7	   unlike	  DKO_GSK3β	  b)	  DKO	  ESCs	  show	  5	  fold	  downregulation	  of	  Pramel7	  when	  stimulated	  with	  PD	  c)	  &	  d)	  Both	  the	  GSK3β	  mutants	  retain	  the	  expression	  of	  Pramel7	  in	  presence	  of	  PD	  	  Surprisingly,	   real-­‐time	   analysis	   performed	   on	   DKO	   ESCs	   showed	   an	   upregulation	   of	  Pramel7	   in	   comparison	   to	  E14	  ESCs	   in	   standard	  ESC	  medium	   (Fig.	   29).	  However,	   this	  can	  be	  a	  compensatory	  mechanism	  seen	  in	  DKO	  ESCs	  discussed	  later.	  
a) b) 
c) d) 
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Figure	  29:	  Upregulation	  of	  Pramel7	  in	  DKO	  ESCs	  compared	  to	  E14	  WT	  ESCs	  
	  Altogether,	  these	  results	  indicate	  that	  GSK3β	  is	  essential	  for	  transcriptional	  regulation	  of	  Pramel7.	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2.5. Regulation	   of	   Pramel7	   does	   not	   depend	   on	   physical	   interaction	   between	  
STAT3	  and	  GSK3β	  In	   order	   to	   address	  whether	  Pramel7	  physically	   interacts	  with	  GSK3β,	  we	   transfected	  HEK	  cells	  with	  Flag-­‐tagged	  Pramel7	  vector	  and	  performed	  a	  pull	  down	  experiment	  using	  antibodies	  against	  Flag	  epitope(performed	  by	  Urs	  Graf).	  The	  precipitated	  material	  was	  purified	  and	  the	  eluate	  was	  analysed	  by	  Western	  blot	  with	  antibodies	  against	  Flag,	  total	  GSK3	  and	  total	  STAT3.	  Neither	  GSK3β	  nor	  STAT3	  was	  co-­‐precipitated	  with	  Flag-­‐tagged	  Pramel7	  (Fig.	  30).	  The	  result	  suggested	  that	  there	  was	  no	  physical	  interaction	  between	  Pramel7	   and	   GSK3β.	   No	   physical	   complex	   was	   formed	   between	   Pramel7,	   GSK3	   and	  STAT3.	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against	  Flag-­‐epitope	  of	  GSK3β	  and	  output	  was	  analysed	  with	  antibodies	  against	  GSK3β	  and	   Stat3.	   It	   was	   confirmed	   that	   there	   was	   no	   physical	   interaction	   between	   the	   two	  proteins	  (Fig.	  31).	  	  
	  
Figure	  31:	  Immunoblot	  analysis	  for	  HA-­‐IP	  done	  on	  HEK	  cells	  expressing	  GSK3β_S9A	  and	  DKO_GSK3β	  ESCs	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C.	  Discussion	  
1. Project	   I:	   Establishment	   of	   pluripotent	   germline	   competent	   rat	  
embryonic	  stem	  cells	  from	  Brown	  Norway	  strain	  	  	  Rat	   is	   the	  most	  extensively	  used	   laboratory	  animal	   in	  biomedical	  research	  particularly	  useful	  as	  a	  surrogate	   for	  studying	  human	  diseases.	  Establishment	  of	   first	  authentic	  rat	  ESCs	   is	  a	  remarkable	  achievement	   that	  makes	   it	  possible	   to	  develop	  genetic	  models	   in	  the	  rat,	  using	  gene	  targeting	  and	  other	  technologies	  that	  are	  readily	  available	  for	  mouse	  ESCs.	  However,	  to	  be	  successful	  at	  this	  objective,	  there	  are	  a	  number	  of	  challenges	  that	  must	  be	  overcome.	  Most	  importantly,	  rat	  ESC	  culture	  system	  is	  in	  its	  infancy	  and	  a	  huge	  amount	  of	  work	  still	  needs	  to	  be	  done	  to	  be	  able	  to	  realize	  the	  full	  potential	  of	  rat	  ESCs	  in	  genetic	  research.	  It	  is	  crucial	  to	  know	  that	  before	  the	  optimization	  and	  standardization	  of	   culture	   conditions	   for	   mESCs,	   it	   was	   believed	   that	   only	   early	   passage	   cells	   were	  germline	  competent	  and	  useful	  for	  gene	  targeting	  (Brook	  and	  Gardner,	  1997).	  The	  same	  applies	  for	  the	  rat	  ESCs	  and	  it	  is	  essential	  to	  deeper	  understand	  the	  underlying	  stem	  cell	  biology	   of	   rat	   in	   order	   to	   sustain	   pluripotency	   and	   produce	   germline-­‐competent	   rat	  ESCs.	   Brown	   Norway	   (BN)	   rat	   is	   a	   widely	   known	   strain	   and	   an	   indispensible	   tool	   in	  experimental	  medicine	  and	  drug	  development	  and	  used	  extensively	  for	  other	  scientific	  research	   purposes.	   The	   BN	   rat	   sequence	   was	   the	   third	   mammalian	   genome	   to	   be	  completely	  deciphered	  which	  makes	  it	  a	  useful	  candidate	  for	  comparing	  with	  human	  and	  mouse	  genomes	  (Gibbs	  et	  al.,	  2004).	  Generation	  of	  pluripotent	  ESCs	  from	  BN	  strain	  will	  be	  particularly	  useful	  for	  rat	  functional	  genomic	  studies	  and	  genetic	  disease	  remodeling.	  The	  knowledge	  of	   genome	   sequence	  makes	   it	   a	   better	   candidate	   for	   gene	   targeting	   as	  well.	   Taking	   this	   into	   consideration,	   BN	   rat	   was	   chosen	   as	   the	   model	   for	   the	  establishment	  of	  pluripotent	  germline-­‐competent	  ESCs.	  
1.1. Derivation	  and	  establishment	  of	  rat	  ESCs	  Buehr	   et	   al	   (2008)	   had	   successfully	   established	   germline-­‐competent	   ESCs	   from	   Dark	  Agouti	  (DA)	  strain	  using	  3i	  and	  2i	  medium	  both	  in	  the	  presence	  of	  LIF	  producing	  DIA-­‐M	  feeders	  and	  feeder	  free	  respectively	  (Buehr	  et	  al.,	  2008).	  Derivation	  of	  BN	  ESCs	  for	  the	  study	  was	   successfully	   performed	   by	   introducing	   a	   few	  modifications	   in	   the	   protocol	  published	   by	   Buehr	   et	   al	   (2008).	   In	   our	   initial	   derivation	   experiments	   from	   BN	   rats,	  there	   were	   concerns	   regarding	   poor	   adherence	   of	   single	   cells	   to	   the	   feeders	   upon	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dissociation	   of	   the	   initial	   outgrowths	   from	   the	   inner	   cell	   mass	   and	   thus	   inability	   to	  develop	  ESC	  colonies.	  This	  could	  have	  been	  either	  due	  to	  the	  strain	  of	  feeders	  used,	  the	  substrate	  used	  to	  coat	   the	  plates	  or	   the	  method	  of	  dissociation	  of	   the	  outgrowths.	   It	   is	  known	   that	  addition	  of	  LIF	  enhances	   the	  derivation	  of	  mouse	  ESCs	   (Ying	  et	  al.,	  2008).	  Normally,	  mitotically	   inactivated	  mouse	   fibroblasts	   are	  used	  as	   feeders	   to	   support	   the	  growth	  of	  the	  ESCs.	  However,	  as	  a	  source	  of	  LIF	  we	  used,	  SNL	  feeders	  derived	  from	  STO	  cell	  line	  expressing	  LIF	  at	  an	  abundant	  level.	  The	  feeders	  also	  supported	  the	  attachment	  of	  the	  inner	  cell	  mass	  for	  outgrowth	  development.	  Replacing	  gelatin	  with	  laminin	  to	  coat	  the	  plates	  and	  using	  Accutase	  instead	  of	  trypsin	  for	  the	  gentle	  enzymatic	  dissociation	  of	  the	  colonies	  also	  promoted	  the	  attachment	  of	  the	  ESCs.	  However,	  laminin	  was	  only	  used	  in	   the	   initial	   steps	   of	   derivation	   and	   expansion	   of	   early	   passages	   to	   enhance	   the	  development	   of	   colonies.	   The	   above	   modifications	   supported	   the	   attachment	   and	  proliferation	   of	   the	   dissociated	   single	   cells	   as	   tightly	   packed	   round	   compact	   colonies.	  Thus,	   the	   abundance	   of	   LIF	   and	   the	   use	   of	   laminin	   and	  Accutase	   led	   to	   the	   successful	  establishment	  of	  five	  ESC	  lines	  in	  2i	  medium	  and	  the	  efficiency	  was	  improved	  from	  15%	  to	  55%	  (Table	  3).	   I	   also	   tried	   to	  establish	   rat	  ESCs	   from	  a	   single	   round	  of	  breeding	  of	  Lewis	   rat	   strain	  using	   the	  optimized	  protocol	   above.	   Interestingly,	   the	   ICMs	  plated	  on	  feeders	  could	  form	  outgrowths	  but	  failed	  to	  adhere	  to	  the	  feeders	  and	  develop	  colonies	  upon	  dissociation.	  Studies	  on	  mESCs	  have	  shown	  discrepancies	  in	  derivation	  efficiency	  of	   ESCs	   from	   different	   strains.	   Unlike	   129	   strain,	   mESCs	   from	   non-­‐permissive	   and	  recalcitrant	  strains	  like	  CBA	  and	  C57/B6	  can	  be	  successfully	  derived	  only	  by	  inhibition	  of	  MEK/ERK	  in	  addition	  to	  the	  LIF	  suggesting	  an	  intrinsic	  difference	  within	  the	  epiblast	  to	  sustain	  pluripotency	  (Batlle-­‐Morera	  et	  al.,	  2008).	  This	  indicates	  that	  the	  efficiency	  of	  rat	   ESC	   derivation	  may	   be	   strain-­‐dependent	   similar	   to	  mESCs.	   Investigations	   into	   the	  differences	   in	  various	   signaling	  pathways,	  mentioned	   in	   the	   introduction,	  between	   the	  two	   species	   will	   be	   essential	   to	   create	   stabilized	   and	   optimized	   ESC	   establishment	  protocol	  for	  rats.	  
1.2. In	  vitro	  and	  in	  vivo	  characterization	  of	  rat	  ESCs	  Expression	  of	  key	  pluripotency	  genes	  such	  as	  Oct4	  and	  early	  embryonic	  stage	  markers,	  SSEA-­‐1	   and	   alkaline	   phosphatase	   is	   an	   essential	   preliminary	   screening	   tool	   for	  pluripotency.	  All	  the	  ESC	  lines	  were	  positive	  for	  the	  above	  markers	  (Fig.	  9).	  Investigation	  of	  the	  differentiation	  potential	  of	  the	  BN	  ESC	  lines	  confirmed	  their	  ability	  to	  differentiate	  
in	  vitro	  upon	  response	  to	  differentiation	  stimuli	  and	  produce	  teratomas	  in	  vivo	  (Fig.	  10	  &	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Fig.	   11).	  However,	  upon	  differentiation,	  high	  proportion	  of	   cell	   death	  was	  observed	   in	  BN_6.1	  and	  BN_6.2	  ESC	  lines	  with	  quite	  a	  few	  cells	  attached.	  This	  made	  the	  analysis	  with	  immunofluorescence	   staining	   of	   differentiation	   markers	   challenging	   in	   these	   lines.	  These	   differences	   between	   the	   lines	   may	   be	   associated	   with	   the	   inherent	   genetic	  variation	  of	  the	  embryos	  from	  which	  the	  ESCs	  were	  derived.	  
1.3. Generation	  of	  germline-­‐competent	  chimeras	  The	  utmost	  proof	  of	  authenticity	  of	  ESCs	  is	  their	  capacity	  to	  colonise	  host	  embryos	  and	  contribute	   to	   differentiated	   progeny	   of	   the	   three	   germ	   layers	   and	   hence	   produce	  germline-­‐competent	  chimeras.	  Lewis	  rat	  blastocysts	  were	  used	  as	  the	  recipient	  embryos	  for	  injecting	  BN	  ESCs	  and	  Wistar	  females	  were	  taken	  as	  the	  foster	  ones.	  Only	  1	  live	  pup	  showing	  no	  chimerism	  was	  obtained	  from	  the	  blastocyst	  injection	  (Table	  5).	  Generation	  of	   just	   one	   pup	   from	   108	   injections	   performed	   points	   towards	   low	   viability	   of	   the	  embryos	   rather	   than	   the	   authenticity	   of	   ESCs.	   Thus,	   the	   handling	   issues	   related	   to	  blastocyst	  injection	  and	  embryo	  transfer	  technique	  might	  have	  been	  the	  potential	  cause	  for	  the	  failure	  to	  generate	  chimeras.	  	  A	  very	  narrow	  time	  window	  exists	   in	  embryonic	  development	   for	   the	  ES	  cell	   injection	  procedure	   to	   be	   successful	   in	   the	   generation	   of	   chimeric	  mice.	   Therefore,	   harvesting,	  injection,	  and	  surgical	  transfer	  of	  the	  rat	  blastocysts	  are	  all	  performed	  the	  same	  day	  and	  these	   are	   the	   three	   main	   areas	   where	   problems	   can	   be	   encountered.	   Harvesting	   the	  embryos	   and	   surgically	   reimplanting	   them	   depend	   on	   the	   rat	   strain,	   the	   laboratory	  conditions,	  and	  the	  conditions	  in	  the	  animal	  facility.	  The	  latter	  two	  are	  quite	  complex	  to	  resolve.	   As	  mentioned	   earlier,	   Lewis	   rat	  were	   used	   as	   the	   donor	   strain	   for	   blastocyst	  injections.	  Regarding	   the	  embryo	  collection,	   the	  Lewis	  strain	   is	   reported	   to	  have	  small	  litters.	   Thus,	   only	   a	   small	   number	   of	   blastocyst	   stage	   embryos	   are	   obtained	   for	  injections.	  Unlike	  the	  mice,	  the	  superovulation	  protocols	  applied	  do	  not	  work	  very	  well	  with	  the	  rats.	  Hence,	  it	  was	  not	  possible	  to	  superovulate	  the	  rats	  to	  increase	  the	  number	  of	  embryos	  for	  blastocyst	  injection.	  Blastocyst	  injections	  should	  also	  be	  performed	  very	  meticulously	   in	   order	   to	   prevent	   any	   damage	   to	   the	   embryos.	   It	   has	   to	   be	   done	   fast	  enough	  to	  transfer	  the	  embryos	  back	  into	  the	  37°C	  incubator	  to	  improve	  the	  chances	  of	  obtaining	   viable	   and	   healthy	   embryos	   to	   transfer.	   Regarding	   the	   ESCs,	   use	   of	   an	  appropriate	  culture	  medium	  along	  with	  incubation	  at	  the	  right	  temperature	  are	  factors	  required	  to	  optimize	  the	  survival	  of	  ESCs.	  Thus,	  it	  is	  possible	  that	  retaining	  the	  ESCs	  and	  embryos	   at	   RT	   for	   injections	   for	   longer	   periods	   of	   time	   reduced	   the	   viability	   of	   the	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injected	   ones.	   With	   respect	   to	   the	   technique,	   there	   are	   other	   factors	   that	   have	   been	  shown	  to	  affect	  the	  efficiency	  of	  chimera	  generation	  in	  mice	  and	  might	  also	  hold	  true	  for	  rat	  ESCs.	  One	  of	  these	  factors	  is	  the	  activation	  of	  ESCs,	  to	  synchronise	  the	  ESCs	  in	  the	  log	  phase	  of	  growth,	  by	  changing	  the	  ESCs	  culture	  media	  just	  2	  hrs	  before	  the	  injection.	  This	  has	   been	   shown	   to	   increase	   the	   efficiency	   of	   chimera	   generation	  by	   giving	   the	  ESCs	   a	  competitive	   advantage	   over	   the	   endogenous	   blastomeres	   of	   the	   ICM	   (Ramírez	   et	   al.,	  2009).	   Another	   study	   by	   Huang	   et	   al	   (2008),	   suggested	   that	   the	   culture	  media	  might	  produce	  damage	  in	  the	  injected	  ESCs	  that	  could	  result	  in	  a	  leak	  of	  their	  cytoplasm	  into	  the	  host	  embryo	  thereby	  poisoning	  it	  and	  affecting	  the	  viability	  of	  the	  embryos	  (Huang	  et	   al.,	   2008).	   To	   summarise,	   blastocyst	   injection	   and	   embryo	   transfer	   technology	   are	  difficult	  and	  time-­‐consuming	  techniques	  that	  require	  a	  huge	  amount	  of	  practice	  and	  are	  most	  efficient	  when	  performed	  by	  skilled	  injectionist.	  	  In	   general,	   several	   factors	   such	   as	   the	   genetic	   background	   of	   the	   ESCs,	   stemness,	  karyotype,	   pathogen	   status	   of	   the	   ESC	   line	   and	   genetic	   background	   of	   the	   recipient	  embryo	  can	  have	  an	  affect	  on	  the	  ability	  of	  the	  ESCs	  to	  colonize	  host	  embryo	  to	  generate	  chimeras	  and	  to	  exhibit	  competence	   in	   transmitting	  their	  genetic	  material	   through	  the	  germline.	  Various	  groups	  have	  established	  ESCs	  from	  different	  rat	  strains	  namely	  Brown	  Norway	   (BN),	   Wistar	   (WI),	   Dark	   Agouti	   (DA),	   Sprague-­‐Dawley	   (SD)	   and	   Fischer	   344	  (F344)	  strains	  (Zhao	  et	  al.,	  2010)	  (Hirabayashi	  et	  al.,	  2010)	  (Li	  et	  al.,	  2008)	  (Buehr	  et	  al.,	  2008).	  However,	  DA	  ESCs	  are	   the	  only	  germline-­‐competent	  ESCs	  generated	   to	  date.	   In	  parallel	  to	  our	  study,	  Zhao	  et	  al	  had	  published	  a	  study	  showing	  derivation	  of	  ESCs	  from	  BN	   rats	   in	   2010,	   where	   they	   injected	   the	   SD	   blastocysts	   with	   BN	   ESCs	   resulting	   in	  generation	  of	  chimeric	  animals	  which	   failed	   to	  produce	  offsprings	  with	   the	  BN	  genetic	  background	  (Zhao	  et	  al.,	  2010).	  Hence,	  the	  genetic	  background	  of	  the	  ESCs	  used	  in	  this	  study	  can	  be	  another	  factor	  to	  consider.	  Confirming	  expression	  of	  pluripotency	  genes	  as	  well	   as	  maintainance	   of	   normal	   karyotype	   in	  ESCs	   are	   essential	   factors	   to	   consider	   in	  order	   to	   eradicate	   the	   cell	   lines	   that	   may	   negatively	   affect	   their	   germline	  transmissibility.	  Chromosomal	  anomaly	  is	  one	  of	  the	  major	  causes	  for	  failure	  of	  germline	  competence	   in	  mESCs	   (Liu	   et	   al.,	   1997)	   (Suzuki	   et	   al.,	   1997).	   The	   established	   rat	   ESC	  lines	  show	  70%	  normal	  karyotype	  and	  it	  is	  possible	  that	  a	  higher	  rate	  may	  be	  necessary	  in	  the	  BN	  strain	  to	  generate	  chimeras	  and	  demonstrate	  germline	  competency	  in	  rats.	  It	  is	  also	  possible	  that	  the	  injected	  ESCs	  might	  have	  problems	  in	  proliferating	  and	  developing	  into	   various	   organs	  during	   embryogenesis	   due	   to	   the	  undergone	   enzymatic	   treatment	  before	  injections.	  It	  has	  been	  shown	  that	  the	  presence	  of	  virus,	  bacteria	  or	  Mycoplasma	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affects	  germline	  transmission	  in	  mESCs	  (Mahabir	  et	  al.,	  2009)	  (Markoullis	  et	  al.,	  2009).	  However,	  this	  was	  not	  the	  reason	  in	  our	  case.	  Lastly	  and	  most	  importantly,	  the	  genetic	  background	  of	  recipient	  embryos	  hugely	  affects	  the	  generation	  of	  chimeras	  and	  germline	  transmission.	  Relatively	  little	  is	  known	  about	  the	  compatibility	  between	  the	  rat	  ESCs	  and	  the	   host	   blastocyst	   genetic	   background.	   Ideally,	   the	   host	   genetic	   background	   should	  provide	   ESCs	   with	   an	   optimal	   developmental	   advantage	   when	   injected	   into	   the	  blastocysts.	  This	  allows	  the	  ESCs	  to	  contribute	  to	  germline-­‐competent	  chimeras	  (Li	  et	  al.,	  2008)	   (Zhao	   et	   al.,	   2010)	   (Tong	   et	   al.,	   2011).	   Several	   groups	   have	   generated	   rat	   ESC	  germline-­‐competent	  chimeras	  in	  the	  combinations	  DA:	  F344	  (Li	  et	  al.,	  2008),	  WI:	  WI	  and	  DA-­‐WI	  (Hirabayashi	  et	  al.,	  2010),	  WI:	  LEA,	  WI:	  WI,	  LEA:	  WI,	  WI-­‐LEA:	  WI	  (Kawamata	  and	  Ochiya,	  2010),	  SD:	  DA-­‐SD	  (Men	  et	  al.,	  2012)	  and	  DA:	  SD	  (Hong	  et	  al.,	  2012).	  Except	  the	  Li	  
et	   al.	   and	  Hong	  et	   al.,	   all	   the	  other	   studies	  derived	   rat	  ESCs	   from	   transgenic	   rats.	   In	   a	  personal	  communication	  with	  Aron	  Guerts	  group,	  it	  was	  mentioned	  that	  BN	  ESCs	  were	  very	  hard	  to	  contribute	  to	  germline	  competent	  chimeras	  due	  to	   the	   lack	  of	  compatible	  hosts	  to	  the	  BN	  ESCs.	  No	  study	  has	  been	  reported	  to	  date	  where	  Lewis	  blastocysts	  are	  used	  as	   the	  host	  embryos	  and	  we	  were	   the	   first	  ones	   to	   inject	  BN	  ESCs	   into	   the	  Lewis	  donor	   blastocysts.	   As	   mentioned	   earlier,	   the	   compatibility	   of	   the	   ESCs	   and	   the	   host	  embryo	  plays	  a	  huge	  part	  in	  the	  generation	  of	  chimeras	  showing	  germline	  transmission.	  Hence,	  it	  can	  be	  suggested	  that	  the	  host-­‐ESCs	  combination	  used	  was	  not	  ideal.	  Thus,	  our	  BN	   ESCs	   fall	   into	   the	   category	   of	   established	   rat	   ESCs	   that	   have	   not	   shown	   germline	  competency	  to	  date.	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2. Project	   II:	   Elucidating	   the	   molecular	   mechanisms	   regulating	  
transcription	  of	  Pramel7	  in	  mouse	  embryonic	  stem	  cells	  
2.1. Link	  between	  Pramel7	  and	  β-­‐catenin:	  In	  accordance	  with	  the	  recent	  publication	  from	  Lyashenko	  and	  colleagues,	  we	  show	  by	  generation	  of	  β-­‐catenin	  ESCs	  that	  β-­‐catenin	  is	  dispensable	  for	  self-­‐renewal	  of	  ESCs	  and	  show	   no	   alteration	   of	   self-­‐renewal	   markers	   (Lyashenko	   et	   al.,	   2011).	   However,	  contradictory	   to	   Lyashenko	   et	   al	   (2011)	   and	   Wray	   et	   al,	   (2011)	   our	   data	   does	   not	  demonstrate	   that	  β-­‐catenin	  ESCs	  are	  LIF-­‐dependent	   (Lyashenko	  et	  al.,	  2011)	   (Wray	  et	  al.,	  2011).	  This	  can	  be	  due	  to	  the	  different	  protocols	  used	  to	  generate	  and	  propagate	  the	  two	  β-­‐catenin	  deficient	  ESC	   lines.	  The	  β-­‐catenin	  null	  ESC	   lines	  were	  generated	  by	  Cre-­‐mediated	  recombination	  and	  cultured	  in	  serum	  conditions	  in	  Lyashenko	  and	  colleagues	  study	   unlike	   the	   ones	   generated	   in	   our	   studies,	   which	   were	   generated	   by	   breeding	  heterozygous	   β-­‐catenin	  mice	   and	   cultured	   in	   2i+LIF	   conditions.	   A	   study	   by	   Hao	   et	   al	  showed	  that	  expression	  of	  Stat3	  was	  activated	  by	  β-­‐catenin	  (Hao	  et	  al.,	  2006).	  Real-­‐time	  analysis	  showed	  no	  differences	  in	  Stat3	  expression	  between	  the	  β-­‐catenin	  KO	  ESCs	  and	  wild	   type	   (Fig.	   18),	   thus	   it	   is	   not	   required	   for	   Stat3	   transcription.	   However,	   an	  upregulation	   of	   Stat3	   was	   observed	   in	   constitutively	   active	   β-­‐catenin	   S33Y	   ESCs	   in	  accordance	  with	  Hao	  et	  al	  (Hao	  et	  al.,	  2006).	  In	   the	   result	   section,	  we	  observe	   that	  Pramel7	   is	  upregulated	   in	  β-­‐catenin	  KO	  ESCs	   in	  comparison	   to	   the	   WT	   ESCs	   in	   2i+LIF	   conditions	   (Fig.	   18)	   and	   overexpression	   of	  Pramel7	  has	  no	  effect	  on	   transcription	  of	  β-­‐catenin	   (Fig.	  19).	  Thus,	   the	   two	  do	  not	  act	  antagonistically	  to	  each	  other	  and	  β-­‐catenin	  seems	  to	  regulate	  transcription	  of	  Pramel7	  directly	   or	   indirectly	   via	   GSK3β	   as	   inhibition	   of	   GSK3β	   in	  WT	   ESCs	   hinders	   Pramel7	  regulation.	  	  Regulation	   of	   GSK3	   occurs	   via	   multiple	   signalling	   pathways.	   It	   functions	   by	  phosphorylating	   its	   targets	  resulting	   in	   their	   inactivation	  (Doble	  and	  Woodgett,	  2003).	  In	   a	   resting	   cell,	   it	   exists	   in	   a	   constitutively	   active	   form	  and	   is	   negatively	   regulated	   in	  response	   to	   a	   cell	   signal.	   Its	   kinase	   activity	   is	   inhibited	   by	   phosphorylation	   of	   its	   N-­‐terminal	  serine	  residue,	  ser9	  (McManus	  et	  al.,	  2005).	  One	  of	  the	  kinases	  involved	  in	  the	  phosphorylation	  of	  GSK3β	   is	  Akt/PKB	   (Doble	   and	  Woodgett,	   2003).	  Another	  model	   in	  which	   the	   inhibiting	   role	   of	   GSK3β	   is	   blocked	   is	   the	   Wnt	   signalling	   pathway.	   When	  exposed	   to	   the	   Wnt	   ligands,	   β-­‐catenin	   escapes	   the	   phosphorylation	   by	   GSK3β	   and	  translocates	   to	   the	  nucleus.	  Transmission	  of	  Wnt	   signal	  after	  binding	  of	  Wnt	   ligand	   to	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the	   Frizzled	   receptor	   and	   LRP5/6	   requires	   the	   GSK3	   mediated	   phosphorylation	   of	  LRP5/6.	  The	  mechanism	  behind	  this	  process	  is	  poorly	  understood.	  However,	  binding	  of	  GSK3β	   along	   with	   the	   rest	   of	   the	   degradation	   complex	   to	   the	   membrane	   prevents	  degradation	   of	   β-­‐catenin.	   However,	   the	   two	   mechanisms	   regulating	   GSK3β	   work	  independent	   of	   each	   other.	   PKB	   mediated	   inhibition	   of	   GSK3β	   does	   not	   lead	   to	  stabilization	  of	  β-­‐catenin	  and	  active	  Wnt	  signalling	  does	  not	  result	  in	  phosphorylation	  of	  GSK3β	   on	   Ser9	   thus	   does	   not	   decrease	   the	   phosphorylation	   of	   its	   other	   targets	  (McManus	  et	  al.,	  2005)	  (Doble	  et	  al.,	  2007).	  Thus,	  there	  might	  be	  two	  different	  pools	  of	  GSK3β	   for	   the	   above	   signalling	   pathways.	   CH	   is	   a	   specific	   inhibitor	   of	   GSK3β,	   which	  mimics	   the	   effect	   of	   active	   Wnt	   canonical	   signalling.	   But,	   the	   mechanism	   behind	   the	  inhibition	  of	  GSK3β	  by	  CH	  is	  not	  well	  documented.	  It	  has	  been	  shown	  in	  WT	  ESCs	  that	  CH	  reduces	  β-­‐catenin	  phosphorylation	  thus	  promoting	  the	  activity	  of	  β-­‐catenin	  (Ying	  et	  
al	  2008).	  We	  observed	  an	  upregulation	  of	  Pramel7	  in	  β-­‐catenin	  KO	  ESCs	  in	  comparison	  to	   WT	   ESCs	   in	   2i+LIF	   conditions	   and	   downregulation	   of	   it	   when	   the	   clones	   were	  compared.	  Thus,	  expression	  of	  Pramel7	  was	  reduced	  in	  a	  dose	  dependent	  manner	  in	  the	  presence	  of	   constitutively	   active	  β-­‐catenin	   (Fig.	   20).	   It	   can	  be	   said	   that	  presence	  of	  β-­‐catenin	  has	  an	   inhibitory	  effect	  on	  Pramel7	   transcription.	  Further	  experiments	  carried	  out	  on	  the	  N-­‐terminal	  mutants	  showed	  discrepancies	   in	   the	  results	  and	  made	  the	  data	  difficult	   to	   interpret	   (Fig.	   21a).	   C-­‐terminal	  mutant	   shows	   an	   upregulation	   in	   Pramel7	  expression	  (Fig.	  21b).	  This	  suggests	  a	  potential	  role	  of	  the	  C-­‐terminal	  region	  of	  β-­‐catenin	  in	  the	  regulation	  of	  Pramel7.	  Nevertheless,	  this	  observation	  is	  based	  on	  a	  single	  ESC	  line	  carrying	   the	   C-­‐terminal	   mutation,	   which	   hinders	   the	   judgement	   of	   the	   results.	  Generation	  and	  analysis	  of	  higher	  number	  of	  mutant	  ESCs	  might	  help	  to	  overcome	  this	  issue.	   However,	   it	   was	   very	   laborious	   to	   derive	   ESCs	   from	   the	   β-­‐catenin	   mutant	  embryos,	   specifically	   the	   ones	   carrying	   the	   C-­‐terminal	   mutation,	   as	   the	   heterozygous	  pregnant	   females	   usually	   have	   a	   uteri-­‐	   vaginal	   defect.	   Activity	   of	   the	   C-­‐terminus	   is	  essential	  for	  mesoderm	  formation	  (Valenta	  et	  al.,	  2011)	  and	  this	  can	  be	  a	  likely	  reason	  for	  the	  defective	  development	  of	  uterus	  in	  the	  heterozygous	  mice.	  However,	  the	  results	  obtained	  from	  β-­‐catenin	  KO	  ESCs	  pinpoints	  that,	  in	  the	  absence	  of	  β-­‐catenin,	  the	  pool	  of	  free	  GSK3β	  might	  be	  involved	  in	  the	  transcriptional	  regulation	  of	  Pramel7.	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2.2. Link	  between	  GSK3β	  and	  Pramel7	  In	   order	   to	   see	   if	   it	   is	   the	   absence	   of	   β-­‐catenin	   and/or	   presence	   and	   activity	   of	   free	  GSK3β	   which	   is	   regulating	   Pramel7	   transcription,	   we	   monitored	   Pramel7	   expression	  using	   QRT-­‐PCR	   after	   CH+LIF	   and	   LY+LIF	   induction.	   CH	   and	   LY	   are	   small	   molecule	  inhibitors	   of	   GSK3β	   and	   PI3K	   respectively.	   In	   CH+LIF	   conditions,	   independently	   of	  presence	  or	  absence	  of	  β-­‐catenin,	  we	  observe	  a	  downregulation	  of	  Pramel7	  transcription	  (Fig.	  22	  &	  Fig.	  25).	  However,	  stimulation	  of	  β-­‐catenin	  KO	  ESCs	  with	  LY+LIF	  showed	  no	  changes	  in	  transcription	  of	  Pramel7	  (Fig.	  23).	  Reduction	  of	  Pramel7	  after	  24	  hrs	  might	  be	  due	  to	  LY	  toxicity	  (Fig.	  23).	  These	  findings	  pinpoint	  GSK3β	  as	  a	  central	  player	  in	  the	  mechanism	   regulating	   Pramel7	   and	   poses	   new	   questions.	   Inhibition	   of	   GSK3β	   by	   CH	  either	   upregulates	   one	   of	   the	   GSK3β	   targets,	  which	   can	   be	   a	   potential	   transcriptional	  repressor	  of	  Pramel7	  or	  it	  downregulates	  Stat3,	  the	  transcriptional	  activator	  of	  Pramel7.	  However,	  western	  blot	  analysis	  on	  β-­‐cateninKO	  ESCs	  stimulated	  with	  CH+LIF	  showed	  no	  changes	  in	  phosphorylation	  of	  Stat3	  at	  tyrosine	  residue	  in	  comparison	  to	  WT	  ESCs	  (Fig.	  24).	  Thus,	  Pramel7	  regulation	  via	  GSK3β	  is	  independent	  of	  LIF/STAT3	  pathway.	  	  Knockdown	  of	  GSK3β	  using	   siRNA	   resulted	   in	   complete	   abrogation	  of	   transcription	  of	  Pramel7	   (Fig.	   25)	   in	   contrast	   to	   its	   downregulation	   when	   the	   activity	   of	   GSK3β	   was	  inhibited	  by	  CH	  (Fig.	  22	  &	  Fig.	  25).	  Ying	  et	  al	  (2008)	  confirmed	  the	  inhibition	  of	  GSK3β	  by	  CH	  by	  interrogating	  DKO	  ESCs	  lacking	  both	  GSK3α	  and	  GSK3β.	  It	  has	  been	  shown	  that	  DKO	   ESCs	   show	   a	   constitutive	   TOPFLASH	   (Wnt/	   β-­‐catenin	   transcriptional	   reporter)	  activation	  50	   fold	  higher	   than	  CH	  treated	  wild	   type	  ESCs	   (Ying	  et	  al.,	  2008).	  Thus,	   it	   is	  known	  that	  CH	  does	  not	  completely	  inhibit	  GSK3β	  and	  therefore,	  the	  ESCs	  in	  our	  study	  still	   express	   Pramel7	   in	   presence	   of	   CH.	   Expression	   of	   Pramel7	  was	   analysed	   in	   DKO	  ESCs	   to	  replicate	   the	  result	  obtained	  with	  GSK3β	  siRNA	  knockdown.	   Intriguingly,	  DKO	  ESCs	   in	   comparison	   to	   WT	   ESCs	   showed	   an	   upregulation	   of	   Pramel7	   in	   serum+LIF	  conditions	  (Fig.	  29).	  However,	  this	  can	  be	  attributed	  to	  the	  compensatory	  mechanisms	  of	  the	   cell	   to	   maintain	   itself	   pluripotent,	   most	   likely	   through	   regulation	   of	   Pramel7	   by	  LIF/STAT3	  pathway.	  WT	  and	  various	  GSK3β	  mutant	  ESCs	  were	  then	  stimulated	  with	  PD	  only	  to	  simulate	  the	  effect	  of	   absence,	  presence	  of	  GSK3β	  and	  activity	  of	  GSK3β.	  WT	  ESCs	  analysed	   for	   the	  expression	  of	  Pramel7	  in	  presence	  of	  PD	  only	  showed	  an	  upregulation	  of	  Pramel7	  (Fig.	  27).	   Interestingly,	   DKO	   ESCs	   cultured	   in	   the	   same	   conditions	   showed	   5-­‐fold	  downregulation	   of	   Pramel7	   (Fig.	   28b)	   whereas	   the	   DKO_GSK3β	   and	   DKO_K85A	   ESCs	  carrying	  an	  active	  form	  of	  GSK3β	  and	  a	  kinase	  inactive	  GSK3β	  respectively	  showed	  slight	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upregulation	  of	  Pramel7	   (Fig.	   28c	  &	  Fig.	   28d).	   PD	   is	   a	   specific	   inhibitor	  of	  Erk	  kinase,	  which	   inhibits	   the	   phosphorylation	   of	   Erk.	   Erk	   activation	   promotes	   responsiveness	   to	  the	   differentiation	   cues.	   Upregulation	   of	   Pramel7	   by	   inhibition	   of	   Erk	   in	   presence	   of	  GSK3β	   suggests	   the	   existence	   of	   a	   yet	   unidentified	   transcription	   factor	   regulated	   by	  these	   two	   kinases	   together,	   which	   is	   involved	   in	   this	   transcriptional	   circuitry.	   One	  possible	   candidate	   can	  be	  ESR1	   (estrogen	   receptor	   alpha),	  which	  has	  binding	   sites	   on	  Pramel7	   promoter.	   ESR1	   belongs	   to	   a	   group	   of	   estrogen	   receptors	   localized	   in	   both	  cytoplasm	  and	  nucleus.	   It	   is	  a	  DNA	  binding	  transcription	  factor,	  which	  modulates	  gene	  and	   subsequently	  protein	  expression	  by	  activating	  or	   repressing	  gene	   transcription.	   It	  can	   recruit	   and	   bind	   to	   transcriptional	   coactivators	   and	   corepressors	   both	   in	   the	  presence	   and	   absence	   of	   hormone	   (Levin,	   2005).	   ESR1	   is	   activated	   upon	  phosphorylation	   of	   Ser118	   by	   Erk	   and	   GSK3β	   blocks	   its	   transcriptional	   activity	   by	  inhibiting	  phosphorylation	  of	  nuclear	  ESR1	  (Kato	  et	  al.,	  1995).	  Activation	  of	  PI3K/AKT	  pathway	  results	  in	  derepression	  of	  ESR1	  by	  inhibiting	  the	  activity	  of	  GSK3β.	  This	  results	  in	   enhanced	   activity	   of	   ESR1	   (Levin,	   2005).	   Cardona-­‐Gomez	   and	   colleagues	   have	   also	  shown	   that	  ESR1	   forms	  a	   complex	  with	  β-­‐catenin	  and	  GSK3β	   in	   the	  hippocampus	  and	  the	  presence	  of	   the	  estradiol	  results	   in	   the	  release	  of	  β-­‐catenin	   from	  the	  complex	   thus	  promoting	   the	   transcriptional	   activity	   of	   β-­‐catenin	   (Cardona-­‐Gomez	   et	   al.,	   2004).	  However,	  this	  has	  not	  been	  shown	  in	  ESCs.	  One	  potential	  explanation	  to	  our	  finding	  that	  Pramel7	  is	  upregulated	  in	  ESCs	  stimulated	  with	  PD	  only	  is	  that	  inhibition	  of	  Erk	  by	  PD	  and	   presence	   of	   GSK3β	   results	   in	   inactivation	   of	   ESR1,	  which	   can	   hypothetically	   be	   a	  transcriptional	   repressor	   of	   Pramel7.	   Taken	   together,	   the	   above	   findings	   confirm	   the	  importance	  of	  both	  presence	  and	  activity	  of	  GSK3β	   in	   the	   transcriptional	  regulation	  of	  Pramel7.	   Further	   experiments	   need	   to	   be	   performed	   to	   define	   the	   role	   of	   “the	  hypothetical	  transcriptional	  repressor-­‐	  ESR1”	  in	  regulation	  of	  Pramel7.	  Another	  question	  that	  still	  lingers	  is	  whether	  the	  GSK3β	  is	  involved	  in	  STAT3-­‐dependent	  transcription	  of	  Pramel7.	  This	  can	  be	  either	   through	  direct	   interaction	  with	  STAT3	  via	  phosphorylation	  of	  STAT3	  or	  by	  forming	  a	  physical	  complex	  with	  it.	  Studies	  carried	  out	  by	  Beurel	  et	  al	  (2008)	  in	  mouse	  primary	  astrocytes,	  microglia	  and	  macrophages	  derived	  cells	   show	   that	   GSK3β	   is	   required	   for	   the	   recruitment	   of	   STAT3	   to	   the	   receptors	   and	  promotes	   tyrosine	   phosphorylation	   (Beurel	   and	   Jope,	   2008).	   Our	   finding	   from	   the	  western	   blot	   analysis	   on	   DKO	   and	   E14	   ESCs	   do	   not	   show	   any	   changes	   in	   the	  phosphorylation	  of	  Stat3	  thus	  suggesting	  that	  the	  role	  of	  GSK3β	  in	  recruitment	  of	  STAT3	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to	  the	  receptor	  does	  not	  occur	  in	  ESCs.	  There	  is	  no	  physical	  interaction	  between	  the	  two	  proteins	  either	  as	  shown	  in	  Fig.	  31.	  	  Presence	  of	  leucine-­‐rich	  repeat	  domain	  on	  Pramel7	  protein	  suggests	  that	  it	  might	  act	  via	  protein-­‐protein	   interactions.	   However,	   our	   immunoprecipitation	   studies	   do	   not	   show	  any	   physical	   interaction	   between	   GSK3β	   and	   Pramel7.	   Thus,	   the	   possible	   regulatory	  mechanism	  can	  be	  via	  direct	   interaction	  between	  GSK3β	  and	  another	  candidate,	  which	  subsequently	  regulates	  the	  expression	  of	  Pramel7	  (Fig.	  32).	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D.	  Concluding	  Remarks	  and	  Future	  Directions	  
	  Embryonic	   stem	   cells	   were	   first	   established	   in	   1981	   from	   the	   inner	   cell	   mass	   of	   the	  mouse	  blastocyst.	   The	   remarkable	  property	   of	   pluripotency	  possessed	  by	  ESCs	  makes	  them	   a	   promising	   tool	   for	   regenerative	   medicine.	   Elucidating	   how	   these	   cells	   are	  established	   and	   propagated	   still	   remains	   a	   fascinating	   scientific	   challenge.	   A	   deeper	  understanding	  of	  the	  mechanisms	  that	  enable	  self-­‐renewal	  of	  ESCs	  in	  a	  pluripotent	  state	  is	  necessary	  to	  realize	  their	  therapeutic	  potential.	  A	  detailed	  investigation	  will	  harness	  the	   methods	   for	   generating	   ESC	   lines	   and	   finding	   differentiation	   methods	   for	   human	  cells	  suitable	  for	  transplantation.	  	  The	  rat	   is	  a	  widely	  used	  organism	  in	  the	  biomedical	  research.	  Given	  the	   importance	  of	  rat	  in	  physiological	  and	  pharmacological	  studies,	  the	  availability	  of	  authentic	  germline-­‐competent	   ESCs	   offers	   the	   opportunity	   to	   knockin	   or	   knockout	   genes	   of	   choice	   by	  homologous	  recombination	  and	  produce	  genetically	  modified	  rats,	  which	  can	  be	  used	  to	  study	   human	   diseases.	   Understanding	   the	   mechanisms	   regulating	   pluripotency	   in	   rat	  ESCs	   is	   essential	   for	   generating	   transgenic	   rats	   and	   may	   help	   in	   finding	   genetic	  regulators	   that	   play	   an	   important	   role	   in	   both	   rat	   and	   human	   ESCs	   self-­‐renewal	   and	  pluripotency	   processes.	   However,	   it	   is	   clear	   from	   our	   study	   on	   rat	   ESCs	   that	   while	  preliminary	   screening	   of	   established	   ESC	   lines	   for	   pluripotency	   markers,	   normal	  karyotype,	   pathogen-­‐free	   status	   and	   differentiation	   potential	   is	   an	   essential	   quality	  control	   measure	   before	   proceeding	   with	   generation	   of	   chimeras	   to	   prove	   the	  authenticity	  of	  ESCs,	   there	   is	  still	  an	  unknown	  variable	   that	  plays	  an	   important	  role	   in	  determining	  whether	  a	  cell	  line	  is	  capable	  of	  being	  transmitted	  through	  germline.	  Hence,	  it	   would	   be	   of	   great	   importance	   to	   deeper	   understand	   how	   signaling	   mechanisms	  regulate	   ESCs	   self-­‐renewal	   and	   differentiation	   in	  mice	   and	   then	   apply	   the	   knowledge	  gained	   to	   the	   rat	   ESCs.	  Although,	   some	  problems	   remain	   in	   the	   rat	   ESC	   field,	   recently	  devised	  techniques	  using	  zinc	   finger	  nucleases	  and	  transcription	  activator-­‐like	  effector	  nucleases	  can	   target	  genes	   for	  producing	  knockout	  and	  knockin	  rats	   (presented	   in	   the	  chapter	   4	   of	   the	   introduction)	   without	   the	   use	   of	   ESCs.	   Unlike	   the	   ESC-­‐based	   gene	  targeting,	   this	   technology	   fails	   to	   produce	   precise	   modifications	   for	   condition	   and	  inducible	   knockouts	   and	   is	   quite	   expensive.	  Nevertheless,	  multiple	  methods	   are	   being	  devised	   to	   target	   rat	   genes,	   which	   will	   largely	   eliminate	   the	   technical	   obstacles	   that	  prevented	  rat	  from	  being	  a	  genetic	  research	  system.	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Regarding	  detailed	  understanding	  of	  the	  mechanisms	  regulating	  pluripotency	  of	  ESCs,	  it	  has	   been	   considered	   to	   depend	   on	   interaction	   between	   various	   important	  transcriptional	  circuitries,	  among	  which	  the	  most	  prominent	  one	  has	  been	  the	  activation	  of	  Stat3	  through	  cytokine	  LIF.	  However,	  downstream	  targets	  of	  Stat3	  have	  still	  remained	  elusive.	  Recently,	  we	  have	  shown	  that	  Pramel7	  is	  a	  direct	  downstream	  target	  of	  Stat3	  in	  the	   LIF/STAT3	   pathway	   and	   plays	   an	   important	   role	   in	  murine	   ESCs.	   Concerning	   the	  second	  study	  reported	  here,	  experiments	  carried	  out	  on	  mESCs	  derived	  and	  expanded	  in	  2i+LIF	   conditions	   clearly	   provide	   evidence	   for	   a	   potential	   role	   of	   GSK3β	  derepression	  and	   inhibition	   of	   Erk	   independent	   of	   LIF/STAT3	   pathway	   in	   regulation	   of	   Pramel7.	  However,	  Pramel7	  is	  not	  a	  direct	  functional	  target	  of	  GSK3β	  and	  hypothetically	  might	  be	  regulated	  by	  a	  transcription	  factor	  such	  as	  ESR1,	  which	  is	  a	  direct	  downstream	  target	  of	  both	  GSK3β	  and	  Erk.	  Future	  work	  is	  required	  to	  explore	  the	  mutual	  interaction	  between	  GSK3β,	  Erk	  and	  ESR1	  in	  the	  regulation	  of	  Pramel7	  transcription.	  It	  will	  also	  be	  of	  interest	  to	  carry	  out	  perturbation	  studies	  on	  ESR1	  to	  demonstrate	  response	  of	  Pramel7.	  Through	  protein	   interaction	   studies,	   one	   can	   identify	   other	   targets	   of	   GSK3β	   and	   Erk	   that	   can	  modulate	  Pramel7	  expression.	  This	  will	  be	  necessary	  for	  thorough	  understanding	  of	  the	  underlying	  mechanisms	  regulating	  pluripotency	  in	  mouse	  ESCs	  via	  Pramel7.	  As	   it	   is	   known	   that	   Pramel7	   plays	   a	   critical	   role	   in	   maintenance	   of	   pluripotency	   in	  mESCs,	  it	  will	  be	  interesting	  to	  functionally	  characterize	  its	  role	  in	  rat	  ESCs	  and	  examine	  whether	   the	   expression	   of	   Pramel7	   can	   stabilize	   rat	   ESCs	   and	   lead	   to	   successful	  derivation	  of	  germline-­‐competent	  lines	  from	  various	  strains.	  It	  is	  known	  that	  inner	  cell	  mass	   contains	   a	   heterogenous	   population	   of	   loosely	   committed	   cells	   which	   are	  differently	  balanced	  or	  biased	   in	  different	   species	  and	  strains.	  Thus,	   it	  will	  be	  of	  great	  interest	   to	  perform	  gene	  expression	  analysis	   on	  different	   rat	   strains	   for	  Pramel7.	   It	   is	  possible	  that	  robust	  germline	  competent	  strain	  like	  DA	  can	  retains	  its	  pluripotency	  due	  to	  higher	  expression	  of	  Pramel7.	  Lastly,	   it	   is	  not	  surprising	  that	  there	  is	  a	  difference	  in	  the	   preimplantation	   development	   of	   mouse	   and	   rat	   where,	   the	   mouse	   reaches	   the	  blastocyst	   stage	   at	   E3.5	   and	   rat	   at	   E4.5.	   This	   difference	   highlights	   the	   complexity	   of	  molecular	   processes	   maintaining	   pluripotency	   in	   the	   two	   species.	   It	   will	   be	   of	  significance	  to	  compare	  the	  expression	  pattern	  of	  Pramel7	  and	  other	  master	  genes	  both	  
in	   vivo	   and	   in	   vitro	   between	   the	   two	   rodent	   species	   and	   eventually	   get	   closer	   to	  understanding	  mechanisms	   regulating	   self-­‐renewal	   and	   pluripotency.	   This	   knowledge	  would	   promote	   the	   establishment	   of	   truly	   pluripotent	   stable	   ESC	   lines	   from	   species	  other	  than	  the	  mice,	  for	  instance	  the	  rat.	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E.	  Materials	  and	  Methods	  
1. Project	   I:	   Establishment	   of	   pluripotent	   germline	   competent	   rat	  
embryonic	  stem	  cells	  from	  Brown	  Norway	  strain	  
1.1. Reagents	  for	  ESC	  derivation	  M2	  medium	  (Sigma,	  M7167)	  Acid	  tyrode’s	  solution	  (Sigma,	  T1788)	  Anti-­‐rat	  whole	  serum	  (Sigma,	  R5256)	  Rat	  complement	  serum	  (self-­‐made)	  
1.2. Cell	  culture	  reagents	  Media	  and	  Supplements	  N2B27	   	  1:1	  (below	  media)	  Neurobasal	  (Gibco,	  21103-­‐049):	  DMEM:F-­‐12	  (Gibco,	  21331-­‐020)	  Penicillin-­‐Streptomycin-­‐L-­‐Glutamine,	  2mM	  (Gibco,	  25030-­‐024)	  N2,	  1:200	  (Gibco,	  17502-­‐	  048)	  B27,	  1:100	  (Gibco,	  17504-­‐044)	  50mM	  2-­‐mercaptoethanol	  (Gibco,	  21985-­‐023)	  	  2i	   	   	   N2B27	  supplemented	  with:	  PD0325901,	  1μM	  	  CHIR99021,	  3μM	  	  	  Embryoid	  Body	  formation	  Neural	  Differentiation	  	   	   DMEM:	  F-­‐12	  (Gibco,	  21331-­‐020)	  	   	   N2,	  1:100(Gibco,	  17502-­‐	  048)	  B27,	  1:50	  (Gibco,	  17504-­‐044)	  Penicillin-­‐Streptomycin-­‐L-­‐Glutamine,	   2mM	   (Gibco,	  25030-­‐024)	  	  Smooth	  Muscle	  Differentiation	  	   DMEM	  	  	   	   	   	   	   10%	  Fetal	  calf	  serum	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1.3. Cytokines	  and	  Inhibitors:	  Leukemia	  Inhibitory	  factor	  (LIF):	  1000U/ml	  (Millipore,	  ESG1107)	  Inhibitors	   	   PD0325901,	  1μM	  (Stemgent,	  04-­‐0006)	  	  	  CHIR99021,	  3μM	  (Stemgent,	  04-­‐0004)	  
1.4. Other	  tissue	  culture	  reagents	  Gelatin	  (0.1%	  in	  distilled	  water,	  autoclaved)	  Laminin,	  10ug/ml	  (Sigma,	  L2020)	  Accutase	  (1x)	  PBS	  (PAA)	  	  
1.5. Derivation	  of	  ESCs	  lines	  from	  Brown	  Norway	  rats	  Brown	  Norway	  (BN)	  male	  and	   female	  rats	  were	  obtained	   from	  JANVIER	  SAS	  and	  used	  for	  derivation	  of	  rat	  ESC	  lines.	  6	  to	  12	  week	  old	  BN	  females	  were	  checked	  for	  estrus	  by	  using	  estrus	  cycle	  monitor	  EC40	  as	  previously	  described	  (Ramos	  S	  D	  et	  al	  2004).	  Wild	  type	   BN	   males	   were	   mated	   with	   wild	   type	   female	   ones	   for	   24hrs	   and	   then	   housed	  separately.	  Rat	  blastocysts	  at	  E4.5	  days	  post	  coitum	  (dpc)	  were	  collected	  by	  flushing	  the	  uterus	  with	   the	  M2	  medium.	   They	  were	   treated	   briefly	  with	   acid	   tyrode’s	   solution	   to	  remove	  zona	  pellucidae.	  The	  blastocysts	  without	  the	  zonae	  were	  then	  incubated	  with	  at	  37°C	   in	   20%	   anti-­‐rat	   whole	   serum	   for	   3	   hrs.	   Later,	   they	  were	  washed	   in	   N2B27	   and	  incubated	   for	   15-­‐20	   mins	   in	   rat	   serum	   as	   a	   source	   of	   complement.	   The	   lysed	  trophectoderm	  was	  then	  removed	  by	  pipetting	  and	  the	  isolated	  ICMs	  were	  transferred	  to	  a	  48-­‐well	  plate	  containing	  N2B27+2i+LIF	  on	  SNL	  feeders	  at	  37°C	  in	  an	  incubator	  with	  5%	   CO2.	   On	   day	   5,	   outgrowths	   of	   the	   ICMs	   were	   washed	   and	   then	   individually	  dissociated	   into	   single	   cell	   suspension	  using	  Accutase,	   spun	  down	  and	  resuspended	   in	  required	   amount	   of	   N2B27+2i+LIF	   and	   transferred	   to	   a	   24-­‐well	   plate	   containing	   SNL	  feeders.	  ESCs	  were	  passaged	  every	  48-­‐72	  hrs.	  Karyotyping	  of	  rat	  ESCs	  Rat	   ESC	   lines	  were	   cultured	   in	   10cm	   laminin	   coated	   dishes	   for	   48	   hrs	   and	   until	   70%	  confluent.	  The	  cells	  were	  then	  incubated	  in	  0.01mg/ml	  colcemid	  for	  3hrs	  at	  37°C.	  Cells	  were	   then	   washed	   with	   PBS,	   disaggregated	   with	   Accutase	   and	   then	   pelleted	   by	  centrifugation	  at	  1000rpm	  for	  4	  mins.	  After	  removing	  the	  supernatant,	   they	  were	  then	  resuspended	  in	  10ml	  of	  pre-­‐warmed	  hypotonic	  solution	  (0.56%	  KCl)	  and	  incubated	  for	  20	  mins	  in	  water	  bath.	  A	  few	  drops	  of	  freshly	  made	  fixative	  consisting	  of	  methanol	  and	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acetic	  acid	  (3:1	  ratio)	  was	  added	  and	  cells	  were	  centrifuged	  at	  1200rpm	  for	  5	  mins.	  After	  2	  more	  rounds	  of	  fixation	  step	  carried	  out	  by	  resuspending	  the	  cells	  in	  10ml	  of	  fixative,	  the	   pelleted	   ESCs	  were	   resuspended	   in	   2ml	   of	   fixative	   at	   the	   final	   step.	   Chromosome	  spreads	  were	  done	  by	  dropping	  the	  cell	  solution	  on	  the	  slides	   from	  approximately	  1m	  height	  and	  the	  karyotype	  analysis	  was	  performed	  using	  the	  Giemsa	  stain.	  
1.6. In	  vitro	  characterization	  of	  rat	  ESCs	  
1.6.1. Expression	  of	  pluripotency	  factors	  The	  established	  ESC	  lines	  were	  screened	  for	  the	  expression	  of	  pluripotency	  factors,	  Oct4	  and	  SSEA-­‐1,	  by	  immunofluorescence	  staining.	  The	  rat	  ESC	  lines	  were	  cultured	  in	  35mm	  culture	  dishes	  until	  70%	  confluents.	  Cells	  were	  fixed	  in	  4%	  PFA	  for	  15	  minutes,	  blocked	  and	  permeabilized	  in	  PBS,	  0.1%	  Triton	  x100,	  3%	  Horse	  serum.	  Primary	  antibodies	  were	  incubated	  in	  the	  same	  buffer	  overnight	  at	  4°C.	  Secondary	  antibodies	  were	  incubated	  for	  1hr	  at	  RT.	  Plates	  were	  washed	  3	  x	  15mins	  in	  PBS	  after	  primary	  and	  secondary	  antibody	  incubations.	  Nuclei	  were	  stained	  with	  DAPI.	  
1.6.2. Alkaline	  phosphatase	  staining	  Reagents	  -­‐10x	  Alkaline	  Phosphatase	  Buffer	  without	  Mg	  
• 1M	  Tris-­‐HCl	  	  
• 1M	  NaCl	  	  Adjust	  the	  pH	  to	  9.5	  and	  autoclave	  the	  solution	  -­‐1xAP	  Buffer	  with	  MgCl2	  =	  AP	  Buffer	  For	  a	  50ml	  Aliquot:	  5ml	  10x	  AP	  Buffer,	  2.5ml	  1M	  MgCl2,	  42.5ml	  ddH2O	  -­‐Staining	  solution	  
• AP	  buffer	  
• 0.5μl/ml	  NBT	  (nitro-­‐blue	  tetrazolium	  chloride)	  
• 3.5μl/ml	  BCIP	  (5-­‐bromo-­‐4-­‐chloro-­‐3'-­‐indolyphosphate	  p-­‐toluidine	  salt)	  -­‐Tris-­‐EDTA	  
• 20mM	  Tris-­‐HCl	  
• 5mM	  EDTA	  	  
• H2O	  ESCs	   were	   cultured	   on	   35mm	   dishes	   prior	   to	   staining	   for	   Alkaline	   phosphatase.	  Adherent	  rat	  ESCs	  were	  once	  washed	  with	  PBS	  and	  fixed	  in	  4%PFA	  for	  15	  minutes.	  Cells	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were	  then	  washed	  twice	  with	  AP	  buffer	  for	  10	  mins.	  Staining	  solution	  was	  added	  to	  the	  dishes	  and	  these	  dishes	  were	  places	  in	  dark	  for	  30-­‐60	  mins.	  The	  intensity	  of	  the	  staining	  was	  checked	  and	  later,	  the	  reaction	  was	  blocked	  by	  adding	  1ml	  of	  Tris-­‐EDTA.	  The	  plates	  were	  then	  washed	  with	  PBS	  thrice	  for	  10	  mins	  and	  stored	  in	  2ml	  of	  PBS	  at	  4°C.	  
1.6.3. Expression	  of	  differentiation	  markers	  For	   embryoid	   body	   formation,	   1-­‐3	  million	   cells	  were	   plated	   on	   low	   attachment	   10cm	  bacterial	  plates	  with	  embryoid	  body	  medium	  (EB).	  Medium	  was	  changed	  every	  48	  hrs	  for	  the	  next	  10	  days.	  For	  monolayer	  differentiation,	  10-­‐50	  thousand	  rat	  ESCs	  were	  plated	  on	  a	  laminin-­‐coated	  6-­‐well	  dishes	  with	  neural	  or	  smooth	  muscle	  differentiation	  medium.	  They	  were	  cultured	  for	  10	  days.	  Medium	  was	  changed	  every	  24	  hrs	  to	  get	  rid	  of	  dead	  cells.	  They	  were	  then	  fixed	  with	  4%PFA	  and	  stained	  for	  differentiation	  markers.	  	  
Table	  8:	  List	  of	  Antibodies	  I	  	   Antibody	   Dilution	   Source	   Catalogue	  number	  Primary	   Oct3/4	   200	   Santa	  Cruz	  Biotechnology	   SC-­‐9081	  	   SSEA-­‐1	   500	   Santa	  Cruz	  Biotechnology	   SC-­‐101462	  	   β-­‐III	  Tubulin	   500	   Sigma	  Aldrich	   T8660	  	   PAX6	   	   	   	  	   Smooth	  muscle	  actin	   500	   Sigma	  Aldrich	   A2547	  	   β-­‐catenin	   500	   BD	  Transduction	  Laboratories	   610154	  Secondary	   Alexa	  fluor	  goat	  anti-­‐rabbit	  594	   500	   Invitrogen	   A11037	  	   Alexa	  fluor	  goat	  anti-­‐mouse	  488	   500	   Invitrogen	   A11029	  	  
1.7. In	  vivo	  characterization	  of	  rat	  ESCs	  	  
1.7.1. Teratoma	  formation	  1x106	   cells	   were	   injected	   subcutaneously	   into	   each	   dorsal	   flank	   of	   NOD/SCID	   mice.	  Three	   weeks	   after	   injection,	   teratomas	   were	   collected	   and	   fixed	   in	   4%	  paraformaldehyde.	   They	   were	   then	   embedded	   in	   paraffin	   wax,	   sectioned	   and	  immunostained	  for	  β-­‐III	  Tubulin,	  Smooth	  muscle	  actin	  and	  β-­‐catenin.	  
1.7.2. Generation	  of	  chimera	  The	  ESCs	  lines	  were	  used	  for	  generating	  chimeric	  animals	  via	  blastocyst	  injection.	  Lewis	  and	  Wistar	  rats	  were	  used	  as	  the	  donor	  and	  foster	  rats	  respectively	  and	  were	  obtained	  from	  JANVIER	  SAS.	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Prior	   to	   the	   injections,	   ESCs	   were	   cultured	   in	   N2B27+2i+LIF	   for	   atleast	   3	   or	   more	  passages	   to	   ensure	   full	   recovery	   from	   any	   stress	   caused	   in	   the	   process	   of	  cryopreservation.	   On	   the	   day	   of	   injection,	   the	   rat	   ESC	   cells	   were	   dissociated	   using	  Accutase	  and	  the	  centrifuged	  pellet	  was	  resuspended	  in	  N2B27+2i+LIF	  to	  separate	  the	  feeders	   from	   the	   ESCs.	   After	   the	   separation,	   the	   ESCs	   were	   centrifuged	   again	   and	  resuspended	   in	   N2B27+2i+LIF+HEPES	   and	   incubated	   on	   ice.	   Donor	   blastocysts	   were	  collected	  at	  E4.5	  dpc	   from	  pregnant	  Lewis	   females	   that	  were	  mated	  with	  Lewis	  males.	  For	   blastocyst	   injection,	   10-­‐12	   rat	   ESCs	   were	   injected	   into	   single	   blastocysts	   using	   a	  beveled	  Transfertip.	  Injected	  blastocyst	  were	  incubated	  at	  37°C	  for	  atleast	  an	  hour	  and	  then	  approximately	  10-­‐12	  blastocysts	  were	  transferred	  into	  the	  uterine	  horns	  of	  day3.5	  pseudo-­‐pregnant	  Wistar	  female.	  Chimerism	  in	  the	  offsprings	  was	  identified	  by	  coat	  color	  chimerism,	  detected	  by	   the	  presence	  of	  non-­‐agouti	  brown	  hairs	  against	  an	  agouti	   coat	  color	  background.	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2. Project	   II:	   Elucidating	   the	   molecular	   mechanisms	   regulating	  
transcription	  of	  Pramel7	  in	  mouse	  embryonic	  stem	  cells	  
2.1. Cell	  culture	  reagents	  
2.1.1. Cell	  culture	  media	  GMEM	  Complete	  	   Glasgow	  Minimal	  Essential	  Medium	  (Sigma,	  G5154)	  Fetal	  Calf	  Serum	  (10%)	  Non-­‐essential	  amino	  acids	  (Gibco,	  11140-­‐035)	  L-­‐Glutamine,	  2mM	  (Gibco,	  25030-­‐024)	  Sodium	  Pyruvate,	  1mM	  (Gibco,	  11360-­‐039)	  50mM	  2-­‐mercaptoethanol	  (Gibco,	  21985-­‐023)	  LIF	  (1000U/ml)	  	  N2B27	   	  1:1	  (below	  media)	  Neurobasal	  (Gibco,	  21103-­‐049):	  DMEM:F-­‐12	  (Gibco,	  21331-­‐020)	  Penicillin-­‐Streptomycin-­‐L-­‐Glutamine,	  2mM	  (Gibco,	  25030-­‐024)	  N2,	  1:200	  (Gibco,	  17502-­‐	  048)	  B27,	  1:100	  (Gibco,	  17504-­‐044)	  50mM	  2-­‐mercaptoethanol	  (Gibco,	  21985-­‐023)	  	  2i	   	   	   N2B27	  supplemented	  with:	  PD0325901,	  1μM	  (Stemgent,	  04-­‐0006)	  CHIR99021,	  3μM	  (Stemgent,	  04-­‐0004)	  	  EB	  formation	  	   Glasgow	  Minimal	  Essential	  Medium	  (GMEM)	  Fetal	  Calf	  Serum	  (10%)	  50mM	  2-­‐mercaptoethanol	  (Gibco,	  21985-­‐023)	  Non-­‐essential	  amino	  acids	  (Gibco,	  11140-­‐035)	  Penicillin-­‐Streptomycin-­‐L-­‐Glutamine,	  2mM	  (Gibco,	  25030-­‐024)	  Sodium	  Pyruvate,	  1mM	  (Gibco,	  11360-­‐039)	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Neural	  Differentiation	  	   	   DMEM:	  F-­‐12	  (Gibco,	  21331-­‐020)	  	   	   N2,	  1:100(Gibco,	  17502-­‐	  048)	  B27,	  1:50	  (Gibco,	  17504-­‐044)	  Penicillin-­‐Streptomycin-­‐L-­‐Glutamine,	   2mM	   (Gibco,	  25030-­‐024)	  	  Smooth	  Muscle	  Differentiation	  	   DMEM	  (PAA,	  E15-­‐810)	  	   	   	   	   	   10%	  Fetal	  calf	  serum	  	  Cytokines	  and	  Inhibitors:	  Leukemia	  Inhibitory	  factor	  (LIF):	  1000U/ml	  (Millipore,	  ESG1107)	  Inhibitors	   	   	   PD0325901,	  1μM	  (Stemgent,	  04-­‐0006)	  	  	  CHIR99021,	  3μM	  (Stemgent,	  04-­‐0004)	  LY294002,	  5μM	  
2.1.2. Other	  tissue	  culture	  reagents	  	  Antibiotics	   Puromycin	  (Sigma,	  P9620)	  Hygrogold	  B	  (Invivogen,	  ):	  150μg/ml,	  100μg/ml	  serum-­‐free	  Geniticin	  (Invitrogen,	  ):	  1mg/ml	  serum	  free	  Gelatin	  (0.1%	  in	  distilled	  water,	  autoclaved)	  Trypsin_EDTA	  (1x)	  PBS	  (PAA)	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2.1.3. Embryonic	  Stem	  Cell	  lines	  
• β-­‐catenin	  knockout	  
• β-­‐catenin	  N-­‐terminal	  mutant	  (D164A)	  
• β-­‐catenin	  C-­‐terminal	  mutant	  (delta	  C)	  
• Wild	  type	  	  Heterozygous	  mice	  obtained	  from	  Prof.	  Basler’s	  Laboratory.	  Mouse	  ESCs	  derived	  and	  cultured	  in	  house	  in	  N2B27+2I+LIF	  	  
• Wild	  type	  	  	  
• STAT3	  knockout	  	  mES	   cells	   derived	   from	   129	   mice	   cultured	   in	   N2B27+2I+LIF	   obtained	   from	   Prof.	  Austin	  Smith’s	  laboratory	  	  
• GSK3	   double	   knockout	   DKO:	   ES	   cells	  with	   targeted	   knockout	   of	   both	   alleles	   of	  
Gsk3-­‐α	  and	  –β.	  	  
• DKO_GKS3β:	  DKO	  ES	  cells	  targeted	  with	  knock-­‐in	  of	  wild	  type	  GKS3β.	  Cultured	  in	  ES	  medium	  with	  hygrogold	  and	  LIF	  
• DKO_K85A:	   DKO	   ES	   cells	   targeted	   with	   knock-­‐in	   of	   kinase	   inactive	   GKS3β.	  Cultured	  in	  ES	  medium	  with	  hygrogold	  and	  LIF	  Obtained	  from	  Bradley	  Doble	  (Kelly	  et	  al.,	  2011)	  	  
• WT_S33Y	  	  Wild	   type	   ESCs	  with	   129	   background	   stably	   expressing	   constitutively	   active	   β-­‐catenin	   due	   to	   single	   point	   mutation	   in	   the	   phosphorylation	   site	   and	   carrying	  neomycin	  resistance.	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2.2. Cell	  culture	  
2.2.1. Tissue	  culture	  routine	  All	  cell	  lines	  were	  maintained	  in	  37C,	  humidified	  incubators	  maintained	  at	  5%	  CO2.	  	  
2.2.2. Generation	  and	  derivation	  of	  mouse	  ESCs	  E2.5	  embryos	  were	  isolated	  from	  intercrossing	  heterozygous	  mice	  for	  the	  mutants.	  They	  were	   then	   incubated	   in	   KSOM+2I	   for	   a	   day	   after	   which	   they	   were	   transferred	   to	  N2B27+2I	  for	  two	  days.	  At	  E4.5,	  most	  embryos	  had	  hatched	  from	  the	  zona	  pellucida	  (ZP)	  and	   the	   ones	   with	   intact	   ZP	   were	   treated	   with	   Acid	   tyrode	   solution	   to	   get	   rid	   of	   it.	  Embryos	   were	   then	   incubated	   with	   10%	   anti-­‐mouse	   serum	   for	   a	   few	   hours	   before	  washing	  them	  in	  N2B27	  and	  transferring	  them	  to	  10%	  complement	  sera	  (rat	  serum)	  for	  10-­‐15	  mins	  to	  lyse	  the	  trophectoderm	  cells.	  The	  embryos	  were	  transferred	  to	  N2B27	  for	  an	   hour	   and	   the	   trophectoderm	   was	   later	   separated	   from	   inner	   cell	   mass	   (ICM)	   by	  mouth-­‐pipetting	   for	   each	   embryo.	   The	   cleaned	   ICM	   was	   then	   transferred	   to	   gelatin	  coated	  48-­‐well	  dish	  to	  grow	  for	  4-­‐5	  days	  in	  N2B27+2I+LIF.	  After	  4-­‐5	  days,	  the	  ICM	  was	  dissociated	  using	  0.5%	  Trypsin-­‐EDTA	  and	  the	  cells	  were	  plated	  on	  a	  new	  gelatin	  coated	  48-­‐well	  dish.	  After	  establishment	  of	  mESCs,	  routine	  serum-­‐free	  culture	  was	  performed	  using	   N2B27	   supplemented	  with	   2I	   and	   LIF.	  Media	  was	   changed	   every	   two	   days	   and	  cells	   were	   passaged	   when	   approaching	   confluency.	   To	   passage,	   cells	   were	   washed	   in	  phosphate	  buffered	  saline	  (PBS),	  incubated	  with	  0.5	  x	  trypsin-­‐EDTA	  for	  approximately	  3	  minutes	   or	   until	   cells	   detached,	   resuspended	   in	   5-­‐10	   trypsin	   volumes	   of	   media,	  harvested	  by	  centrifugation	  (1000rpm,	  4mins)	  and	  replated	  at	  the	  required	  density.	  
2.2.3. In	  vitro	  differentiation	  of	  mESCs	  	  For	   embryoid	   body	   differentiation,	   1-­‐3	   million	   mESCs	   were	   plated	   on	   10cm	   low-­‐attachment	  bacterial	  plates	  and	  cultured	  in	  EB	  medium	  for	  10	  days.	  Media	  was	  changed	  daily.	  EBs	  were	  washed,	   centrifuged	  and	  collected	  after	  10	  days	   in	  RLT	  buffer	  with	  2-­‐mercaptoethanol	   for	   RNA	   extraction	   and	   real-­‐time	   PCR	   analysis.	   For	   monolayer	  differentiation,	   10-­‐50	   thousand	   ESCs	   were	   plated	   on	   gelatin	   coated	   6-­‐well	   dish	   and	  cultured	  with	  either	  neural	  or	  smooth	  muscle	  differentiation	  media	  for	  10	  days.	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2.3. Manipulation	  of	  Cells	  
2.3.1. Stable	  transfection-­‐	  Electroporation	  In	   order	   to	   stably	   integrate	   transgene	   into	   mESCs,	   8μg	   of	   β-­‐catenin	   S33Y	   plasmid	  encoding	   the	   single	   point	   mutation	   in	   β-­‐catenin	   was	   linearized	   by	   restriction	   digest	  (enzyme	  Ssp1),	  purified	  by	  DNA	  purification	  kit	  and	  electroporated	  into	  cells.	  5	  million	  cells	  per	  transfection	  were	  harvested	  by	  trypsinisation,	  washed	  in	  PBS,	  resuspended	  in	  800μL	   PBS	   and	   placed	   in	   an	   electroporation	   cuvette	   (Biorad,	   165-­‐2081EDU).	   10μg	  linearized	   DNA	  was	   added	   to	   the	   cuvette.	   Cells	   were	   then	   electroporated	   (Cap	   3.0μF,	  0.8kV)	   and	   transferred	   to	   9.2ml	   pre-­‐warmed	  N2B27+2I+LIF	  medium.	   Cells	  were	   then	  plated	   in	   gelatinized	   6cm	   tissue-­‐culture	   dishes	   at	   2	   million	   cells	   per	   dish	   in	  N2B27+2I+LIF.	  24	  hours	  later	  the	  appropriate	  selective	  drug,	  neomycin	  was	  added.	  Cells	  were	  cultured	  for	  a	  further	  9-­‐11	  days,	  changing	  media	  every	  2	  days.	  Once	  colonies	  had	  reached	   a	   suitable	   size,	   isolated	   colonies	   were	   ‘picked’	   and	   transferred	   to	   gelatine-­‐coated	  96-­‐well	   tissue	  culture	  plates.	  This	  was	  considered	  passage	  1	   for	  newly-­‐derived	  transgenic	   lines.	   Lines	  were	   expanded	   by	   passaging	   to	  multi-­‐well	   plates	   of	   increasing	  well	  size	  until	  sufficient	  cells	  were	  obtained	  to	  freeze	  down,	  typically	  a	  6-­‐well	  plate.	  	  
2.3.2. Transient	  transfection	  –	  Lipofection	  for	  siRNA	  knockdown	  for	  GSK3β	  siRNAs	  were	  transfected	  at	  a	  final	  concentration	  of	  20	  nM	  using	  Lipofectamine	  RNAiMax	  (Invitrogen)	   according	   to	   the	  manufacturer’s	   instructions.	   Embryonic	   stem	   cells	  were	  transfected	   and	   maintained	   in	   2i	   +	   LIF	   for	   a	   further	   48h.	   Gsk3α,	   Gsk3β	   and	   control	  siRNAs	  were	  obtained	  from	  Qiagen	  (GS606496,	  GS56637	  and	  SI03650325,	  respectively).	  
2.4. Molecular	  Biology	  
2.4.1. DNA	  extraction	  and	  genotyping	  for	  mESCs	  mESCs	  pellets	  were	  collected	  and	  digested	  with	  50μl	  of	  DNA	   lysis	  buffer	   (100mM	  Tris	  HCl,	  ph	  7.5;	  5mM	  EDTA;	  100mM	  NaCl;	  0.2%	  SDS;	  1mg/ml	  proteinase	  K	  added	  just	  before	  use)	  at	  55C	  overnight.	  The	  samples	  were	  then	  heat	  inactivated	  at	  95C	  for	  15	  minutes	  and	  stored	  at	  -­‐20C	  for	  long	  -­‐term	  storage.	  To	  test	  for	  the	  presence	  of	  wild	  type	  and	  mutant	  alleles	   in	   the	   ESCs	   derived,	   genomic	   PCR	  was	   carried	   out.	   The	   PCR	  mix,	   primers	   and	  program	  are	  given	  below.	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PCR	  mix:	  Genomic	  DNA	   2μL	  10x	  Buffer	   	   2μL	  Q	  solution	   	   4	  μL	  MgCl2	  	   	   0.8	  μL	  Primers	  (10μM)	   1μL	  each	  dNTPs	  (10mM)	   0.5μL	   	  Taq	  polymerase	   0.5μL	  dH2O	   	   	   8.2μL	  	  PCR	  conditions	  for	  β-­‐catenin	  KO	  ESCs	  95C-­‐	  2’	  35	  cycles	  95C-­‐	  30”	  56C-­‐	  40”	  72C-­‐	  55”	  72C-­‐	  5’	  4C-­‐	  ∞	 
	 Primers	  for	  β-­‐catenin	  KO	  and	  WT	  genotypes	  RM41,	  RM42	  and	  RM43	  (Brault	  et	  al.,	  2001)	  	  PCR	  condition	  for	  β-­‐catenin	  D164A	  and	  DC	  mutants	  95C-­‐	  2’	  35	  cycles	  95C-­‐	  30”	  58C-­‐	  40”	  72C-­‐	  55”	  72C-­‐	  5’	  4C-­‐	  ∞	 	  Primers	  for	  D164A	  and	  Δ	  C	  mutant	  D164A:	  5301.1	  and	  5301.2	  (Valenta	  et	  al.,	  2011)	  	  DC:	  5301.3	  and	  5301.4	  (Valenta	  et	  al.,	  2011)	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2.4.2. Immunofluroscence	  Cells	   were	   fixed	   in	   4%	   PFA	   for	   15	   minutes,	   blocked	   and	   permeablised	   in	   PBS,	   0.1%	  Triton	  x100,	  3%	  Horse	  Serum,	  1%	  BSA.	  Primary	  antibodies	  were	  incubated	  in	  the	  same	  buffer	  overnight	  at	  4C.	  Secondary	  antibodies	  were	  incubated	  for	  1hr	  at	  RT.	  Plates	  were	  washed	   3	   x	   15mins	   in	   PBS	   after	   primary	   and	   secondary	   antibody	   incubations.	   Nuclei	  were	  stained	  with	  DAPI.	  The	  table	  below	  lists	  the	  different	  antibodies	  used.	  
	  
Table	  9:	  List	  of	  Antibodies	  for	  immunofluorescence	  	   Antibody	   Dilution	   Source	   Catalogue	  number	  Primary	   Oct3/4	   200	   Santa	  Cruz	  Biotechnology	   SC-­‐9081	  SSEA-­‐1	   500	   Santa	  Cruz	  Biotechnology	   SC-­‐101462	  β-­‐III	  Tubulin	   500	   Sigma	  Aldrich	   T8660	  Smooth	  muscle	  actin	   500	   Sigma	  Aldrich	   A2547	  Secondary	   Alexa	  fluor	  goat	  anti-­‐rabbit	  594	   500	   Invitrogen	   A11037	  Alexa	  fluor	  goat	  anti-­‐mouse	  488	   500	   Invitrogen	   A11029	  	  
2.4.3. RNA	  extraction	  2-­‐3	  million	   cells	  were	   harvested	   by	   trypsinisation,	  washed	   in	   PBS	   and	   lysed	   in	   buffer	  RLT	   (Qiagen	   RNeasy	   kit).	   Lysates	   were	   stored	   at	   -­‐80C	   or	   used	   directly	   for	   RNA	  extraction.	   Lysates	   were	   homogenized	   by	   spinning	   through	   a	   Qiashredder	   (Qiagen,	  79654)	  and	  subjected	  to	  RNA	  extraction	  using	  the	  RNeasy	  Kit	  (Qiagen,	  74104)	  according	  to	   the	  manufacturers	   protocol	   and	   incorporating	   an	   on-­‐column	  DNase	   digest	   (Qiagen,	  79254)	   to	   remove	   genomic	   DNA.	   Eluted	   RNA	   concentration	   was	   determined	   by	   OD	  measurement	   using	   Nanodrop	   1000	   spectrometer.	   Resuspended	   RNA	  was	   stored	   at	   -­‐80C.	  
2.4.4. cDNA	  synthesis	  cDNA	   was	   synthesized	   using	   the	   Invitrogen	   Superscript	   III	   First-­‐Strand	   Synthesis	   Kit	  (Invitrogen,	   11752050)	   according	   to	   the	   manufacturer’s	   protocol	   using	   oligo-­‐dT	  primers.	  0.5-­‐1μg	  RNA	  was	  used	  as	  template.	  cDNA	  was	  diluted	  1:10	  in	  sterile	  water	  and	  used	  for	  qRT-­‐PCR.	  
2.4.5. qRT-­‐PCR	  Real-­‐time	  quantitative	  PCR	  was	  performed	  using	  the	  Applied	  Biosystems	  machine.	  Sybr	  Green	   based	   qRT-­‐PCR	   was	   performed.	   Reactions	   were	   performed	   in	   10μL	   reaction	  volumes	   using	   the	   Sybr	   Green	   Master	   Mix	   (Qiagen,	   )	   in	   triplicates.	   Values	   were	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calculated	  using	  the	  comparative	  threshold	  cycle	  (ΔCt)	  method.	  See	  the	  table	  below	  for	  the	  primers	  used.	  	  Master	  mix	  per	  reaction:	  cDNA:	  	   	   	   2μl	  Sybr	  green	  Master	  mix:	   5μl	  Primer	  (10μM):	   	   0.5μl	  PCR	  grade	  water:	   	   2μl	  	  
Table	  10:	  Sybr	  Green	  Real-­‐Time	  PCR	  primers	  Gene	   Forward	  primer	   Reverse	  primer	  Oct3/4	   5’-­‐ggc	  gtt	  cgc	  ttt	  gga	  aag	  gtg	  ttc	  -­‐3’	   5’-­‐ctc	  gaa	  cca	  cat	  cct	  tct	  ct	  -­‐3’	  Nanog	   5'-­‐aca	  agg	  gtc	  tgc	  tac	  tga	  gat	  gc-­‐3'	   5'-­‐gga	  gac	  ttc	  ttg	  cat	  ctg	  ctg	  g-­‐3'	  Rex1	   5'-­‐aga	  aag	  cag	  gat	  cgc	  ctc	  ac-­‐3'	   5'-­‐agg	  gaa	  ctc	  gct	  tcc	  aga	  ac-­‐3'	  Pramel7	   5'-­‐gag	  gag	  aag	  cag	  aac	  atc	  agc	  aag	  a-­‐3'	   5'-­‐ctc	  tta	  gag	  gcg	  tga	  cat	  cta	  ggt	  t-­‐3'	  STAT3	   5'-­‐ggc	  aag	  ggc	  ttc	  tcc	  ttc	  tg-­‐3'	   5'-­‐agc	  tgc	  tgc	  ttg	  ttg	  gtg	  tat	  gg-­‐3'	  Axin2	   5’-­‐ggg	  gga	  aaa	  cac	  agc	  tta	  ca-­‐3’	   5’-­‐act	  ggg	  tcg	  ctt	  ttg	  aa-­‐	  3’	  CyclinD1	   5’-­‐gcc	  atc	  caa	  act	  gag	  gaa	  aa-­‐3’	   5’-­‐tca	  cct	  ctt	  ccc	  tca	  cat	  cc-­‐3’	  Β-­‐catenin	   5’-­‐gtg	  caa	  ttc	  ctg	  agc	  tga	  ca-­‐	  3’	   5’-­‐ctt	  aaa	  gat	  ggc	  cag	  caa	  gc-­‐3’	  FGF5	   5'-­‐aaa	  gtc	  aat	  ggc	  tcc	  cac	  gaa-­‐3'	   5'-­‐ctt	  cag	  tct	  gta	  ctt	  cac	  tgg-­‐3'	  Sox9	   5’-­‐aca	  cac	  ttt	  cgt	  gga	  ggc	  gta	  ga-­‐3’	   5’-­‐	  acc	  agg	  ggc	  cac	  tgt	  cag	  atg	  t	  -­‐3’	  GATA4	   5’-­‐gcc	  tgt	  atg	  taa	  tgc	  ctg	  cg-­‐	  3’	   5’-­‐ccg	  agc	  agg	  aat	  ttg	  aag	  agg	  -­‐3’	  T-­‐brachyury	   5'-­‐atg	  cca	  aag	  aaa	  gaa	  acg	  ac-­‐3'	   5'-­‐aga	  ggc	  tgt	  aga	  aca	  tga	  tt-­‐3'	  GSK3β	   5’-­‐tcc	  att	  cct	  ttg	  gaa	  tct	  gc	  -­‐3’	   5’-­‐caa	  ttc	  agc	  caa	  cac	  aca	  cag	  c	  -­‐3’	  β-­‐actin	   5'-­‐cat	  cca	  ggc	  tgt	  gct	  gtc	  cct	  gta	  tgc-­‐3'	   5'-­‐gat	  ctt	  cat	  ggt	  gct	  agg	  agc	  cag	  agc-­‐3'	  	  
2.4.6. Western	  blot	  analysis	  Cultured	  mESCs	  were	   scraped	  and	   resuspended	   in	  200μl	  of	  RIPA	  buffer	   (containing-­‐-­‐-­‐	  Protease	  inhibitors	  was	  added	  freshly	  before	  use.)	  Samples	  were	  then	  centrifuged	  for	  3	  minutes	  at	  full	  speed	  at	  4C.	  The	  supernatant	  was	  transferred	  to	  a	  new	  tube	  and	  protein	  concentration	  was	  determined	  using	  the	  BCA	  protein	  assay	  kit.	  10μg	  of	  protein	  extract	  was	  used	   for	  Western	  blot	   analysis.	   Samples	  were	   subjected	   to	   SDS-­‐PAGE	  and	  blotted	  onto	   PVDF	   membrane	   (Millipore,	   Volketswil,	   Switzerland)	   at	   100	   V	   for	   1.5h	   at	   4°C.	  Immunodetection	   and	   chemiluminescent	   visualization	   were	   performed	   as	  recommended	  by	  the	  supplier	  of	  the	  chemiluminescence	  blotting	  kit	  (Roche	  Diagnostics,	  Rotkreuz,	  Switzerland).	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2.4.7. Immunoprecipitation	  mES	  cells	  were	  grown	  in	  10cm	  dishes	  in	  the	  appropriate	  conditions.	  Cells	  were	  washed	  once	   in	   cold	   PBS.	   Lysates	   were	   collected	   by	   scraping	   the	   plates	   with	   a	   cell	   scraper	  (Greiner)	  and	  pippeting	  the	  lysate	  into	  1.5ml	  eppendorfs	  on	  ice.	  They	  were	  then	  either	  stored	  at	  -­‐80C	  or	  processed	  through	  sonication	  and	  then	  frozen	  with	  liquid	  N2.	  25μL	  Flag	  or	  HA	  bead	   slurry	  per	   sample	  was	  placed	   in	  1.5ml	  eppendorfs,	   centrifuged,	  supernatant	  removed	  and	  beads	  washed	  in	  1ml	  PBS	  2-­‐3	  times	  and	  then	  with	  NE	  buffer.	  50ul	  of	  sample	  was	  removed	  as	  an	  input	  sample.	  Bradford	  assay	  was	  carried	  to	  measure	  the	   protein	   lysate	   concentration	   and	   1mg	   of	   it	   was	   added	   to	   the	   beads	   containing	  antibody.	  The	  tubes	  were	  tumbled	  overnight	  at	  4C,	  beads	  pulled	  down	  by	  centrifugation,	  supernatant	  removed	  and	  beads	  washed	  in	  1ml	  cold	  NE	  buffer	  3	  times.	  On	  the	  last	  wash,	  all	  supernatant	  was	  removed,	  14μL	  of	  sample	  buffer	  and	  reducing	  agent	  mix	  added	  and	  samples	  boiled	  for	  5mins.	  Lysates	  can	  be	  stored	  at	  -­‐20C	  or	  used	  directly	  for	  Western	  blot	  analysis.	  See	  table	  4	  for	  details	  of	  antibodies	  and	  concentration.	  	  
Table	  11:	  List	  of	  Antibodies	  and	  concentration	  for	  Western	  Blot	  and	  Immunoprecipitation	  	   Antibody	   Dilution	   Source	   Catalogue	  number	  Primary	   β	  -­‐catenin	   5000	   BD	  transduction	  laboratories	   610154	  Anti-­‐GSK3α/β	   1000	   Invitrogen	   44610	  Total	  GSK3	   1000	   Cell	  signalling	  technology	   5676P	  Phospho	  STAT3	  (Y705)	   1000	   Cell	  signalling	  technology	   9131S	  Phospho	  STAT3	  (S727)	   1000	   Cell	  signalling	  technology	   9134S	  Total	  STAT3	   2000	   Santa	  Cruz	  Biotechnology	   SC482	  (C-­‐20)	  Anti-­‐tubulin	   10000	   Sigma	  Aldrich	   T9026	  Anti-­‐Flag	   	   	   	  Secondary	   Goat	  anti-­‐rabbit	  HRP	   2000-­‐5000	   Santa	  Cruz	  Biotechnology	   SC2030	  Goat	  anti-­‐mouse	  HRP	   2000-­‐5000	   Santa	  Cruz	  Biotechnology	   SC2031	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